業績（論文）

Index

英文原著

全て開く

2022年

Kono K, Igaki M, Nomura T, Mori K, Hiraki K, Hayashi H, Kawabe N, Mizoguchi K, Fujimoto S, Tamura Y: Physical function of outpatients and inpatients on dialysis who received physical therapy: an exploratory, crosssectional study by JSPTDM. Journal of allied health sciences 13(1):10-15, 2022
Kurozumi A, Okada Y, Mita T, Wakasugi S, Katakami N, Yoshii H, Kanda K, Nishida K, Mine S, Tanaka Y, Gosho M, Shimomura I, Watada H: Associations between continuous glucose monitoring-derived metrics and HbA1c in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 186:109836, 2022
Andica C, Kamagata K, Uchida W, Takabayashi K, Shimoji K, Kaga H, Someya Y, Tamura Y, Kawamori R, Watada H, Hori M, Aoki S: White matter fiber-specific degeneration in older adults with metabolic syndrome. Mol Metab 62:101527, 2022
Malik A O, Chen H, Tang F, Chan P S, Cooper A, Gomes M B, Hejjaji V, Ji L, Khunti K, Kosiborod M, Nicolucci A, Peri-Okonny P A, Shestakova M V, Vora J, Watada H, Arnold S V: Association of country economy and socioeconomic factors on risk factor control for primary prevention of cardiovascular disease in patients with diabetes mellitus: Insights from the DISCOVER Study. Indian Heart J, 2022
Kadowaki T, Maegawa H, Watada H, Yabe D, Node K, Murohara T, Wada J: Interconnection between cardiovascular, renal, and metabolic disorders: a narrative review with a focus on Japan. Diabetes Obes Metab, 2022
Tanaka A, Imai T, Shimabukuro M, Taguchi I, Sezai A, Toyoda S, Watada H, Ako J, Node K: Association between serum insulin levels and heart failure-related parameters in patients with type 2 diabetes and heart failure treated with canagliflozin: a post-hoc analysis of the randomized CANDLE trial. Cardiovasc Diabetol 21(1):151, 2022
Mita T, Katakami N, Takahara M, Kawashima M, Wada F, Akiyama H, Morita N, Kidani Y, Yajima T, Shimomura I, Watada H: Changes in Treatment Satisfaction Over 3 Years in Patients With Type 2 Diabetes After Initiating Second-line Treatment. J Clin Endocrinol Metab 107(9):2424-2432, 2022
Nishida Y, Mita T, Hiki M, Matsushita Y, Naito T, Watada H: Retrospective Study on the Effects of Glucose Abnormality on COVID-19 Outcomes in Japan. Diabetes Ther 13(2):325-339, 2022
Takahara M, Mita T, Katakami N, Wada F, Morita N, Kidani Y, Yajima T, Shimomura I, Watada H: Three-Year Glycaemic Control and Management in Patients with Type 2 Diabetes Initiating Second-Line Treatment in Japan: A Prospective Observational Study, J-DISCOVER. Diabetes Ther 13(2):251-264, 2022
Katakami N, Mita T, Maeda N, Sato Y, Watada H, Shimomura I: Evaluation of the effect of tofogliflozin on the tissue characteristics of the carotid wall-a sub-analysis of the UTOPIA trial. Cardiovasc Diabetol 21(1):19, 2022
Kadowaki T, Inagaki N, Watada H, Sasaki K, Mori-Anai K, Iwasaki T, Teranishi T: Real-World Evidence of Treatment with Teneligliptin/Canagliflozin Combination Tablets for Type 2 Diabetes Mellitus: A Post-Marketing Surveillance in Japan. Adv Ther 39(4):1642-1658, 2022
Uemura F, Okada Y, Mita T, Torimoto K, Wakasugi S, Katakami N, Yoshii H, Matsushita K, Nishida K, Inokuchi N, Tanaka Y, Gosho M, Shimomura I, Watada H: Risk Factor Analysis for Type 2 Diabetes Patients About Hypoglycemia Using Continuous Glucose Monitoring: Results from a Prospective Observational Study. Diabetes Technol Ther 24(6):435-445, 2022
Takamura K, Fujimoto S, Mita T, Kawaguchi Y O, Kurita M, Kadowaki S, Kamo Y, Aoshima C, Nozaki Y O, Takahashi D, Kudo A, Hiki M, Tomizawa N, Ikeda F, Satoh H, Watada H, Minamino T: Identification of Risk Factors for Coronary Artery Disease in Asymptomatic Patients with Type 2 Diabetes Mellitus. J Clin Med 11(5), 2022
Arnold S V, Khunti K, Tang F, Chen H, Cid-Ruzafa J, Cooper A, Fenici P, Gomes M B, Hammar N, Ji L, Saraiva G L, Medina J, Nicolucci A, Ramirez L, Rathmann W, Shestakova M V, Shimomura I, Surmont F, Vora J, Watada H, Kosiborod M: Incidence rates and predictors of microvascular and macrovascular complications in patients with type 2 diabetes: Results from the longitudinal global discover study. Am Heart J 243:232-239, 2022
Kikuta J, Kamagata K, Takabayashi K, Taoka T, Yokota H, Andica C, Wada A, Someya Y, Tamura Y, Kawamori R, Watada H, Naganawa S, Aoki S: An Investigation of Water Diffusivity Changes along the Perivascular Space in Elderly Subjects with Hypertension. AJNR Am J Neuroradiol 43(1):48-55, 2022
Sasaki A, Yokote K, Naitoh T, Fujikura J, Hayashi K, Hirota Y, Inagaki N, Ishigaki Y, Kasama K, Kikkawa E, Koyama H, Masuzaki H, Miyatsuka T, Nozaki T, Ogawa W, Ohta M, Okazumi S, Shimabukuro M, Shimomura I, Nishizawa H, Saiki A, Seki Y, Shojima N, Tsujino M, Ugi S, Watada H, Yamauchi T, Yamaguchi T, Ueki K, Kadowaki T, Tatsuno I: Metabolic surgery in treatment of obese Japanese patients with type 2 diabetes: a joint consensus statement from the Japanese Society for Treatment of Obesity, the Japan Diabetes Society, and the Japan Society for the Study of Obesity. Diabetol Int 13(1):1-30, 2022
Tokutsu A, Okada Y, Mita T, Torimoto K, Wakasugi S, Katakami N, Yoshii H, Uryu K, Nishida K, Arao T, Tanaka Y, Gosho M, Shimomura I, Watada H: Relationship between blood glucose variability in ambulatory glucose profile and standardized continuous glucose monitoring metrics: Subanalysis of a prospective cohort study. Diabetes Obes Metab 24(1):82-93, 2022
Murata S, Hagiwara A, Kaga H, Someya Y, Nemoto K, Goto M, Kamagata K, Irie R, Hori M, Andica C, Wada A, Kumamaru K K, Shimoji K, Otsuka Y, Hoshito H, Tamura Y, Kawamori R, Watada H, Aoki S: Comparison of Brain Volume Measurements Made with 0.3- and 3-T MR Imaging. Magn Reson Med Sci 21(3):517-524, 2022
Fukae T, Miyatsuka T, Himuro M, Wakabayashi Y, Iida H, Aoyama S, Mita T, Ikeda F, Haruna H, Takubo N, Nishida Y, Shimizu T, Watada H: Genetic ablation of p62/SQSTM1 demonstrates little effect on pancreatic beta-cell function under autophagy deficiency. Biochem Biophys Res Commun 612:99-104, 2022
Suzuki L, Miyatsuka T, Himuro M, Wakabayashi Y, Osonoi S, Miura M, Katahira T, Fujitani Y, Iida H, Mizukami H, Nishida Y, Watada H: Cumulative autophagy insufficiency in mice leads to progression of β-cell failure. Biochem Biophys Res Commun 611:38-45, 2022
Arnold S V, Khunti K, Tang F, Chen H, Nicolucci A, Gomes M B, Ji L, Shestakova M V, Watada H, Cooper A, Fenici P, Hammar N, Medina J, Kosiborod M: Impact of micro- and macrovascular complications of type 2 diabetes on quality of life: Insights from the DISCOVER prospective cohort study. Endocrinol Diabetes Metab 5(2):e00321, 2022
Nicolucci A, Chen H, Cooper A, Fenici P, Gomes M B, Hammar N, Ji L, Khunti K, Kosiborod M, Medin J, Shestakova M V, Shimomura I, Tang F, Vora J, Watada H, Arnold S V: Quality of life in people with type 2 diabetes in the 3 years following initiation of second-line therapy: The DISCOVER study. Diabetes Res Clin Pract 185:109218, 2022
Tanaka R, Fujimura S, Kado M, Fukuta T, Arita K, Hirano-Ito R, Mita T, Watada H, Kato Y, Miyauchi K, Mizuno H: Phase I/IIa Feasibility Trial of Autologous Quality- and Quantity-Cultured Peripheral Blood Mononuclear Cell Therapy for Non-Healing Extremity Ulcers. Stem Cells Transl Med 11(2):146-158, 2022
Reilhac C, Dubourg J, Thang C, Grouin J M, Fouqueray P, Watada H: Efficacy and safety of imeglimin add-on to insulin monotherapy in Japanese patients with type 2 diabetes (TIMES 3): A randomized, double-blind, placebo-controlled phase 3 trial with a 36-week open-label extension period. Diabetes Obes Metab 24(5):838-848, 2022
Sasaki S, Lee M Y Y, Wakabayashi Y, Suzuki L, Winata H, Himuro M, Matsuoka T A, Shimomura I, Watada H, Lynn F C, Miyatsuka T: Spatial and transcriptional heterogeneity of pancreatic beta cell neogenesis revealed by a time-resolved reporter system. Diabetologia 65(5):811-828, 2022
Someya Y, Tamura Y, Kaga H, Sugimoto D, Kadowaki S, Suzuki R, Aoki S, Hattori N, Motoi Y, Shimada K, Daida H, Ishijima M, Kaneko K, Nojiri S, Kawamori R, Watada H: Sarcopenic obesity is associated with cognitive impairment in community-dwelling older adults: The Bunkyo Health Study. Clin Nutr 41(5):1046-1051, 2022
Sugimoto M, Tabata H, Kaga H, Someya Y, Kakehi S, Abudurezake A, Naito H, Ito N, Shi H, Otsuka H, Umemura F, Yoshizawa Y, Kawamori R, Watada H, Tamura Y: Association of ALDH2 Genotypes and Alcohol Intake with Dietary Patterns: The Bunkyo Health Study. Nutrients 14(22), 2022
Yamamoto H, Eshima H, Kakehi S, Kawamori R, Watada H, Tamura Y: Impaired fatigue resistance, sarcoplasmic reticulum function, and mitochondrial activity in soleus muscle of db/db mice. Physiol Rep 10(18):e15478, 2022
Kaga H, Tamura Y, Someya Y, Naito H, Tabata H, Kakehi S, Yamasaki N, Sato M, Kadowaki S, Suzuki R, Sugimoto D, Kawamori R, Watada H: Prediabetes is an independent risk factor for sarcopenia in older men, but not in older women: the Bunkyo Health Study. J Cachexia Sarcopenia Muscle, 2022
Yoshii H, Mita T, Katakami N, Okada Y, Osonoi T, Aso K, Kurozumi A, Wakasugi S, Sato F, Ishii R, Gosho M, Shimomura I, Watada H: The importance of continuous glucose monitoring-derived metrics beyond HbA1c for optimal individualized glycemic control. J Clin Endocrinol Metab 107(10):e3990-e4003, 2022
Yoshii H, Mita T, Katakami N, Okada Y, Osonoi T, Aso K, Kurozumi A, Wakasugi S, Sato F, Ishii R, Gosho M, Shimomura I, Watada H: The Importance of Continuous Glucose Monitoring-derived Metrics Beyond HbA1c for Optimal Individualized Glycemic Control. J Clin Endocrinol Metab 107(10):e3990-e4003, 2022

2021年

Arnold S V, Khunti K, Bonnet F, Charbonnel B, Chen H, Cid-Ruzafa J, Cooper A, Fenici P, Gomes M B, Hammar N, Ji L, Luporini-Saraiva G, Medina J, Nicolucci A, Ramirez L, Shestakova M V, Shimomura I, Surmont F, Tang F, Vora J, Watada H, Kosiborod M, investigators D: Type 2 diabetes and heart failure: insights from the global DISCOVER study. ESC Heart Fail 8(2):1711-1716, 2021
Sanke H, Mita T, Yoshii H, Someya Y, Yamashiro K, Shimizu T, Ohmura C, Onuma T, Watada H: Olfactory dysfunction predicts the development of dementia in older patients with type 2 diabetes. Diabetes Res Clin Pract 174:108740, 2021
Wakasugi S, Mita T, Katakami N, Okada Y, Yoshii H, Osonoi T, Nishida K, Shiraiwa T, Torimoto K, Kurozumi A, Gosho M, Shimomura I, Watada H: Associations between continuous glucose monitoring-derived metrics and diabetic retinopathy and albuminuria in patients with type 2 diabetes. BMJ Open Diabetes Res Care 9(1), 2021
Kiya M, Tamura Y, Takeno K, Someya Y, Kakehi S, Sato M, Yamasaki N, Kadowaki S, Suzuki R, Furukawa Y, Sugimoto D, Kaga H, Funayama T, Nishitani-Yokoyama M, Shimada K, Daida H, Aoki S, Satoh H, Kawamori R, Watada H: Adipose Insulin Resistance and Decreased Adiponectin Are Correlated With Metabolic Abnormalities in Nonobese Men. J Clin Endocrinol Metab 106(5):e2228-e2238, 2021
Sato M, Tamura Y, Nakagata T, Someya Y, Kaga H, Yamasaki N, Kiya M, Kadowaki S, Sugimoto D, Satoh H, Kawamori R, Watada H: Prevalence and Features of Impaired Glucose Tolerance in Young Underweight Japanese Women. J Clin Endocrinol Metab 106(5):e2053-e2062, 2021
Ji L, Bonnet F, Chen H, Cooper A, Hammar N, Leigh P, Luporini Saraiva G, Ramirez L, Medina J, Nicolucci A, Rathmann W, Shestakova M V, Surmont F, Tang F, Watada H, Investigators D: Early versus late intensification of glucose-lowering therapy in patients with type 2 diabetes: Results from the DISCOVER study. Diabetes Res Clin Pract 178:108947, 2021
Khunti K, Charbonnel B, Chen H, Cherney D Z, Cooper A, Fenici P, Gomes M B, Hammar N, Heerspink H J L, Ji L, Medina J, Nicolucci A, Ramirez L, Rathmann W, Shestakova M V, Shimomura I, Tang F, Watada H, Kosiborod M, Investigators D: Prevalence and progression of chronic kidney disease among patients with type 2 diabetes: Insights from the DISCOVER study. Diabetes Obes Metab 23(8):1956-1960, 2021
Khunti K, Charbonnel B, Cooper A, Gomes M B, Ji L, Leigh P, Nicolucci A, Rathmann W, Shestakova M V, Siddiqui A, Tang F, Watada H, Chen H, investigators D: Associations between second-line glucose-lowering combination therapies with metformin and HbA1c, body weight, quality of life, hypoglycaemic events and glucose-lowering treatment intensification: The DISCOVER study. Diabetes Obes Metab 23(8):1823-1833, 2021
Tsunemi A, Sato J, Sugimoto S, Iwagaki Y, Enomoto M, Someya Y, Kiya M, Matsuhashi E, Wakabayashi Y, Funayama T, Mita T, Uchida T, Miyatsuka T, Azuma K, Shimizu T, Kanazawa A, Satoh H, Watada H: A Pilot Study of Intervention With a Mobile Application Visualizing the Macronutrient Content for Type 2 Diabetes at a Japanese Center. J Clin Med Res 13(8):425-433, 2021
Takeno K, Tamura Y, Kakehi S, Kaga H, Kawamori R, Watada H: ALDH2 rs671 Is Associated With Elevated FPG, Reduced Glucose Clearance and Hepatic Insulin Resistance in Japanese Men. J Clin Endocrinol Metab 106(9):e3573-e3581, 2021
Nishio R, Takeshita A, Uchida T, Herai T, Sakamoto K, Shimizu Y, Arai M, Tatsushima K, Fukuhara N, Okada M, Nishioka H, Yamada S, Koibuchi N, Watada H, Takeuchi Y: GH-induced LH hyporesponsiveness as a potential mechanism for hypogonadism in male patients with acromegaly. Endocr J 68(8):953-968, 2021
Araki E, Terauchi Y, Watada H, Deenadayalan S, Christiansen E, Horio H, Kadowaki T: Efficacy and safety of oral semaglutide in Japanese patients with type 2 diabetes: A post hoc subgroup analysis of the PIONEER 1, 3, 4 and 8 trials. Diabetes Obes Metab 23(12):2785-2794, 2021
Fukaishi T, Nakagawa Y, Fukunaka A, Sato T, Hara A, Nakao K, Saito M, Kohno K, Miyatsuka T, Tamaki M, Matsuhisa M, Matsuoka T A, Yamada T, Watada H, Fujitani Y: Characterisation of Ppy-lineage cells clarifies the functional heterogeneity of pancreatic beta cells in mice. Diabetologia 64(12):2803-2816, 2021
Kakehi S, Tamura Y, Ikeda S I, Kaga N, Taka H, Ueno N, Shiuchi T, Kubota A, Sakuraba K, Kawamori R, Watada H: Short-term physical inactivity induces diacylglycerol accumulation and insulin resistance in muscle via lipin1 activation. Am J Physiol Endocrinol Metab 321(6):E766-E781, 2021
Otsuka H, Tabata H, Shi H, Kaga H, Someya Y, Abulaiti A, Naito H, Umemura F, Kakehi S, Ishijima M, Kawamori R, Watada H, Tamura Y: Associations of Exercise Habits in Adolescence and Old Age with Risk of Osteoporosis in Older Adults: The Bunkyo Health Study. J Clin Med 10(24), 2021
Mita T, Someya Y, Osonoi Y, Osonoi T, Saito M, Nakayama S, Ishida H, Sato H, Gosho M, Watada H: Lower intake of saturated fatty acids is associated with persistently higher arterial stiffness in patients with type 2 diabetes. J Diabetes Investig 12(2):226-233, 2021
Kanazawa A, Aida M, Yoshida Y, Kaga H, Katahira T, Suzuki L, Tamaki S, Sato J, Goto H, Azuma K, Shimizu T, Takahashi T, Yamashiro Y, Watada H: Effects of Synbiotic Supplementation on Chronic Inflammation and the Gut Microbiota in Obese Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Study. Nutrients 13(2), 2021
Tsunemi A, Uchida T, Kuroda K, Ikemoto Y, Ochiai A, Goto H, Sugiyama R, Satoh H, Itakura A, Watada H: Effect of thyroxine treatment on pregnancy outcomes in infertile Japanese women with TSH levels between 2.5 muIU/mL and the upper reference limit: a retrospective study. Endocr J 68(2):171-177, 2021
Patel K K, Gomes M B, Charbonnel B, Chen H, Cid-Ruzafa J, Fenici P, Hammar N, Ji L, Kennedy K F, Khunti K, Kosiborod M, Pocock S, Shestakova M V, Shimomura I, Surmont F, Watada H, Arnold S V: Global patterns of comprehensive cardiovascular risk factor control in patients with type 2 diabetes mellitus: Insights from the DISCOVER study. Diabetes Obes Metab 23(1):39-48, 2021
Ueki K, Tanizawa Y, Nakamura J, Yamada Y, Inagaki N, Watada H, Shimomura I, Nishimura R, Miyoshi H, Abiko A, Katagiri H, Hayashi M, Shimada A, Naruse K, Fujimoto S, Fujiwara M, Shikata K, Okada Y, Araki E, Yamazaki T, Kadowaki T, Group J B R: Long-term safety and efficacy of alogliptin, a DPP-4 inhibitor, in patients with type 2 diabetes: a 3-year prospective, controlled, observational study (J-BRAND Registry). BMJ Open Diabetes Res Care 9(1), 2021
Katakami N, Mita T, Yoshii H, Shiraiwa T, Yasuda T, Okada Y, Torimoto K, Umayahara Y, Kaneto H, Osonoi T, Yamamoto T, Kuribayashi N, Maeda K, Yokoyama H, Kosugi K, Ohtoshi K, Hayashi I, Sumitani S, Tsugawa M, Ryomoto K, Taki H, Nakamura T, Kawashima S, Sato Y, Watada H, Shimomura I: Effect of tofogliflozin on arterial stiffness in patients with type 2 diabetes: prespecified sub-analysis of the prospective, randomized, open-label, parallel-group comparative UTOPIA trial. Cardiovasc Diabetol 20(1):4, 2021
Wakasugi S, Mita T, Katakami N, Okada Y, Yoshii H, Osonoi T, Kuribayashi N, Taneda Y, Kojima Y, Gosho M, Shimomura I, Watada H: Associations between continuous glucose monitoring-derived metrics and arterial stiffness in Japanese patients with type 2 diabetes. Cardiovasc Diabetol 20(1):15, 2021
Iwasaki M, Kudo A, Asahi K, Machii N, Iseki K, Satoh H, Moriyama T, Yamagata K, Tsuruya K, Fujimoto S, Narita I, Konta T, Kondo M, Shibagaki Y, Kasahara M, Watanabe T, Shimabukuro M: Fast walking is a preventive factor against new-onset diabetes mellitus in a large cohort from a Japanese general population. Sci Rep 11(1):716, 2021
Goldenberg J Z, Day A, Brinkworth G D, Sato J, Yamada S, Jonsson T, Beardsley J, Johnson J A, Thabane L, Johnston B C: Efficacy and safety of low and very low carbohydrate diets for type 2 diabetes remission: systematic review and meta-analysis of published and unpublished randomized trial data. BMJ 372:m4743, 2021
Otsuka H, Tabata H, Someya Y, Tamura Y: Trends in the prevalence of underweight in women across generations in Japan. J Bone Miner Metab 39(4):719-720, 2021
Watada H, Kawakita Y, Tanaka K, Oh A, Nishigaki N, Nakajima T, Fujikawa K, Akazawa M: A Claims-Based Cohort Study on the Treatment Patterns of Japanese Patients with Type 2 Diabetes Mellitus and the Association of Early First Physician Visit with Time to Prescription of Oral Hypoglycemic Agents. Diabetes Ther 12(7):2035-2047, 2021
Sugimoto T, Araki A, Fujita H, Honda K, Inagaki N, Ishida T, Kato J, Kishi M, Kobayashi K, Kouyama K, Noma H, Ohishi M, Satoh-Asahara N, Shimada H, Sugimoto K, Suzuki S, Takeya Y, Tamura Y, Tokuda H, Umegaki H, Watada H, Yamada Y, Sakurai T: The Multi-Domain Intervention Trial in Older Adults With Diabetes Mellitus for Prevention of Dementia in Japan: Study Protocol for a Multi-Center, Randomized, 18-Month Controlled Trial. Front Aging Neurosci 13:680341, 2021
Koga T, Sasaki F, Saeki K, Tsuchiya S, Okuno T, Ohba M, Ichiki T, Iwamoto S, Uzawa H, Kitajima K, Meno C, Nakamura E, Tada N, Fukui Y, Kikuta J, Ishii M, Sugimoto Y, Nakao M, Yokomizo T: Expression of leukotriene B4 receptor 1 defines functionally distinct DCs that control allergic skin inflammation. Cell Mol Immunol 18(6):1437-1449, 2021
Oshima M, Toyama T, Hara A, Shimizu M, Kitajima S, Iwata Y, Sakai N, Furuichi K, Haneda M, Babazono T, Yokoyama H, Iseki K, Araki S I, Ninomiya T, Hara S, Suzuki Y, Iwano M, Kusano E, Moriya T, Satoh H, Nakamura H, Makino H, Wada T: Combined changes in albuminuria and kidney function and subsequent risk for kidney failure in type 2 diabetes. BMJ Open Diabetes Res Care 9(1), 2021
Tanaka R, Ito-Hirano R, Fujimura S, Arita K, Hagiwara H, Mita T, Itoh M, Kawaji H, Ogawa T, Watada H, Masuda H, Asahara T, Mizuno H: Ex vivo conditioning of peripheral blood mononuclear cells of diabetic patients promotes vasculogenic wound healing. Stem Cells Transl Med 10(6):895-909, 2021
Satoh H, Okazaki K, Ohira T, Sakai A, Hosoya M, Yasumura S, Kawasaki Y, Hashimmoto K, Ohtsuru A, Takahashi A, Watanabe K, Shimabukuro M, Kazama J J, Hashimoto S, Kobashi G, Ohira H, Ohto H, Kamiya K: Relationship Between Risk of Hyper-Low-density Lipoprotein Cholesterolemia and Evacuation After the Great East Japan Earthquake. J Epidemiol 32(6):277-282, 2021
Ifuku M, Takahashi K, Hosono Y, Iso T, Ishikawa A, Haruna H, Takubo N, Komiya K, Kurita M, Ikeda F, Watada H, Shimizu T: Left atrial dysfunction and stiffness in pediatric and adult patients with Type 1 diabetes mellitus assessed with speckle tracking echocardiography. Pediatr Diabetes 22(2):303-319, 2021
Nishio R, Uchida T, Suzuki L, Onose H, Goto H, Yamada E, Satoh H, Watada H: Influence of Short-Term Dietary and Therapeutic Iodine Restriction on the Therapeutic Effects of Radioactive Iodine Therapy in Patients with Graves' Disease. Thyroid 31(3):439-445, 2021
Tateishi R, Matsumura T, Okanoue T, Shima T, Uchino K, Fujiwara N, Senokuchi T, Kon K, Sasako T, Taniai M, Kawaguchi T, Inoue H, Watada H, Kubota N, Shimano H, Kaneko S, Hashimoto E, Watanabe S, Shiota G, Ueki K, Kashiwabara K, Matsuyama Y, Tanaka H, Kasuga M, Araki E, Koike K: Hepatocellular carcinoma development in diabetic patients: a nationwide survey in Japan. J Gastroenterol 56(3):261-273, 2021
Eshima H, Tamura Y, Kakehi S, Kakigi R, Kawamori R, Watada H: Maintenance of contractile force and increased fatigue resistance in slow-twitch skeletal muscle of mice fed a high-fat diet. J Appl Physiol (1985) 130(3):528-536, 2021
Hagiwara A, Fujimoto K, Kamagata K, Murata S, Irie R, Kaga H, Someya Y, Andica C, Fujita S, Kato S, Fukunaga I, Wada A, Hori M, Tamura Y, Kawamori R, Watada H, Aoki S: Age-Related Changes in Relaxation Times, Proton Density, Myelin, and Tissue Volumes in Adult Brain Analyzed by 2-Dimensional Quantitative Synthetic Magnetic Resonance Imaging. Invest Radiol 56(3):163-172, 2021
Yamasaki N, Tamura Y, Takeno K, Kakehi S, Someya Y, Funayama T, Furukawa Y, Kaga H, Suzuki R, Sugimoto D, Kadowaki S, Sato M, Nakagata T, Nishitani-Yokoyama M, Shimada K, Daida H, Aoki S, Satoh H, Kawamori R, Watada H: Author Correction: Both higher fitness level and higher current physical activity level may be required for intramyocellular lipid accumulation in non-athlete men. Sci Rep 11(1):7304, 2021
Bongaerts B, Arnold S V, Charbonnel B H, Chen H, Cooper A, Fenici P, Gomes M, Ji L, Khunti K, Kosiborod M, Medina J, Nicolucci A, Shestakova M, Shimomura I, Tang F, Watada H, Rathmann W: Inappropriate intensification of glucose-lowering treatment in older patients with type 2 diabetes: the global DISCOVER study. BMJ Open Diabetes Res Care 9(1), 2021
Kuroda K, Matsumura Y, Ikemoto Y, Segawa T, Hashimoto T, Fukuda J, Nakagawa K, Uchida T, Ochiai A, Horimoto Y, Arakawa A, Nojiri S, Itakura A, Sugiyama R: Analysis of the risk factors and treatment for repeated implantation failure: OPtimization of Thyroid function, IMmunity, and Uterine Milieu (OPTIMUM) treatment strategy. Am J Reprod Immunol 85(5):e13376, 2021
Nakagata T, Tamura Y, Kaga H, Sato M, Yamasaki N, Someya Y, Kadowaki S, Sugimoto D, Satoh H, Kawamori R, Watada H: Ingestion of an exogenous ketone monoester improves the glycemic response during oral glucose tolerance test in individuals with impaired glucose tolerance: A cross-over randomized trial. J Diabetes Investig 12(5):756-762, 2021
Yamasaki N, Tamura Y, Kaga H, Sato M, Kiya M, Kadowaki S, Suzuki R, Furukawa Y, Sugimoto D, Funayama T, Someya Y, Kakehi S, Nojiri S, Satoh H, Kawamori R, Watada H: A decrease in plasma glucose levels is required for increased endogenous glucose production with a single administration of a sodium-glucose co-transporter-2 inhibitor tofogliflozin. Diabetes Obes Metab 23(5):1092-1100, 2021
Taya N, Katakami N, Mita T, Okada Y, Wakasugi S, Yoshii H, Shiraiwa T, Otsuka A, Umayahara Y, Ryomoto K, Hatazaki M, Yasuda T, Yamamoto T, Gosho M, Shimomura I, Watada H: Associations of continuous glucose monitoring-assessed glucose variability with intima-media thickness and ultrasonic tissue characteristics of the carotid arteries: a cross-sectional analysis in patients with type 2 diabetes. Cardiovasc Diabetol 20(1):95, 2021
Bonnet F, Chen H, Cooper A, Gomes M B, Ji L, Leigh P, Ramirez L, Shestakova M V, Shimomura I, Siddiqui A, Tang F, Vora J, Watada H, Khunti K: What are the factors associated with long-term glycaemic control in patients with type 2 diabetes and elevated glycated haemoglobin (>/=7.0%) at initiation of second-line therapy? Results from the DISCOVER study. Diabetes Obes Metab 23(10):2336-2343, 2021
Kuroda K, Ikemoto Y, Horikawa T, Moriyama A, Ojiro Y, Takamizawa S, Uchida T, Nojiri S, Nakagawa K, Sugiyama R: Novel approaches to the management of recurrent pregnancy loss: The OPTIMUM (OPtimization of Thyroid function, Thrombophilia, Immunity, and Uterine Milieu) treatment strategy. Reprod Med Biol 20(4):524-536, 2021
Nicolucci A, Chen H, Cid-Ruzafa J, Cooper A, Fenici P, Gomes M B, Hammar N, Khunti K, Kosiborod M, Leigh P, Medin J, Rathmann W, Shestakova M V, Shimomura I, Siddiqui A, Tang F, Watada H, Ji L, investigators D: Health-related quality of life in patients with type 2 diabetes initiating a second-line glucose-lowering therapy: The DISCOVER study. Diabetes Res Clin Pract 180:108974, 2021
Someya Y, Tamura Y, Kaga H, Sugimoto D, Kadowaki S, Suzuki R, Aoki S, Hattori N, Motoi Y, Shimada K, Daida H, Ishijima M, Kaneko K, Nojiri S, Kawamori R, Watada H: Insulin resistance and muscle weakness are synergistic risk factors for silent lacunar infarcts: the Bunkyo Health Study. Sci Rep 11(1):21093, 2021
Katakami N, Mita T, Yoshii H, Shiraiwa T, Yasuda T, Okada Y, Torimoto K, Umayahara Y, Kaneto H, Osonoi T, Yamamoto T, Kuribayashi N, Maeda K, Yokoyama H, Kosugi K, Ohtoshi K, Hayashi I, Sumitani S, Tsugawa M, Ryomoto K, Taki H, Nakamura T, Kawashima S, Sato Y, Watada H, Shimomura I, investigators U s: The Influence of Tofogliflozin on Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus. Diabetes Ther 12(9):2499-2515, 2021
Komatsu M, Watada H, Kaneko S, Ross Agner B F, Nishida T, Kaku K: Efficacy and safety of the fixed-ratio combination of insulin degludec and liraglutide by baseline glycated hemoglobin, body mass index and age in Japanese individuals with type 2 diabetes: A subgroup analysis of two phase III trials. J Diabetes Investig 12(9):1610-1618, 2021
Mochida A, Mita T, Azuma K, Osonoi Y, Masuyama A, Nakajima K, Goto H, Nishida Y, Miyatsuka T, Mitsumata M, Watada H: Defective autophagy in vascular smooth muscle cells enhances the healing of abdominal aortic aneurysm. Physiol Rep 9(17):e15000, 2021
Watada H: Inceptor intercepts insulin signaling in pancreatic beta-cells. J Diabetes Investig 12(9):1540-1541, 2021
Sato M, Tamura Y, Kaga H, Yamasaki N, Kiya M, Kadowaki S, Sugimoto D, Funayama T, Someya Y, Kakehi S, Nojiri S, Satoh H, Kawamori R, Watada H: Short-Term SGLT2 Inhibitor Administration Does Not Alter Systemic Insulin Clearance in Type 2 Diabetes. Biomedicines 9(9), 2021

2020年

Katahira T, Miyatsuka T, Miura M, Suzuki L, Himuro M, Nishida Y, Satoh H, Watada H: Conversion of pancreatic α cells into insulin-producing cells modulated by β-cell insufficiency and supplemental insulin administration. Biochem Biophys Res Commun 521(1):178-183, 2020
Someya Y, Tamura Y, Kaga H, Sugimoto D, Kadowaki S, Suzuki R, Aoki S, Hattori N, Motoi Y, Shimada K, Daida H, Ishijima M, Kaneko K, Nojiri S, Kawamori R, Watada H: Reduced muscle strength of knee extensors is a risk factor for silent lacunar infarcts among Japanese elderly people: the Bunkyo Health Study. JCSM Clinical Reports 5(3):79-85, 2020
Araki E, Watada H, Uchigata Y, Tomonaga O, Fujii H, Ohashi H, Okabe T, Asano M, Thoren F, Kim H, Yajima T, Langkilde A M: Efficacy and safety of dapagliflozin in Japanese patients with inadequately controlled type 1 diabetes (DEPICT-5): 52-week results from a randomized, open-label, phase III clinical trial. Diabetes Obes Metab 22(4):540-548, 2020
Shinohara M, Uchida T, Funayama T, Watanabe M, Kusaoi M, Yamaji K, Tamura N, Goto H, Sato H, Watada H: Effect of Plasma Exchange in Thyroid Storm With Consideration of Its Distribution Into the Extravascular Space. J Endocr Soc 4(4):bvaa023, 2020
Watada H, Sakamaki H, Yabe D, Yamamoto F, Murata T, Hanada K, Hirase T, Okamura T: Cost-Effectiveness Analysis of Linagliptin in Japan Based on Results from the Asian Subpopulation in the CARMELINA((R)) Trial. Diabetes Ther 11(8):1721-1734, 2020
Khunti K, Gomes M B, Kosiborod M, Nicolucci A, Pocock S, Rathmann W, Shestakova M V, Shimomura I, Watada H, Chen H, Cid-Ruzafa J, Fenici P, Hammar N, Tang F, Ji L, Committee D S, all D i: Metformin discontinuation in patients beginning second-line glucose-lowering therapy: results from the global observational DISCOVER study programme. BMJ Open 10(8):e034613, 2020
Kakehi S, Tamura Y, Takeno K, Ikeda S I, Ogura Y, Saga N, Miyatsuka T, Naito H, Kawamori R, Watada H: Endurance Runners with Intramyocellular Lipid Accumulation and High Insulin Sensitivity Have Enhanced Expression of Genes Related to Lipid Metabolism in Muscle. J Clin Med 9(12), 2020
Mita T, Osonoi Y, Osonoi T, Saito M, Nakayama S, Someya Y, Ishida H, Gosho M, Watada H: Breakfast skipping is associated with persistently increased arterial stiffness in patients with type 2 diabetes. BMJ Open Diabetes Res Care 8(1), 2020
Funamizu T, Iwata H, Nishida Y, Miyosawa K, Doi S, Chikata Y, Shitara J, Endo H, Wada H, Naito R, Ogita M, Dohi T, Kasai T, Okazaki S, Isoda K, Miyauchi K, Daida H: Increased risk of cardiovascular mortality by strict glycemic control (pre-procedural HbA1c < 6.5%) in Japanese medically-treated diabetic patients following percutaneous coronary intervention: a 10-year follow-up study. Cardiovasc Diabetol 19(1):21, 2020
Khunti K, Chen H, Cid-Ruzafa J, Fenici P, Gomes M B, Hammar N, Ji L, Kosiborod M, Pocock S, Shestakova M V, Shimomura I, Tang F, Watada H, Nicolucci A, investigators D: Glycaemic control in patients with type 2 diabetes initiating second-line therapy: Results from the global DISCOVER study programme. Diabetes Obes Metab 22(1):66-78, 2020
Sakai A, Nakano H, Ohira T, Maeda M, Okazaki K, Takahashi A, Kawasaki Y, Satoh H, Ohtsuru A, Shimabukuro M, Kazama J, Hashimoto S, Hosoya M, Yasumura S, Yabe H, Ohto H, Kamiya K, G F H M S: Relationship between the prevalence of polycythemia and factors observed in the mental health and lifestyle survey after the Great East Japan Earthquake. Medicine (Baltimore) 99(1):e18486, 2020
Watada H, Ross Agner B F, Doshi A, Bardtrum L, Ranthe M F, Billings L K: IDegLira Improves Glycemic Control in Japanese Patients with Uncontrolled Type 2 Diabetes on Premixed Insulin Therapy. Diabetes Ther 11(1):331-339, 2020
Kaga H, Tamura Y, Takeno K, Kakehi S, Someya Y, Funayama T, Furukawa Y, Suzuki R, Sugimoto D, Kadowaki S, Nishitani-Yokoyama M, Shimada K, Daida H, Aoki S, Giacca A, Sato H, Kawamori R, Watada H: Shape of the glucose response curve during an oral glucose tolerance test is associated with insulin clearance and muscle insulin sensitivity in healthy non-obese men. J Diabetes Investig 11(4):874-877, 2020
Kakehi S, Tamura Y, Kubota A, Takeno K, Kawaguchi M, Sakuraba K, Kawamori R, Watada H: Effects of blood flow restriction on muscle size and gene expression in muscle during immobilization: A pilot study. Physiol Rep 8(14):e14516, 2020
Katakami N, Mita T, Takahara M, Yajima T, Wada F, Kawashima M, Shimomura I, Watada H, Group J D S: Baseline Characteristics of Patients with Type 2 Diabetes Initiating Second-Line Treatment in Japan: Findings from the J-DISCOVER Study. Diabetes Ther 11(7):1563-1578, 2020
Rathmann W, Charbonnel B, Gomes M B, Hammar N, Khunti K, Kosiborod M, Kuss O, Shestakova M V, Watada H, Shimomura I, Tang F, Cid-Ruzafa J, Chen H, Fenici P, Surmont F, Ji L, investigators D: Socioeconomic factors associated with hypoglycaemia in patients starting second-line glucose-lowering therapy: The DISCOVER study. Diabetes Res Clin Pract 165:108250, 2020
Yamauchi T, Kamiya H, Utsunomiya K, Watada H, Kawanami D, Sato J, Kitada M, Koya D, Harada N, Shide K, Joo E, Suzuki R, Bouchi R, Ohta Y, Kondo T: Medical nutrition therapy and dietary counseling for patients with diabetes-energy, carbohydrates, protein intake and dietary counseling. Diabetol Int 11(3):224-239, 2020
Hirayama S, Hori A, Isshiki M, Hirayama A, Ueno T, Tamura Y, Kaga H, Watada H, Kawamori R, Miida T: Fasting serum free glycerol concentration is a potential surrogate marker of visceral obesity and insulin sensitivity in middle-aged Japanese men. J Clin Lipidol 14(4):522-530, 2020
Katakami N, Mita T, Yoshii H, Shiraiwa T, Yasuda T, Okada Y, Torimoto K, Umayahara Y, Kaneto H, Osonoi T, Yamamoto T, Kuribayashi N, Maeda K, Yokoyama H, Kosugi K, Ohtoshi K, Hayashi I, Sumitani S, Tsugawa M, Ryomoto K, Taki H, Nakamura T, Kawashima S, Sato Y, Watada H, Shimomura I, investigators U s: Tofogliflozin does not delay progression of carotid atherosclerosis in patients with type 2 diabetes: a prospective, randomized, open-label, parallel-group comparative study. Cardiovasc Diabetol 19(1):110, 2020
Kawasaki Y, Nakano H, Hosoya M, Yasumura S, Ohira T, Satoh H, Suzuki H, Sakai A, Ohtsuru A, Takahashi A, Kobashi G, Kamiya K: Influence of post-disaster evacuation on childhood obesity and hyperlipidemia. Pediatr Int 62(6):669-676, 2020
Watada H, Takami A, Spranger R, Amano A, Hashimoto Y, Niemoeller E: Efficacy and Safety of 1:1 Fixed-Ratio Combination of Insulin Glargine and Lixisenatide Versus Lixisenatide in Japanese Patients With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs: The LixiLan JP-O1 Randomized Clinical Trial. Diabetes Care 43(6):1249-1257, 2020
Komaru Y, Takeuchi T, Suzuki L, Asano T, Urayama K Y: Recurrent cardiovascular events in patients with newly diagnosed acute coronary syndrome: Influence of diabetes and its management with medication. J Diabetes Complications 34(3):107511, 2020
Yoshida Y, Kashiwabara K, Hirakawa Y, Tanaka T, Noso S, Ikegami H, Ohsugi M, Ueki K, Mita T, Watada H, Koya D, Mise K, Wada J, Shimizu M, Wada T, Ito Y, Narita I, Kashihara N, Nangaku M, Matsuyama Y: Conditions, pathogenesis, and progression of diabetic kidney disease and early decliner in Japan. BMJ Open Diabetes Res Care 8(1), 2020
Yamasaki N, Tamura Y, Takeno K, Kakehi S, Someya Y, Funayama T, Furukawa Y, Kaga H, Suzuki R, Sugimoto D, Kadowaki S, Sato M, Nakagata T, Nishitani-Yokoyama M, Shimada K, Daida H, Aoki S, Satoh H, Kawamori R, Watada H: Both higher fitness level and higher current physical activity level may be required for intramyocellular lipid accumulation in non-athlete men. Sci Rep 10(1):4102, 2020
Takahashi M, Miyatsuka T, Suzuki L, Osonoi S, Himuro M, Miura M, Katahira T, Wakabayashi Y, Fukunaka A, Nishida Y, Fujitani Y, Takeda S, Mizukami H, Itakura A, Watada H: Biphasic changes in beta-cell mass around parturition are accompanied by increased serotonin production. Sci Rep 10(1):4962, 2020
Eshima H, Tamura Y, Kakehi S, Kakigi R, Hashimoto R, Funai K, Kawamori R, Watada H: A chronic high-fat diet exacerbates contractile dysfunction with impaired intracellular Ca(2+) release capacity in the skeletal muscle of aged mice. J Appl Physiol (1985) 128(5):1153-1162, 2020
Hashimoto S, Nagai M, Ohira T, Fukuma S, Hosoya M, Yasumura S, Satoh H, Suzuki H, Sakai A, Ohtsuru A, Kawasaki Y, Takahashi A, Okazaki K, Kobashi G, Kamiya K, Yamashita S, Fukuhara S I, Ohto H, Fukushima Health Management Survey G: Influence of post-disaster evacuation on incidence of hyperuricemia in residents of Fukushima Prefecture: the Fukushima Health Management Survey. Clin Exp Nephrol 24(11):1025-1032, 2020
Sato M, Tamura Y, Someya Y, Takeno K, Kaga H, Kadowaki S, Sugimoto D, Kakehi S, Funayama T, Furukawa Y, Suzuki R, Nakagata T, Nishitani-Yokoyama M, Shimada K, Daida H, Aoki S, Sato H, Kawamori R, Watada H: Characteristics associated with elevated 1-h plasma glucose levels during a 75-g oral glucose tolerance test in non-obese Japanese men. J Diabetes Investig 11(6):1520-1523, 2020
Tsunemi A, Sato J, Kurita M, Wakabayashi Y, Waseda N, Koshibu M, Shinohara M, Ozaki A, Nakamura H, Hirano N, Ikeda F, Satoh H, Watada H: Effect of real-life insulin pump with predictive low-glucose management use for 3 months: Analysis of the patients treated in a Japanese center. J Diabetes Investig 11(6):1564-1569, 2020
Yabe D, Higashiyama H, Kadowaki T, Origasa H, Shimomura I, Watada H, Tobe K, Iglay K, Tokita S, Seino Y: Real-world Observational Study on Patient Outcomes in Diabetes (RESPOND): study design and baseline characteristics of patients with type 2 diabetes newly initiating oral antidiabetic drug monotherapy in Japan. BMJ Open Diabetes Res Care 8(2), 2020
Aoyama S, Nishida Y, Fujitani Y, Fukunaka A, Miyatsuka T, Suzuki L, Himuro M, Yoshimori T, Watada H: Rubicon in pancreatic beta cells plays a limited role in maintaining glucose homeostasis following increased insulin resistance. Endocr J 67(11):1119-1126, 2020
Someya Y, Tamura Y, Takeno K, Kakehi S, Funayama T, Furukawa Y, Eshima H, Watanabe K, Kurihara T, Yanagiya T, Kaga H, Suzuki R, Sugimoto D, Kadowaki S, Kawamori R, Watada H: Decreased Muscle Strength of Knee Flexors is Associated with Impaired Muscle Insulin Sensitivity in Non-Diabetic Middle-Aged Japanese Male Subjects. Diabetes Ther 11(10):2401-2410, 2020
Uzawa H, Kohno D, Koga T, Sasaki T, Fukunaka A, Okuno T, Jo-Watanabe A, Kazuno S, Miyatsuka T, Kitamura T, Fujitani Y, Watada H, Saeki K, Yokomizo T: Leukotriene A4 hydrolase deficiency protects mice from diet-induced obesity by increasing energy expenditure through neuroendocrine axis. FASEB J 34(10):13949-13958, 2020
Terauchi Y, Yabe D, Kaneto H, Amano A, Baxter M, Watanabe D, Watada H, Inagaki N: Benefits of the fixed-ratio combination of insulin glargine 100 units/mL and lixisenatide (iGlarLixi) in Japanese people with type 2 diabetes: A subgroup and time-to-control analysis of the LixiLan JP phase 3 trials. Diabetes Obes Metab 22 Suppl 4:35-47, 2020
Watada H, Yamauchi T, Yamamoto F, Taniguchi A, Yarush L, Heilmann C, Yasui A: Safety and tolerability of empagliflozin and linagliptin combination therapy in patients with type 2 diabetes mellitus: a pooled analysis of data from five randomized, controlled clinical trials. Expert Opin Drug Saf 19(9):1193-1202, 2020
Kobayashi M, Satoh H, Matsuo T, Kusunoki Y, Tokushima M, Watada H, Namba M, Kitamura T: Plasma glucagon levels measured by sandwich ELISA are correlated with impaired glucose tolerance in type 2 diabetes. Endocr J 67(9):903-922, 2020

2019年

Himuro, M., Miyatsuka, T., Suzuki, L., Miura, M., Katahira, T., Goto, H., Nishida, Y., Sasaki, S., Koike, M., Shiota, C., Gittes, G., Fujitani, Y., Watada, H. Cellular Autophagy in α Cells Plays a Role in the Maintenance of Islet Architecture. J Endocr Soc 3(11): 1979-1992, 2019
Tamaki, S., Kanazawa, A., Sato, J., Tamura, Y., Asahara, T., Takahashi, T., Matsumoto, S., Yamashiro, Y., Watada, H. Clinical factors associated with bacterial translocation in Japanese patients with type 2 diabetes: A retrospective study. PLoS One 14(9): e0222598, 2019
Sugimoto, D., Tamura, Y., Takeno, K., Kaga, H., Someya, Y., Kakehi, S., Funayama, T., Furukawa, Y., Suzuki, R., Kadowaki, S., Nishitani-Yokoyama, M., Shimada, K., Daida, H., Aoki, S., Kanazawa, A., Kawamori, R., Watada, H. Clinical Features of Non-obese, Apparently Healthy Japanese Men with Reduced Adipose Tissue Insulin Sensitivity. J Clin Endocrinol Metab 104(6): 2325-2333, 2019
Sawada, S., Gando, Y., Kawakami, R., Blair, S. N., Lee, I. M., Tamura, Y., Tsuda, H., Saito, H., Miyachi, M. Combined aerobic and resistance training, and incidence of diabetes: A retrospective cohort study in Japanese older women. J Diabetes Investig 10(4): 997-1003, 2019
Hara, A., Nakagawa, Y., Nakao, K., Tamaki, M., Ikemoto, T., Shimada, M., Matsuhisa, M., Mizukami, H., Maruyama, N., Watada, H., Fujitani, Y. Development of monoclonal mouse antibodies that specifically recognize pancreatic polypeptide. Endocr J 66(5): 459-468, 2019
Satoh, J., Yokono, K., Ando, R., Asakura, T., Hanzawa, K., Ishigaki, Y., Kadowaki, T., Kasuga, M., Katagiri, H., Kato, Y., Kurosawa, K., Miura, M., Nakamura, J., Nishitsuka, K., Ogawa, S., Okamoto, T., Sakuma, S., Sakurai, S., Satoh, H., Shimauchi, H., Shimokawa, H., Shoji, W., Sugiyama, T., Suwabe, A., Tachi, M., Takahashi, K., Takahashi, S., Terayama, Y., Tomita, H., Tsuchiya, Y., Waki, H., Watanabe, T., Yahata, K., Yamashita, H. Diabetes Care Providers' Manual for Disaster Diabetes Care. J Diabetes Investig 10(4): 1118-1142, 2019
Satoh, J., Yokono, K., Ando, R., Asakura, T., Hanzawa, K., Ishigaki, Y., Kadowaki, T., Kasuga, M., Katagiri, H., Kato, Y., Kurosawa, K., Miura, M., Nakamura, J., Nishitsuka, K., Ogawa, S., Okamoto, T., Sakuma, S., Sakurai, S., Satoh, H., Shimauchi, H., Shimokawa, H., Shoji, W., Sugiyama, T., Suwabe, A., Tachi, M., Takahashi, K., Takahashi, S., Terayama, Y., Tomita, H., Tsuchiya, Y., Waki, H., Watanabe, T., Yahata, K., Yamashita, H. Diabetes care providers' manual for disaster diabetes care. Diabetol Int 10: 153-179, 2019
Eshima, H., Tamura, Y., Kakehi, S., Nakamura, K., Kurebayashi, N., Murayama, T., Kakigi, R., Sakurai, T., Kawamori, R., Watada, H. Dysfunction of muscle contraction with impaired intracellular Ca(2+) handling in skeletal muscle and the effect of exercise training in male db/db mice. J Appl Physiol (1985) 126(1): 170-182, 2019
Rosenstock, J., Allison, D., Birkenfeld, A. L., Blicher, T. M., Deenadayalan, S., Jacobsen, J. B., Serusclat, P., Violante, R., Watada, H., Davies, M. Effect of Additional Oral Semaglutide vs Sitagliptin on Glycated Hemoglobin in Adults With Type 2 Diabetes Uncontrolled With Metformin Alone or With Sulfonylurea The PIONEER 3 Randomized Clinical Trial. Jama 321(15): 1466-1480, 2019
Mita, T., Hiyoshi, T., Yoshii, H., Chimori, H., Ikeda, K., Shimizu, M., Kojima, Y., Yamamto, H., Yasuda, D., Sato, J., Watada, H. The Effect of Linagliptin versus Metformin Treatment Related Qualiy of Life in Patients with Type 2 Diabetes Mellitus. Diabes Ther 10(1): 119-134, 2019
Araki, E., Yamashita, S., Arai, H., Yokote, K., Satoh, J., Inoguchi, T., Nakamura, J., Maegawa, H., Yoshioka, N., Tanizawa, Y., Watada, H., Suganami, H., Ishibashi, S. The Efficacy and Safety of Pemafibrate in Patients with Type 2 Diabetes and Elevated Triglyceride levels: 52-Week Data From The PROVIDE Study. Diabetes Obes Metab 21(7): 1737-1744, 2019
Yazawa, R., Nishida, Y., Aoyama, S., Tanida, I., Miyatsuka, T., Suzuki, L., Himuro, M., Haruna, H., Takubo, N., Shimizu, T., Watada, H. Establishment of a system for screening autophagic flux regulators using a modified fluorescent reporter and CRISPR/Cas9. Biochem Biophys Res Commun 516(3): 686-692, 2019
Satoh, H., Ohira, T., Nagai, M., Hosoya, M., Sakai, A., Yasumura, S., Ohtsuru, A., Kawasaki, Y., Suzuki, H., Takahashi, A., Sugiura, Y., Shishido, H., Hayashi, Y., Takahashi, H., Kobashi, G., Ozasa, K., Hashimoto, S., Ohto, H., Abe, M., Kamiya, Fukushima Health Management Survey G. Evacuation is a risk factor for diabetes development among evacuees of the Great East Japan earthquake: A 4-year follow-up of the Fukushima Health Management Survey. Diabetes Metab 45(3): 312-315, 2019
Kudo, A., Asahi, K., Satoh, H., Iseki, K., Moriyama, T., Yamagata, K., Tsuruya, K., Fujimoto, S., Narita, I., Konta, T., Kondo, M., Shibagaki, Y., Kasahara, M., Watanabe, T., Shimabukuro, M. Fast eating is a strong risk factor for new-onset diabetes among the Japanese general population. Sci Rep 9: 8210, 2019
Kadowaki, S., Tamura, Y., Someya, Y., Takeno, K., Kaga, H., Sugimoto, D., Kakehi, S., Funayama, T., Furukawa, Y., Suzuki, R., Nishitani-Yokoyama, M., Shimada, K., Daida, H., Aoki, S., Kanazawa, A., Kawamori, R., Watada, H. Fatty Liver Has Stronger Association With Insulin Resistance Than Visceral Fat Accumulation in Nonobese Japanese Men. J Endocr Soc 3(7): 1409-1416, 2019
Watada, H., Shiramoto, M., Irie, S., Terauchi, Y., Yamada, Y., Shiosakai, K., Myobatake, Y., Taguchi, T. G protein-coupled receptor 119 agonist DS-8500a effects on pancreatic beta-cells in Japanese type 2 diabetes mellitus patients. J Diabetes Investig 10(1): 84-93, 2019
Kaga, H., Tamura, Y., Takeno, K., Kakehi, S., Someya, Y., Funayama, T., Furukawa, Y., Suzuki, R., Sugimoto, D., Kadowaki, S., Nishitani-Yokoyama, M., Shimada, K., Daida, H., Aoki, S., Giacca, A., Kanazawa, A., Kawamori, R., Watada, H. Higher C-Peptide Level During Glucose Clamp Is Associated With Muscle Insulin Resistance in Nonobese Japanese Men. J Endocr Soc 3(10): 1847-1857, 2019
Zhou, F. L., Watada, H., Tajima, Y., Berthelot, M., Kang, D., Esnault, C., Shuto, Y., Maegawa, H., Koya, D. Identification of subgroups of patients with type 2 diabetes with differences in renal function preservation, comparing patients receiving sodium-glucose co-transporter-2 inhibitors with those receiving dipeptidyl peptidase-4 inhibitors, using a supervised machine-learning algorithm (PROFILE study): A retrospective analysis of a Japanese commercial medical database. Diabetes Obes Metab 21(8): 1925-1934, 2019
Iso, T., Takahashi, K., Yazaki, K., Ifuku, M., Nii, M., Fukae, T., Yazawa, R., Ishikawa, A., Haruna, H., Takubo, N., Kurita, M., Ikeda, F., Watada, H., Shimizu, T. In-Depth Insight Into the Mechanisms of Cardiac Dysfunction in Patients With Type 1 Diabetes Mellitus Using Layer-Specific Strain Analysis. Circ J 83(6): 1330-1337, 2019
Hirai, H., Asahi, K., Yamaguchi, S., Mori, H., Satoh, H., Iseki, K., Moriyama, T., Yamagata, K., Tsuruya, K., Fujimoto, S., Narita, I., Konta, T., Kondo, M., Shibagaki, Y., Kasahara, M., Watanabe, T., Shimabukuro, M. New risk prediction model of coronary heart disease in participants with and without diabetes: Assessments of the Framingham risk and Suita scores in 3-year longitudinal database in a Japanese population. Sci Rep 9(1): 2813, 2019
Katahira, T., Kanazawa, A., Shinohara, M., Koshibu, M., Kaga, H., Mita, T., Tosaka, Y., Komiya, K., Miyatsuka, T., Ikeda, F., Azuma, K., Takayanagi, N., Ogihara, T., Ohmura, C., Miyachi, A., Mieno, E., Yamashita, S., Watada, H. Postprandial Plasma Glucagon Kinetics in Type 2 Diabetes Mellitus: Comparison of Immunoassay and Mass Spectrometry. J Endocr Soc 3(1): 42-51, 2019
Mita, T., Katakami, N., Okada, Y., Yoshii, H., Osonoi, T., Nishida, K., Shiraiwa, T., Torimoto, K., Kurozumi, A., Wakasugi, S., Gosho, M., Shimomura, I., Watada, H. Protocol of a Prospective Observational Study on the Relationship Between Glucose Fluctuation and Cardiovascular Events in Patients with Type 2 Diabetes. Diabetes Ther 10(5): 1565-1575, 2019
Ohmura, H., Mita, T., Matsuoka, J., Nojiri, S., Nishizaki, Y., Watada, H., Daida, H. Real-World Data on the Incidence of Macrovascular Complications in Japanese Patients with Type 2 Diabetes: The Sitagliptin Registration Type 2 Diabetes-Juntendo Collaborating Project. Diabetes Ther 10(3): 1099-1111, 2019
Someya, Y., Tamura, Y., Kaga, H., Nojiri, S., Shimada, K., Daida, H., Ishijima, M., Kaneko, K., Aoki, S., Miida, T., Hirayama, S., Konishi, S., Hattori, N., Motoi, Y., Naito, H., Kawamori, R., Watada, H. Skeletal muscle function and need for long-term care of urban elderly people in Japan (the Bunkyo Health Study): a prospective cohort study. BMJ Open 9(9): e031584, 2019
Tomiyama, H., Ohkuma, T., Ninomiya, T., Mastumoto, C., Kario, K., Hoshide, S., Kita, Y., Inoguchi, T., Maeda, Y., Kohara, K., Tabara, Y., Nakamura, M., Ohkubo, T., Watada, H., Munakata, M., Ohishi, M., Ito, N., Nakamura, M., Shoji, T., Vlachopoulos, C., Aboyans, V., Yamashina, A., Collaborative Group for J BAVELs. Steno-Stiffness Approach for Cardiovascular Disease Risk Assessment in Primary Prevention. Hypertension 73(3): 508-513, 2019
Watada, H., Kaneko, S., Komatsu, M., Agner, B., Nishida, T., Ranthe, M., Nakamura, J. Superior HbA1c control with the fixed-ratio combination of insulin degludec and liraglutide (IDegLira) compared with a maximum dose of 50 units of insulin degludec in Japanese individuals with type 2 diabetes in a phase 3, double-blind, randomized trial. Diabetes Obes Metab 21(12): 2694-2703, 2019
Suzuki, R., Tamura, Y., Takeno, K., Kakehi, S., Funayama, T., Furukawa, Y., Kaga, H., Sugimoto, D., Kadowaki, S., Someya, Y., Kanazawa, A., Kawamori, R., Watada, H. Three days of a eucaloric, low-carbohydrate/high-fat diet increases insulin clearance in healthy non-obese Japanese men. Sci Rep 9(1): 3857, 2019
Gomes, M. B., Rathmann, W., Charbonnel, B., Khunti, K., Kosiborod, M., Nicolucci, A., Pocock, S. J., Shestakova, M. V., Shimomura, I., Tang, F., Watada, H., Chen, H., Cid-Ruzafa, J., Fenici, P., Hammar, N., Surmont, F., Ji, L. Treatment of type 2 diabetes mellitus worldwide: Baseline patient characteristics in the global DISCOVER study. Diabetes Res Clin Pract 151: 20-32, 2019
Nicolucci, A., Charbonnel, B., Gomes, M. B., Khunti, K., Kosiborod, M., Shestakova, M. V., Shimomura, I., Watada, H., Chen, H., Cid-Ruzafa, J., Fenici, P., Hammar, N., Surmont, F., Tang, F., Pocock, S. Treatment patterns and associated factors in 14 668 people with type 2 diabetes initiating a second-line therapy: Results from the global DISCOVER study programme. Diabetes Obes Metab 21(11): 2474-2485, 2019
Watada, H., Shiramoto, M., Ueda, S., Tang, W., Asano, M., Thoren, F., Kim, H., Yajima, T., Boulton, D. W., Araki, E.　Pharmacokinetics and pharmacodynamics of dapagliflozin in combination with insulin in Japanese patients with type 1 diabetes. Diabetes Obes Metab, 2019, 21(4): 876-882

2018年

Araki, E., Yamashita, S., Arai, H., Yokote, K., Satoh, J., Inoguchi, T., Nakamura, J., Maegawa, H., Yoshioka, N., Tanizawa, Y., Watada, H., Suganami, H., Ishibashi, S. Effects of Pemafibrate, a Novel Selective PPARα Modulator, on Lipid and Glucose Metabolism in Patients With Type 2 Diabetes and Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial. Diabetes Care 41(3): 538-546, 2018
Chinzei, K., Shimizu, A., Mori, K., Harada, K., Takeda, H., Hashizume, M., Ishizuka, M., Kato, N., Kawamori, R., Kyo, S., Nagata, K., Yamane, T., Sakuma, I., Ohe, K., Mitsuishi, M. Regulatory Science on AI-based Medical Devices and Systems. Advanced Biomedical Engineering 7: 118-123, 2018
Cigliola, V., Ghila, L., Thorel, F., van Gurp, L., Baronnier, D., Oropeza, D., Gupta, S., Miyatsuka, T., Kaneto, H., Magnuson, M. A., Osipovich, A. B., Sander, M., Wright, C. E. V., Thomas, M. K., Furuyama, K., Chera, S., Herrera, P. L.　Pancreatic islet-autonomous insulin and smoothened-mediated signalling modulate identity changes of glucagon(+) alpha-cells. Nat Cell Biol 20(11): 1267-1277, 2018
Furukawa, Y., Tamura, Y., Takeno, K., Funayama, T., Kaga, H., Suzuki, R., Watanabe, T., Kakehi, S., Kanazawa, A., Kawamori, R., Watada, H. Impaired peripheral insulin sensitivity in non-obese Japanese patients with type 2 diabetes mellitus and fatty liver. J Diabetes Investig 9(3): 529-535, 2018
Goto, H., Mita, T., Fujitani, Y., Fujimoto, S., Takahashi, K., Satoh, H., Hirose, T., Hiyoshi, T., Ai, M., Okada, Y., Nishimura, H., Kuroda, H., Matsubara, T., Gosho, M., Ishii, H., Watada, H. Effects of linagliptin versus voglibose on treatment-related quality of life in patients with type 2 diabetes: sub-analysis of the L-STEP study. Endocr J 65(5): 657-668, 2018
Honda, A., Komiya, K., Hara, A., Fukunaka, A., Suzuki, L., Miyatsuka, T., Ogihara, T., Fujitani, Y., Watada, H. Normal pancreatic β-cell function in mice with Rip-Cre-mediated inactivation of p62/SQSTM1. Endocrine Journal 65(1): 83-89, 2018
Horikawa, Y., Enya, M., Mabe, H., Fukushima, K., Takubo, N., Ohashi, M., Ikeda, F., Hashimoto, K. I., Watada, H., Takeda, J. NEUROD1-deficient diabetes (MODY6): Identification of the first cases in Japanese and the clinical features. Pediatr Diabetes 19(2): 236-242, 2018
Irie, Y., Katakami, N., Mita, T., Takahara, M., Matsuoka, T. A., Gosho, M., Watada, H., Shimomura, I., Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis, C. Evaluation of the Effect of Alogliptin on Tissue Characteristics of the Carotid Wall: Subanalysis of the SPEAD-A Trial. Diabetes Ther 9(1): 317-329, 2018
Kaku, K., Yamada, Y., Watada, H., Abiko, A., Nishida, T., Zacho, J., Kiyosue, A. Safety and efficacy of once-weekly semaglutide vs additional oral antidiabetic drugs in Japanese people with inadequately controlled type 2 diabetes: A randomized trial. Diabetes Obes Metab 20(5): 1202-1212, 2018
Kamitani, M., Miyatsuka, T., Miura, M., Azuma, K., Suzuki, L., Himuro, M., Katahira, T., Nishida, Y., Fujitani, Y., Watada, H. Heterogeneity of autophagic status in pancreatic β cells under metabolic stress. Biochem Biophys Res Commun 496(2): 328-334, 2018
Kanda, E., Kashihara, N., Matsushita, K., Usui, T., Okada, H., Iseki, K., Mikami, K., Tanaka, T., Wada, T., Watada, H., Ueki, K., Nangaku, M., Research Working Group for Establishing Guidelines for Clinical Evaluation of Chronic Kidney Disease. Guidelines for clinical evaluation of chronic kidney disease : AMED research on regulatory science of pharmaceuticals and medical devices. Clin Exp Nephrol 22(6): 1446-1475, 2018
Katakami, N., Mita, T., Gosho, M., Takahara, M., Irie, Y., Yasuda, T., Matsuoka, T. A., Osonoi, T., Watada, H., Shimomura, I. Clinical Utility of Carotid Ultrasonography in The Prediction of Cardiovascular Events in Patients with Diabetes: A Combined Analysis of Data Obtained in Five Longitudinal Studies. J Atheroscler Thromb 25(10): 1053-1066, 2018
Katakami, N., Mita, T., Irie, Y., Takahara, M., Matsuoka, T. A., Gosho, M., Watada, H., Shimomura, I., Sitagliptin Preventive study of Intima-media thickness Evaluation (SPIKE) Collaborators. Effect of sitagliptin on tissue characteristics of the carotid wall in patients with type 2 diabetes: a post hoc sub-analysis of the sitagliptin preventive study of intima-media thickness evaluation (SPIKE). Cardiovasc Diabetol 17(1): 24, 2018
Katakami, N., Mita, T., Takahara, M., Hashigami, K., Kawashima, M., Shimomura, I., Watada, H., J-DISCOVER study group. Rationale and Design for the J-DISCOVER Study: DISCOVERing the Treatment Reality of Type 2 Diabetes in a Real-World Setting in Japan-A Protocol. Diabetes Ther 9(1): 165-175, 2018
Kawamori, R., Haneda, M., Suzaki, K., Cheng, G., Shiki, K., Miyamoto, Y., Solimando, F., Lee, C., Lee, J., George, J. Empagliflozin as add-on to linagliptin in a fixed-dose combination in Japanese patients with type 2 diabetes: Glycaemic efficacy and safety profile in a 52-week, randomized, placebo-controlled trial. Diabetes Obes Metab 20(9): 2200-2209, 2018
Kosiborod, M., Gomes, M. B., Nicolucci, A., Pocock, S., Rathmann, W., Shestakova, M. V., Watada, H., Shimomura, I., Chen, H., Cid-Ruzafa, J., Fenici, P., Hammar, N., Surmont, F., Tang, F., Khunti, K., DISCOVER investigators. Vascular complications in patients with type 2 diabetes: prevalence and associated factors in 38 countries (the DISCOVER study program). Cardiovasc Diabetol 17(1): 150, 2018
Kudoh, A., Satoh, H., Hirai, H., Watanabe, T., Shimabukuro, M. Preliminary Evidence for Adipocytokine Signals in Skeletal Muscle Glucose Uptake. Front Endocrinol (Lausanne) 9: 295, 2018
Kurozumi, A., Okada, Y., Satoh, H., Inoue, I., Chimori, H., Akita, E., Shiraiwa, T., Fujitani, Y., Mita, T., Gosho, M., Watada, H. Effects of linagliptin monotherapy compared with voglibose on postprandial lipid profiles in Japanese patients with type 2 diabetes: linagliptin study of effects on postprandial blood glucose (L-STEP) sub-study 1. Endocr J 65(4): 415-425, 2018
Masuyama, A., Mita, T., Azuma, K., Osonoi, Y., Nakajima, K., Goto, H., Nishida, Y., Miyatsuka, T., Mitsumata, M., Watada, H. Defective autophagy in vascular smooth muscle cells enhances atherosclerotic plaque instability. Biochem Biophys Res Commun 505(4): 1141-1147, 2018
Mita, T., Hiyoshi, T., Yoshii, H., Chimori, H., Ikeda, K., Sato, J., Watada, H. Study Protocol for the Initial Choice of DPP-4 Inhibitor in Japanese Patients with Type 2 diabetes Mellitus: Effect of Linagliptin on QOL (INTEL-QOL) Trial. Diabetes Ther 9(3): 1403-1412, 2018
Miura, M., Miyatsuka, T., Katahira, T., Sasaki, S., Suzuki, L., Himuro, M., Nishida, Y., Fujitani, Y., Matsuoka, T. A., Watada, H. Suppression of STAT3 signaling promotes cellular reprogramming into insulin-producing cells induced by defined transcription factors. EBioMedicine 36: 358-366, 2018
Ogata, E., Asahi, K., Yamaguchi, S., Iseki, K., Sato, H., Moriyama, T., Yamagata, K., Tsuruya, K., Fujimoto, S., Narita, I., Konta, T., Kondo, M., Shibagaki, Y., Kasahara, M., Watanabe, T., Shimabukuro, M. Low fasting plasma glucose level as a predictor of new-onset diabetes mellitus on a large cohort from a Japanese general population. Sci Rep 8(1): 13927, 2018
Ohkuma, T., Ninomiya, T., Tomiyama, H., Kario, K., Hoshide, S., Kita, Y., Inoguchi, T., Maeda, Y., Kohara, K., Tabara, Y., Nakamura, M., Ohkubo, T., Watada, H., Munakata, M., Ohishi, M., Ito, N., Nakamura, M., Shoji, T., Vlachopoulos, C., Aboyans, V., Yamashina, A., collaborative group for the Japan Brachial-Ankle pulse wave VELocity individual participant data meta-analysis of prospective studies to examine the significance of the Ankle-Brachial Index (J-BAVEL-ABI). Ankle-brachial index measured by oscillometry is predictive for cardiovascular disease and premature death in the Japanese population: An individual participant data meta-analysis. Atherosclerosis 275: 141-148, 2018
Oshima, M., Toyama, T., Haneda, M., Furuichi, K., Babazono, T., Yokoyama, H., Iseki, K., Araki, S., Ninomiya, T., Hara, S., Suzuki, Y., Iwano, M., Kusano, E., Moriya, T., Satoh, H., Nakamura, H., Shimizu, M., Hara, A., Makino, H., Wada, T., Research Group of Diabetic Nephropathy, Ministry of Health, Labour, and Welfare of Japan. Estimated glomerular filtration rate decline and risk of end-stage renal disease in type 2 diabetes. PLoS One 13(8): e0201535, 2018
Osonoi, Y., Mita, T., Azuma, K., Nakajima, K., Masuyama, A., Goto, H., Nishida, Y., Miyatsuka, T., Fujitani, Y., Koike, M., Mitsumata, M., Watada, H. Defective autophagy in vascular smooth muscle cells enhances cell death and atherosclerosis. Autophagy 14(11): 1991-2006, 2018
Sagesaka, H., Sato, Y., Someya, Y., Tamura, Y., Shimodaira, M., Miyakoshi, T., Hirabayashi, K., Koike, H., Yamashita, K., Watada, H., Aizawa, T. Type 2 Diabetes: When Does It Start?. J Endocr Soc 2(5): 476-484, 2018
Shioya-Yamada, M., Shimada, K., Nishitani-Yokoyama, M., Sai, E., Takeno, K., Tamura, Y., Watada, H., Kawamori, R., Daida, H., Kawai, S. Association Between Visceral Fat Accumulation and Exercise Tolerance in Non-Obese Subjects Without Diabetes. J Clin Med Res 10(8): 630-635, 2018
Someya, Y., Tamura, Y., Suzuki, R., Kaga, H., Kadowaki, S., Sugimoto, D., Kakehi, S., Funayama, T., Furukawa, Y., Takeno, K., Sato, J., Kanazawa, A., Kawamori, R., Watada, H. Characteristics of Glucose Metabolism in Underweight Japanese Women. J Endocr Soc 2(3): 279-289, 2018
Suzuki, L., Miyatsuka, T., Himuro, M., Nishio, R., Goto, H., Uchida, T., Nishida, Y., Kanazawa, A., Watada, H. Everolimus Directly Suppresses Insulin Secretion Independently of Cell Growth Inhibition. J Endocr Soc 2(7): 589-596, 2018
Taira, M., Imamura, M., Takahashi, A., Kamatani, Y., Yamauchi, T., Araki, S., Tanaka, N., van Zuydam, N., Ahlqvist, E., Toyoda, M., Umezono, T., Kawai, K., Imanishi, M., Watada, H., Suzuki, D., Maegawa, H., Babazono, T., Kaku, K., Kawamori, R., SUMMIT Consortium., Groop LC., McCarthy, MI., Kadowaki, T., Maeda, S. A variant within the FTO confers susceptibility to diabetic nephropathy in Japanese patients with type 2 diabetes. PLoS One 13(12): e0208654, 2018
Tanaka, R., Masuda, H., Fujimura, S., Ito-Hirano, R., Arita, K., Kakinuma, Y., Hagiwara, H., Kado, M., Hayashi, A., Mita, T., Ogawa, T., Watada, H., Mizuno, H., Sawada, N., Asahara, T. Quality-Quantity Control Culture Enhances Vasculogenesis and Wound Healing Efficacy of Human Diabetic Peripheral Blood CD34+ Cells. Stem Cells Transl Med 7(5): 428-438, 2018,
Terauchi, Y., Yamada, Y., Watada, H., Nakatsuka, Y., Shiosakai, K., Washio, T., Taguchi, T. Efficacy and safety of the G protein-coupled receptor 119 agonist DS-8500a in Japanese type 2 diabetes mellitus patients with inadequate glycemic control on sitagliptin: A phase 2 randomized placebo-controlled study. J Diabetes Investig 9(6): 1333-1341, 2018
Tomiyama, H., Ohkuma, T., Ninomiya, T., Mastumoto, C., Kario, K., Hoshide, S., Kita, Y., Inoguchi, T., Maeda, Y., Kohara, K., Tabara, Y., Nakamura, M., Ohkubo, T., Watada, H., Munakata, M., Ohishi, M., Ito, N., Nakamura, M., Shoji, T., Vlachopoulos, C., Yamashina, A., collaborative group for J-BAVEL-IAD (Japan Brachial-Ankle Pulse Wave Velocity Individual Participant Data Meta-Analysis of Prospective Studies to Examine the Significance of Inter-Arm Blood Pressure Difference). Simultaneously Measured Interarm Blood Pressure Difference and Stroke: An Individual Participants Data Meta-Analysis. Hypertension 71(6): 1030-1038, 2018
Uesato, T., Ogihara, T., Hara, A., Iida, H., Miyatsuka, T., Fujitani, Y., Takeda, S., Watada, H. Enhanced Expression of the Key Mitosis Regulator Cyclin B1 Is Mediated by PDZ-Binding Kinase in Islets of Pregnant Mice. Journal of Endocrine Society 2(3): 207-219, 2018
Yamada, Y., Terauchi, Y., Watada, H., Nakatsuka, Y., Shiosakai, K., Washio, T., Taguchi, T. Efficacy and Safety of GPR119 Agonist DS-8500a in Japanese Patients with Type 2 Diabetes: a Randomized, Double-Blind, Placebo-Controlled, 12-Week Study. Adv Ther 35(3): 367-381, 2018

2017年

Yamamoto, Y., Miyatsuka, T., Sasaki, S., Miyashita, K., Kubo, F., Shimo, N., Takebe, S., Watada, H., Kaneto, H., Matsuoka, T., Shimomura, I. Preserving expression of Pdx1 improves β-cell failure in diabetic mice. Biochem Biophys Res Commun 483(1): 418-424, 2017
Ohkuma, T., Tomiyama, H., Ninomiya, T., Kario, K., Hoshide, S., Kita, Y., Inoguchi, T., Maeda, Y., Kohara, K., Tabara, Y., Nakamura, M., Ohkubo, T., Watada, H., Munakata, M., Ohishi, M., Ito, N., Nakamura, M., Shoji, T., Vlachopoulos, C., Yamashina, A. Proposed Cutoff Value of Brachial-Ankle Pulse Wave Velocity for the Management of Hypertension. Circ J 81(10): 1540-1542, 2017
Sato, J., Kanazawa, A., Makita, S., Hatae, C., Komiya, K., Shimizu, T., Ikeda, F., Tamura, Y., Ogihara, T., Mita, T., Goto, H., Uchida, T., Miyatsuka, T., Takeno, K., Shimada, S., Ohmura, C., Watanabe, T., Kobayashi, K., Miura, Y., Iwaoka, M., Hirashima, N., Fujitani, Y., Watada, H. A randomized controlled trial of 130 g/day low-carbohydrate diet in type 2 diabetes with poor glycemic control. Clin Nutr 36(4): 992-1000, 2017
Mita, T., Katakami, N., Shiraiwa, T., Yoshii, H., Onuma, T., Kuribayashi, N., Osonoi, T., Kaneto, H., Kosugi, K., Umayahara, Y., Yamamoto, T., Matsumoto, K., Yokoyama, H., Tsugawa, M., Gosho, M., Shimomura, I., Watada, H., Collaborators on the Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE) Trial. Erratum. Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE). A Randomized Controlled Trial. Diabetes Care 2016;39: 455-464. Diabetes Care 40(6): 808, 2017
Mita, T., Katakami, N., Yoshii, H., Onuma, T., Kaneto, H., Osonoi, T., Shiraiwa, T., Kosugi, K., Umayahara, Y., Yamamoto, T., Yokoyama, H., Kuribayashi, N., Jinnouchi, H., Gosho, M., Shimomura, I., Watada, H., Collaborators on the Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A) Trial. Alogliptin, a Dipeptidyl Peptidase 4 Inhibitor, Prevents the Progression of Carotid Atherosclerosis in Patients With Type 2 Diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A). Diabetes Care 2016;39: 139-148. Diabetes Care 40(6): 808, 2017
Satoh, H., Ohira, T., Moriya, C., Inoue, I., Kuribayashi, S., Seino, H., Hirai, H., Hiyoshi, T., Watada, H., L-CGM Study Group. Effects of linagliptin vs. voglibose on daily glucose excursions during continuous glucose monitoring of Japanese type 2 diabetes patients (L-CGM): A randomized, open-label, two-arm, parallel comparative trial.　 Diabetes Metab 43(6): 550-553, 2017
Watada, H., Su, Q., Li, P., Iwamoto, N., Qian, L., Yang, W. Comparison of insulin lispro mix 25 with insulin lispro mix 50 as an insulin starter in Asian patients with type 2 diabetes: a phase 4, open-label, randomized trial (CLASSIFY study). Diabetes Metab Res Rev 33(1): e2816, 2017
Mita, T., Katakami, N., Shiraiwa, T., Yoshii, H., Gosho, M., Ishii, H., Shimomura, I., Watada, H., SPIKE Trial Site Investigators. The Influence of Sitagliptin on Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus Receiving Insulin Treatment: A Prespecified Sub-Analysis. Diabetes Ther 8(3): 693-704, 2017
Mita, T., Katakami, N., Shiraiwa, T., Yoshii, H., Gosho, M., Shimomura, I., Watada, H. Dose-Dependent Effect of Sitagliptin on Carotid Atherosclerosis in Patients with Type 2 Diabetes Mellitus Receiving Insulin Treatment: A Post Hoc Analysis. Diabetes Ther 8(5): 1135-1146, 2017
Katakami, N., Mita, T., Yoshii, H., Shiraiwa, T., Yasuda, T., Okada, Y., Umayahara, Y., Kaneto, H., Osonoi, T., Yamamoto, T., Kuribayashi, N., Maeda, K., Yokoyama, H., Kosugi, K., Ohtoshi, K., Hayashi, I., Sumitani, S., Tsugawa, M., Ohashi, M., Taki, H., Nakamura, T., Kawashima, S., Sato, Y., Watada, H., Shimomura, I., UTOPIA study investigators. Rationale, Design, and Baseline Characteristics of the Utopia Trial for Preventing Diabetic Atherosclerosis Using an SGLT2 Inhibitor: A Prospective, Randomized, Open-Label, Parallel-Group Comparative Study. Diabetes Ther 8(5): 999-1013, 2017
Odawara, M., Kawamori, R., Tajima, N., Iwamoto, Y., Kageyama, S., Yodo, Y., Ueki, F., Hotta, N. Long-term treatment study of global standard dose metformin in Japanese patients with type 2 diabetes mellitus. Diabetol Int 8(3): 286-295, 2017
Ishii, H., Niiya, T., Ono, Y., Inaba, N., Jinnouchi, H., Watada, H. Improvement of quality of life through glycemic control by liraglutide, a GLP-1 analog, in insulin-naive patients with type 2 diabetes mellitus: the PAGE1 study. Diabetol Metab Syndr 9: 3, 2017
Watada, H., Imori, M., Li, P., Iwamoto, N. Insulin lispro 25/75 and insulin lispro 50/50 as starter insulin in Japanese patients with type 2 diabetes: subanalysis of the CLASSIFY randomized trial. Endocr J 64(7): 705-717, 2017
Uchida, T., Nishimoto, K., Fukumura, Y., Asahina, M., Goto, H., Kawano, Y., Shimizu, F., Tsujimura, A., Seki, T., Mukai, K., Kabe, Y., Suematsu, M., Sanchez, G. C., Yao, T., Horie, S., Watada, H. Disorganized Steroidogenesis in Adrenocortical Carcinoma, a Case Study. Endocr Pathol 28(1): 27-35, 2017
Honda, A., Uchida, T., Komiya, K., Goto, H., Takeno, K., Sato, J., Suzuki, R., Himuro, M., Watada, H. RELATIONSHIP BETWEEN THE EFFECTIVENESS OF INORGANIC IODINE AND THE SEVERITY OF GRAVES' THYROTOXICOSIS: A RETROSPECTIVE STUDY. Endocr Pract 23(12): 1408-1413, 2017
Sato, J., Uchida, T., Komiya, K., Goto, H., Takeno, K., Suzuki, R., Honda, A., Himuro, M., Watada, H. Comparison of the therapeutic effects of prednisolone and nonsteroidal anti-inflammatory drugs in patients with subacute thyroiditis. Endocrine 55(1): 209-214, 2017
Onose, H., Uchida, T., Sato, J., Ishii, S., Yamada, E., Yamada, T., Watada, H. Monocyte and Basophil Counts as Predictors of Neutrophil Count Recovery in Patients with Thiamazole-induced Agranulocytosis. Exp Clin Endocrinol Diabetes 125(1): 49-52, 2017
Suzuki, L., Kanazawa, A., Uzawa, H., Osonoi, Y., Masuyama, A., Azuma, K., Takeno, K., Takayanagi, N., Sato, J., Someya, Y., Komiya, K., Goto, H., Mita, T., Ikeda, F., Ogihara, T., Shimizu, T., Ohmura, C., Saito, M., Osonoi, T., Watada, H. Safety and efficacy of metformin up-titration in Japanese patients with type 2 diabetes mellitus treated with vildagliptin and low-dose metformin. Expert Opin Pharmacother 18(18): 1921-1928, 2017
Sai, E., Shimada, K., Yokoyama, T., Hiki, M., Sato, S., Hamasaki, N., Maruyama, M., Morimoto, R., Miyazaki, T., Fujimoto, S., Tamura, Y., Aoki, S., Watada, H., Kawamori, R., Daida, H. Myocardial triglyceride content in patients with left ventricular hypertrophy: comparison between hypertensive heart disease and hypertrophic cardiomyopathy. Heart Vessels 32(2): 166-174, 2017
Shigiyama, F., Kumashiro, N., Furukawa, Y., Funayama, T., Takeno, K., Wakui, N., Ikehara, T., Nagai, H., Taka, H., Fujimura, T., Uchino, H., Tamura, Y., Watada, H., Nemoto, T., Shiraga, N., Sumino, Y., Hirose, T. Characteristics of hepatic insulin-sensitive nonalcoholic fatty liver disease. Hepatol Commun 1(7): 634-647, 2017
Ohkuma, T., Ninomiya, T., Tomiyama, H., Kario, K., Hoshide, S., Kita, Y., Inoguchi, T., Maeda, Y., Kohara, K., Tabara, Y., Nakamura, M., Ohkubo, T., Watada, H., Munakata, M., Ohishi, M., Ito, N., Nakamura, M., Shoji, T., Vlachopoulos, C., Yamashina, A., Collaborative Group for J-BAVEL (Japan Brachial-Ankle Pulse Wave Velocity Individual Participant Data Meta-Analysis of Prospective Studies). Brachial-Ankle Pulse Wave Velocity and the Risk Prediction of Cardiovascular Disease: An Individual Participant Data Meta-Analysis. Hypertension 69(6): 1045-1052, 2017
Mita, T., Katakami, N., Shiraiwa, T., Yoshii, H., Gosho, M., Shimomura, I., Watada, H. The Effect of Sitagliptin on the Regression of Carotid Intima-Media Thickening in Patients with Type 2 Diabetes Mellitus: A Post Hoc Analysis of the Sitagliptin Preventive Study of Intima-Media Thickness Evaluation. Int J Endocrinol 2017: 1925305, 2017
Nishioka, K., Uchida, T., Usui, C., Tanaka, R., Matsushima, T., Matsumoto, Y., Nakamura, I., Nishioka, K., Hattori, N. High prevalence of anti-TSH receptor antibody in fibromyalgia syndrome. Int J Rheum Dis 20(6): 685-690, 2017
Hashimoto, S., Nagai, M., Fukuma, S., Ohira, T., Hosoya, M., Yasumura, S., Satoh, H., Suzuki, H., Sakai, A., Ohtsuru, A., Kawasaki, Y., Takahashi, A., Ozasa, K., Kobashi, G., Kamiya, K., Yamashita, S., Fukuhara, S., Ohto, H., Abe, M., Fukushima Health Management Survey Group. Influence of Post-disaster Evacuation on Incidence of Metabolic Syndrome. J Atheroscler Thromb 24(3): 327-337, 2017
Kuramitsu, S., Miyauchi, K., Yokoi, H., Suwa, S., Nishizaki, Y., Yokoyama, T., Nojiri, S., Iwabuchi, M., Shirai, S., Ando, K., Okazaki, S., Tamura, H., Watada, H., Daida, H. Effect of sitagliptin on plaque changes in coronary artery following acute coronary syndrome in diabetic patients: The ESPECIAL-ACS study. J Cardiol 69(1): 369-376, 2017
Koga, M., Inada, S., Nakao, T., Kawamori, R., Kasayama, S. The Glycated Albumin (GA) to HbA1c Ratio Reflects Shorter-Term Glycemic Control than GA: Analysis of Patients with Fulminant Type 1 Diabetes. J Clin Lab Anal 31(1): e22023 2017
Hamamura, M., Mita, T., Osonoi, Y., Osonoi, T., Saito, M., Tamasawa, A., Nakayama, S., Someya, Y., Ishida, H., Gosho, M., Kanazawa, A., Watada, H. Relationships Among Conventional Cardiovascular Risk Factors and Lifestyle Habits With Arterial Stiffness in Type 2 Diabetic Patients. J Clin Med Res 9(4): 297-302, 2017
Saito, D., Kanazawa, A., Shigihara, N., Sato, F., Uchida, T., Sato, J., Goto, H., Miyatsuka, T., Ikeda, F., Ogihara, T., Ohmura, C., Watada, H. Efficacy and Safety of Vildagliptin as an Add-On Therapy in Inadequately Controlled Type 2 Diabetes Patients Treated With Basal Insulin. J Clin Med Res 9(3): 193-199, 2017
Sugaya, Y., Satoh, H. Liver-specific G0 /G1 switch gene 2 (G0s2) expression promotes hepatic insulin resistance by exacerbating hepatic steatosis in male Wistar rats. J Diabetes 9(8): 754-763, 2017
Ji, L., Bonnet, F., Charbonnel, B., Gomes, M. B., Kosiborod, M., Khunti, K., Nicolucci, A., Pocock, S., Rathmann, W., Shestakova, M. V., Shimomura, I., Watada, H., Fenici, P., Hammar, N., Hashigami, K., Macaraeg, G., Surmont, F., Medina, J. Towards an improved global understanding of treatment and outcomes in people with type 2 diabetes: Rationale and methods of the DISCOVER observational study program. J Diabetes Complications 31(7): 1188-1196, 2017
Chen, W., Qian, L., Watada, H., Li, P., Iwamoto, N., Imori, M., Yang, W. Impact of diet on the efficacy of insulin lispro mix 25 and insulin lispro mix 50 as starter insulin in East Asian patients with type 2 diabetes: Subgroup analysis of the Comparison Between Low Mixed Insulin and Mid Mixed Insulin as Starter Insulin For Patients with Type 2 Diabetes Mellitus (CLASSIFY Study) randomized trial. J Diabetes Investig 8(1): 75-83, 2017
Mita, T., Katakami, N., Shiraiwa, T., Yoshii, H., Gosho, M., Shimomura, I., Watada, H., Sitagliptin Preventive Study of Intima-media Thickness Evaluation (SPIKE) Trial. Changes in carotid intima-media thickening in patients with type 2 diabetes mellitus: Subanalysis of the Sitagliptin Preventive Study of Intima-Media Thickness Evaluation. J Diabetes Investig 8(2): 254-255, 2017
Takahashi, A., Ohira, T., Hosoya, M., Yasumura, S., Nagai, M., Ohira, H., Hashimoto, S., Satoh, H., Sakai, A., Ohtsuru, A., Kawasaki, Y., Suzuki, H., Kobashi, G., Ozasa, K., Yamashita, S., Kamiya, K., Abe, M., Fukushima Health Management Survey Group. Effect of evacuation on liver function after the Fukushima Daiichi Nuclear Power Plant accident: The Fukushima Health Management Survey. J Epidemiol 27(4): 180-185, 2017
Yokomichi, H., Nagai, A., Hirata, M., Kiyohara, Y., Muto, K., Ninomiya, T., Matsuda, K., Kamatani, Y., Tamakoshi, A., Kubo, M., Nakamura, Y., BioBank Japan Cooperative Hospital Group., Yamagata, Z. Survival of macrovascular disease, chronic kidney disease, chronic respiratory disease, cancer and smoking in patients with type 2 diabetes: BioBank Japan cohort. J Epidemiol 27(3S): S98-S106, 2017
Suzuki, L., Hirayama, S., Fukui, M., Sasaki, M., Hiroi, S., Ayaori, M., Terai, S., Tozuka, M., Watada, H., Miida, T. Lipoprotein-X in cholestatic patients causes xanthomas and promotes foam cell formation in human macrophages. Journal of Clinical Lipidology 11(1): 110-118, 2017
Osada, T., Suzuki, R., Ogawa, A., Tanaka, M., Hori, M., Aoki, S., Tamura, Y., Watada, H., Kawamori, R. Functional subdivisions of the hypothalamus using areal parcellation and their signal changes related to glucose metabolism. NeuroImage 162: 1-12, 2017
Eshima, H., Tamura, Y., Kakehi, S., Kurebayashi, N., Murayama, T., Nakamura, K., Kakigi, R., Okada, T., Sakurai, T., Kawamori, R., Watada, H. Long-term, but not short-term high-fat diet induces fiber composition changes and impaired contractile force in mouse fast-twitch skeletal muscle. Physiol Rep 5(7): e13250, 2017
Fukunaka, A., Fukada, T., Bhin, J., Suzuki, L., Tsuzuki, T., Takamine, Y., Bin, B. H., Yoshihara, T., Ichinoseki-Sekine, N., Naito, H., Miyatsuka, T., Takamiya, S., Sasaki, T., Inagaki, T., Kitamura, T., Kajimura, S., Watada, H., Fujitani, Y. Zinc transporter ZIP13 suppresses beige adipocyte biogenesis and energy expenditure by regulating C/EBP-β expression. Plos Genetics 13(8): e1006950, 2017
Ogihara, T., Mita, T., Osonoi, Y., Osonoi, T., Saito, M., Tamasawa, A., Nakayama, S., Someya, Y., Ishida, H., Gosho, M., Kanazawa, A., Watada, H. Relationships between lifestyle patterns and cardio-renal-metabolic parameters in patients with type 2 diabetes mellitus: A cross-sectional study. PLoS One 12(3): e0173540, 2017
Sato, J., Kanazawa, A., Hatae, C., Makita, S., Komiya, K., Shimizu, T., Ikeda, F., Tamura, Y., Ogihara, T., Mita, T., Goto, H., Uchida, T., Miyatsuka, T., Ohmura, C., Watanabe, T., Kobayashi, K., Miura, Y., Iwaoka, M., Hirashima, N., Watada, H. One year follow-up after a randomized controlled trial of a 130 g/day low-carbohydrate diet in patients with type 2 diabetes mellitus and poor glycemic control. PLoS One 12(12): e0188892, 2017
Sakai, A., Nakano, H., Ohira, T., Hosoya, M., Yasumura, S., Ohtsuru, A., Satoh, H., Kawasaki, Y., Suzuki, H., Takahashi, A., Sugiura, Y., Shishido, H., Hayashi, Y., Takahashi, H., Kobashi, G., Ozasa, K., Hashimoto, S., Ohto, H., Abe, M., Fukushima Health Management Survey Group. Persistent prevalence of polycythemia among evacuees 4 years after the Great East Japan Earthquake: A follow-up study. Preventive Medicine Reports 5: 251-256, 2017
Funayama, T., Tamura, Y., Takeno, K., Kawaguchi, M., Kakehi, S., Watanabe, T., Furukawa, Y., Kaga, H., Yamamoto, R., Kanazawa, A., Fujitani, Y., Kawamori, R., Watada, H. Effects of alcohol abstinence on glucose metabolism in Japanese men with elevated fasting glucose: A pilot study. Sci Rep 7: 40277, 2017
Kaga, H., Tamura, Y., Takeno, K., Kakehi, S., Funayama, T., Furukawa, Y., Nishitani-Yokoyama, M., Shimada, K., Daida, H., Aoki, S., Giacca, A., Kanazawa, A., Kawamori, R., Watada, H. Correlates of insulin clearance in apparently healthy non-obese Japanese men. Sci Rep 7(1): 1462, 2017
Mita, T., Katakami, N., Shiraiwa, T., Yoshii, H., Kuribayashi, N., Osonoi, T., Kaneto, H., Kosugi, K., Umayahara, Y., Gosho, M., Shimomura, I., Watada, H. Relationship between frequency of hypoglycemic episodes and changes in carotid atherosclerosis in insulin-treated patients with type 2 diabetes mellitus. Sci Rep 7: 39965, 2017
Sato, J., Kanazawa, A., Azuma, K., Ikeda, F., Goto, H., Komiya, K., Kanno, R., Tamura, Y., Asahara, T., Takahashi, T., Nomoto, K., Yamashiro, Y., Watada, H. Probiotic reduces bacterial translocation in type 2 diabetes mellitus: A randomised controlled study. Sci Rep 7(1): 12115, 2017

2016年

Kakehi, S., Tamura, Y., Takeno, K., Sakurai, Y., Kawaguchi, M., Watanabe, T., Funayama, T., Sato, F., Ikeda, S., Kanazawa, A., Fujitani, Y., Kawamori, R., Watada, H. Increased intramyocellular lipid/impaired insulin sensitivity is associated with altered lipid metabolic genes in muscle of high responders to a high-fat diet. Am J Physiol Endocrinol Metab 310(1): E32-E40, 2016
Ohira, T., Hosoya, M., Yasumura, S., Satoh, H., Suzuki, H., Sakai, A., Ohtsuru, A., Kawasaki, Y., Takahashi, A., Ozasa, K., Kobashi, G., Kamiya, K., Yamashita, S., Abe, M., Fukushima Health Management Survey Group. Effect of Evacuation on Body Weight After the Great East Japan Earthquake. Am J Prev Med 50(5): 553-560, 2016
Ikeda, S., Tamura, Y., Kakehi, S., Sanada, H., Kawamori, R., Watada, H. Exercise-induced increase in IL-6 level enhances GLUT4 expression and insulin sensitivity in mouse skeletal muscle. Biochem Biophys Res Commun 473(4): 947-952, 2016
Kubo, F., Miyatsuka, T., Sasaki, S., Takahara, M., Yamamoto, Y., Shimo, N., Watada, H., Kaneto, H., Gannon, M., Matsuoka, T. A., Shimomura, I. Sustained expression of GLP-1 receptor differentially modulates β-cell functions in diabetic and nondiabetic mice. Biochem Biophys Res Commun 471(1): 68-74, 2016
Tanaka, A., Inoue, T., Kitakaze, M., Oyama, J., Sata, M., Taguchi, I., Shimizu, W., Watada, H., Tomiyama, H., Ako, J., Sakata, Y., Anzai, T., Uematsu, M., Suzuki, M., Eguchi, K., Yamashina, A., Saito, Y., Sato, Y., Ueda, S., Murohara, T., Node, K. Rationale and design of a randomized trial to test the safety and non-inferiority of canagliflozin in patients with diabetes with chronic heart failure: the CANDLE trial. Cardiovasc Diabetol 15(1): 57, 2016
Mita, T., Katakami, N., Shimomura, I., Watada, H. Response to Comment on Mita et al. Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE): A Randomized Controlled Trial. Diabetes Care 2016;39:455-464. Diabetes Care 39(7): e104-e105, 2016
Mita, T., Katakami, N., Shiraiwa, T., Yoshii, H., Onuma, T., Kuribayashi, N., Osonoi, T., Kaneto, H., Kosugi, K., Umayahara, Y., Yamamoto, T., Matsumoto, K., Yokoyama, H., Tsugawa, M., Gosho, M., Shimomura, I., Watada, H., Collaborators on the Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE) Trial. Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE): A Randomized Controlled Trial. Diabetes Care 39(3): 455-464, 2016
Mita, T., Katakami, N., Yoshii, H., Onuma, T., Kaneto, H., Osonoi, T., Shiraiwa, T., Kosugi, K., Umayahara, Y., Yamamoto, T., Yokoyama, H., Kuribayashi, N., Jinnouchi, H., Gosho, M., Shimomura, I., Watada, H., Collaborators on the Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A) Trial. Alogliptin, a Dipeptidyl Peptidase 4 Inhibitor, Prevents the Progression of Carotid Atherosclerosis in Patients With Type 2 Diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A). Diabetes Care 39(1): 139-148, 2016
Fujitani, Y., Fujimoto, S., Takahashi, K., Satoh, H., Hirose, T., Hiyoshi, T., Ai, M., Okada, Y., Gosho, M., Mita, T., Watada, H. Effects of linagliptin monotherapy compared with voglibose on postprandial blood glucose responses in Japanese patients with type 2 diabetes: Linagliptin Study of Effects on Postprandial blood glucose (L-STEP). Diabetes Res Clin Pract 121: 146-156, 2016
Yamaguchi, H., Arakawa, S., Kanaseki, T., Miyatsuka, T., Fujitani, Y., Watada, H., Tsujimoto, Y., Shimizu, S. Golgi membrane-associated degradation pathway in yeast and mammals. EMBO J 35(18): 1991-2007, 2016
Uchida, T., Suzuki, R., Kasai, T., Onose, H., Komiya, K., Goto, H., Takeno, K., Ishii, S., Sato, J., Honda, A., Kawano, Y., Himuro, M., Yamada, E., Yamada, T., Watada, H. Cutoff value of thyroid uptake of (99m)Tc-pertechnetate to discriminate between Graves' disease and painless thyroiditis: a single center retrospective study. Endocr J 63(2): 143-149, 2016
Teramukai, S., Okuda, Y., Miyazaki, S., Kawamori, R., Shirayama, M., Teramoto, T. Dynamic prediction model and risk assessment chart for cardiovascular disease based on on-treatment blood pressure and baseline risk factors. Hypertens Res 39(2): 113-118, 2016
Ohira, T., Hosoya, M., Yasumura, S., Satoh, H., Suzuki, H., Sakai, A., Ohtsuru, A., Kawasaki, Y., Takahashi, A., Ozasa, K., Kobashi, G., Hashimoto, S., Kamiya, K., Yamashita, S., Abe, M., Fukushima Health Management Survey Group. Evacuation and Risk of Hypertension After the Great East Japan Earthquake: The Fukushima Health Management Survey. Hypertension 68(3): 558-564, 2016
Hirai, H., Fukushima, N., Hasegawa, K., Watanabe, T., Hasegawa, O., Satoh, H. Superior Mesenteric Artery Syndrome Complicated by Diabetic Ketoacidosis and Graves' Disease in Slowly Progressive Insulin Dependent Diabetes Mellitus (SPIDDM): A Case Report and a Review of the Literature. Intern Med 55(15): 2035-2042, 2016
Hirai, H., Midorikawa, S., Suzuki, S., Sasano, H., Watanabe, T., Satoh, H. Somatostatin-secreting Pheochromocytoma Mimicking Insulin-dependent Diabetes Mellitus. Intern Med 55(20): 2985-2991, 2016
Hirai, H., Ogata, E., Ohki, S., Fukuda, I., Tanaka, M., Watanabe, T., Satoh, H. Hypoglycemia Associated with a Gastrointestinal Stromal Tumor Producing High-molecular-weight Insulin Growth Factor II: A Case Report and Literature Review. Intern Med 55(10): 1309-1314, 2016
Satoh, H., Ohira, T., Nagai, M., Hosoya, M., Sakai, A., Watanabe, T., Ohtsuru, A., Kawasaki, Y., Suzuki, H., Takahashi, A., Kobashi, G., Ozasa, K., Yasumura, S., Yamashita, S., Kamiya, K., Abe, M. Prevalence of Renal Dysfunction among Evacuees and Non-evacuees after the Great East Earthquake: Results from the Fukushima Health Management Survey. Intern Med 55(18): 2563-2569, 2016
Satoh, H., Ohira, T., Nagai, M., Hosoya, M., Sakai, A., Watanabe, T., Ohtsuru, A., Kawasaki, Y., Suzuki, H., Takahashi, A., Kobashi, G., Ozasa, K., Yasumura, S., Yamashita, S., Kamiya, K., Abe, M. Hypo-high-density Lipoprotein Cholesterolemia Caused by Evacuation after the Fukushima Daiichi Nuclear Power Plant Accident: Results from the Fukushima Health Management Survey. Intern Med 55(15): 1967-1976, 2016
Takeno, K., Tamura, Y., Kawaguchi, M., Kakehi, S., Watanabe, T., Funayama, T., Furukawa, Y., Kaga, H., Yamamoto, R., Kim, M., Nishitani-Yokoyama, M., Shimada, K., Daida, H., Aoki, S., Taka, H., Fujimura, T., Sawada, S., Giacca, A., Kanazawa, A., Fujitani, Y., Kawamori, R., Watada, H. Relation between insulin sensitivity and metabolic abnormalities in Japanese men with BMI of 23-25 kg/m2. J Clin Endocrinol Metab 101(10): 3676-3684, 2016
Schnell, O., Weng, J., Sheu, W. H., Watada, H., Kalra, S., Soegondo, S., Yamamoto, N., Rathod, R., Zhang, C., Grzeszczak, W. Acarbose reduces body weight irrespective of glycemic control in patients with diabetes: results of a worldwide, non-interventional, observational study data pool. J Diabetes Complications 30(4): 628-637, 2016
Yasuda, H., Hotta, N., Kasuga, M., Kashiwagi, A., Kawamori, R., Yamada, T., Baba, Y., Alev, L., Nakajo, K. Efficacy and safety of 40 mg or 60 mg duloxetine in Japanese adults with diabetic neuropathic pain: Results from a randomized, 52-week, open-label study. J Diabetes Investig 7(4): 100-108, 2016
Moriya, C., Satoh, H. Teneligliptin Decreases Uric Acid Levels by Reducing Xanthine Dehydrogenase Expression in White Adipose Tissue of Male Wistar Rats. J Diabetes Res 2016: 3201534, 2016
Ueyama, M., Nishida, N., Korenaga, M., Korenaga, K., Kumagai, E., Yanai, H., Adachi, H., Katsuyama, H., Moriyama, S., Hamasaki, H., Sako, A., Sugiyama, M., Aoki, Y., Imamura, M., Murata, K., Masaki, N., Kawaguchi, T., Torimura, T., Hyogo, H., Aikata, H., Ito, K., Sumida, Y., Kanazawa, A., Watada, H., Okamoto, K., Honda, K., Kon, K., Kanto, T., Mizokami, M., Watanabe, S. The impact of PNPLA3 and JAZF1 on hepatocellular carcinoma in non-viral hepatitis patients with type 2 diabetes mellitus. J Gastroenterol 51(4): 370-379, 2016
Sato, J., Kanazawa, A., Ikeda, F., Shigihara, N., Kawaguchi, M., Komiya, K., Uchida, T., Ogihara, T., Mita, T., Shimizu, T., Fujitani, Y., Watada, H. Effect of treatment guidance using a retrospective continuous glucose monitoring system on glycaemic control in outpatients with type 2 diabetes mellitus: A randomized controlled trial. J Int Med Res 44(1): 109-121, 2016
Hirai, H., Ogata, E., Kikuchi, N., Kohno, T., Machii, N., Hasegawa, K., Watanabe, T., Satoh, H. The effects of liraglutide on both hypereosinophilic insulin allergy and the characteristics of anti-insulin antibodies in type 2 diabetes mellitus: a case report. J Med Case Rep 10: 202, 2016
Uchida, T., Himuro, M., Komiya, K., Goto, H., Takeno, K., Honda, A., Sato, J., Kawano, Y., Suzuki, R., Watada, H. Evanescent Hyperechoic Changes After Fine-Needle Aspiration Biopsy of the Thyroid in a Series With a Low Overall Prevalence of Complications. Journal of Ultrasound in Medicine 35(3): 599-604, 2016
Imamura, M., Takahashi, A., Yamauchi, T., Hara, K., Yasuda, K., Grarup, N., Zhao, W., Wang, X., Huerta-Chagoya, A., Hu, C., Moon, S., Long, J., Kwak, S. H., Rasheed, A., Saxena, R., Ma, R. C., Okada, Y., Iwata, M., Hosoe, J., Shojima, N., Iwasaki, M., Fujita, H., Suzuki, K., Danesh, J., Jorgensen, T., Jorgensen, M. E., Witte, D. R., Brandslund, I., Christensen, C., Hansen, T., Mercader, J. M., Flannick, J., Moreno-Macias, H., Burtt, N. P., Zhang, R., Kim, Y. J., Zheng, W., Singh, J. R., Tam, C. H., Hirose, H., Maegawa, H., Ito, C., Kaku, K., Watada, H., Tanaka, Y., Tobe, K., Kawamori, R., Kubo, M., Cho, Y. S., Chan, J. C., Sanghera, D., Frossard, P., Park, K. S., Shu, X. O., Kim, B. J., Florez, J. C., Tusie-Luna, T., Jia, W., Tai, E. S., Pedersen, O., Saleheen, D., Maeda, S., Kadowaki, T. Genome-wide association studies in the Japanese population identify seven novel loci for type 2 diabetes. Nat Commun 7: 10531, 2016
Osonoi, Y., Mita, T., Osonoi, T., Saito, M., Tamasawa, A., Nakayama, S., Someya, Y., Ishida, H., Kanazawa, A., Gosho, M., Fujitani, Y., Watada, H. Relationship between dietary patterns and risk factors for cardiovascular disease in patients with type 2 diabetes mellitus: a cross-sectional study. Nutr J 15: 15, 2016
Matsuba, R., Imamura, M., Tanaka, Y., Iwata, M., Hirose, H., Kaku, K., Maegawa, H., Watada, H., Tobe, K., Kashiwagi, A., Kawamori, R., Maeda, S. Replication Study in a Japanese Population of Six Susceptibility Loci for Type 2 Diabetes Originally Identified by a Transethnic Meta- Analysis of Genome-Wide Association Studies. PLoS One 11(4): e0154093, 2016
Foley, J., Bhosekar, V., Kawamori, R. Does the treatment of type 2 diabetes mellitus with the DPP -4 inhibitor vildagliptin reduce HbA1c to a greater extent in Japanese patients than in Caucasian patients? Vasc Health Risk Manag 12: 9-12, 2016

2015年

Shimo, N., Matsuoka, T. A., Miyatsuka, T., Takebe, S., Tochino, Y., Takahara, M., Kaneto, H., Shimomura, I. Short-term selective alleviation of glucotoxicity and lipotoxicity ameliorates the suppressed expression of key beta-cell factors under diabetic conditions. Biochem Biophys Res Commun 467(4): 948-954, 2015
Osonoi, Y., Mita, T., Osonoi, T., Saito, M., Tamasawa, A., Nakayama, S., Someya, Y., Ishida, H., Kanazawa, A., Gosho, M., Fujitani, Y., Watada, H. Poor sleep quality is associated with increased arterial stiffness in Japanese patients with type 2 diabetes mellitus. BMC Endocr Disord 15: 29, 2015
Kawata, T., Daimon, M., Miyazaki, S., Ichikawa, R., Maruyama, M., Chiang, S., Ito, C., Sato, F., Watada, H., Daida, H. Coronary microvascular function is independently associated with left ventricular filling pressure in patients with type 2 diabetes mellitus. Cardiovasc Diabetol 14: 98, 2015
Takagi, M., Uno, H., Nishi, R., Sugimoto, M., Hasegawa, S., Piao, J., Ihara, N., Kanai, S., Kakei, S., Tamura, Y., Suganami, T., Kamei, Y., Shimizu, T., Yasuda, A., Ogawa, Y., Mizutani, S. ATM Regulates Adipocyte Differentiation and Contributes to Glucose Homeostasis. Cell Rep 10(6): 957-967, 2015
Weng, J., Soegondo, S., Schnell, O., Sheu, W., Grzeszczak, W., Watada, H., Yamamoto, N., Kalra, S. Efficacy of acarbose in different geographical regions of the world: analysis of a real-life database. Diabetes Metab Res Rev 31(2): 155-167, 2015
Home, P. D., Dain, M. P., Freemantle, N., Kawamori, R., Pfohl, M., Brette, S., Pilorget, V., Scherbaum, W. A., Vespasiani, G., Vincent, M., Balkau, B. Four-year evolution of insulin regimens, glycaemic control, hypoglycaemia and body weight after starting insulin therapy in type 2 diabetes across three continents. Diabetes Res Clin Pract 108(2): 350-359, 2015
Arakawa, S., Watanabe, T., Sone, H., Tamura, Y., Kobayashi, M., Kawamori, R., Atsumi, Y., Oshida, Y., Tanaka, S., Suzuki, S., Makita, S., Ohsawa, I., Sato, Y. The factors that affect exercise therapy for patients with type 2 diabetes in Japan: a nationwide survey. Diabetol Int 6(1): 19-25, 2015
Sasaki, S., Miyatsuka, T., Matsuoka, T., Takahara, M., Yamamoto, Y., Yasuda, T., Kaneto, H., Fujitani, Y., German, M., Akiyama, H., Watada, H., Shimomura, I. Activation of GLP-1 and gastrin signalling induces in vivo reprogramming of pancreatic exocrine cells into beta cells in mice. Diabetologia 58(11): 2582-2591, 2015
Kawasaki, Y., Hosoya, M., Yasumura, S., Ohira, T., Satoh, H., Suzuki, H., Sakai, A., Ohtsuru, A., Takahashi, A., Ozasa, K., Kobashi, G., Kamiya, K., Yamashita, S., Abe, M., Fukushima Health Management Survey Group. The basic data for residents aged 16 years or older who received a comprehensive health check examinations in 2011-2012 as a part of the Fukushima Health Management Survey after the great East Japan earthquake. Fukushima J Med Sci 60(2): 159-169, 2015
Kawasaki, Y., Hosoya, M., Yasumura, S., Ohira, T., Satoh, H., Suzuki, H., Sakai, A., Ohtsuru, A., Takahashi, A., Ozasa, K., Kobashi, G., Kamiya, K., Yamashita, S., Abe, M., Fukushima Health Management Survey Group. The Basic Data for Residents Aged 15 Years or Younger Who Received a Comprehensive Health Check in 2011-2012 as a Part of the Fukushima Health Management Survey after the Great East Japan Earthquake. Fukushima J Med Sci 61(2): 101-110, 2015
Suzuki, H., Ohira, T., Takeishi, Y., Hosoya, M., Yasumura, S., Satoh, H., Kawasaki, Y., Takahashi, A., Sakai, A., Ohtsuru, A., Kobashi, G., Ozasa, K., Yamashita, S., Kamiya, K., Abe, M., Fukushima Health Management Survey Group. Increased prevalence of atrial fibrillation after the Great East Japan Earthquake: Results from the Fukushima Health Management Survey. Int J Cardiol 198: 102-105, 2015
Nakajima, K., Mita, T., Osonoi, Y., Azuma, K., Takasu, T., Fujitani, Y., Watada, H. Effect of Repetitive Glucose Spike and Hypoglycaemia on Atherosclerosis and Death Rate in Apo E-Deficient Mice. Int J Endocrinol 2015: 406394, 2015
Tosaka, Y., Kanazawa, A., Ikeda, F., Iida, M., Sato, J., Matsumoto, K., Uchida, T., Tamura, Y., Ogihara, T., Mita, T., Shimizu, T., Goto, H., Ohmura, C., Fujitani, Y., Watada, H. Switching from Twice-Daily Basal Insulin Injections to Once-Daily Insulin Degludec Injection for Basal-Bolus Insulin Regimen in Japanese Patients with Type 1 Diabetes: A Pilot Study. Int J Endocrinol 2015: 176261, 2015
Sai, E., Shimada, K., Yokoyama, T., Sato, S., Nishizaki, Y., Miyazaki, T., Hiki, M., Tamura, Y., Aoki, S., Watada, H., Kawamori, R., Daida, H. Evaluation of myocardial triglyceride accumulation assessed on 1H-magnetic resonance spectroscopy in apparently healthy Japanese subjects. Intern Med 54(4): 367-373, 2015
Tanaka, R., Yamashiro, K., Okuma, Y., Shimura, H., Nakamura, S., Ueno, Y., Tanaka, Y., Miyamoto, N., Tomizawa, Y., Nakahara, T., Furukawa, Y., Watada, H., Kawamori, R., Hattori, N., Urabe, T. Effects of Pioglitazone for Secondary Stroke Prevention in Patients with Impaired Glucose Tolerance and Newly Diagnosed Diabetes: The J-SPIRIT Study. J Atheroscler Thromb 22(12): 1305-1316, 2015
Fujimaki, K., Ogihara, T., Morris, D., Oda, H., Iida, H., Fujitani, Y., Mirmira, R., Evans-Molina, C., Watada, H. SET7/9 Enzyme Regulates Cytokine-induced Expression of Inducible Nitric-oxide Synthase through Methylation of Lysine 4 at Histone 3 in the Islet β Cell. J Biol Chem 290(27): 16607-16618, 2015
Matsuoka, T. A., Kaneto, H., Kawashima, S., Miyatsuka, T., Tochino, Y., Yoshikawa, A., Imagawa, A., Miyazaki, J., Gannon, M., Stein, R., Shimomura, I. Preserving Mafa expression in diabetic islet beta-cells improves glycemic control in vivo. J Biol Chem 290(12): 7647-7657, 2015
Ohmura, H., Mita, T., Taneda, Y., Sugawara, M., Funayama, H., Matsuoka, J., Watada, H., Daida, H. Efficacy and Safety of Sitagliptin in Japanese Patients With Type 2 Diabetes. J Clin Med Res 7(4): 211-219, 2015
Osawa, S., Yasuda, T., Kansasneto, H., Shimo, N., Yamamoto, Y., Kawamori, D., Miyatsuka, T., Matsuoka, T., Shimomura, I. Case of aniridia with a heterozygous PAX6 mutation in which the glucagon response to arginine was evaluated. J Diabetes Investig 6(1): 105-106, 2015
Tanimoto, M., Kanazawa, A., Hirose, T., Yoshihara, T., Kobayashi-Kimura, S., Nakanishi, R., Tosaka, Y., Sasaki-Omote, R., Kudo-Fujimaki, K., Komiya, K., Ikeda, F., Someya, Y., Mita, T., Fujitani, Y., Watada, H. Comparison of sitagliptin with nateglinide on postprandial glucose and related hormones in drug-naive Japanese patients with type 2 diabetes mellitus: A pilot study J. Diabetes Investig 6(5): 560-566, 2015
Satoh, H., Ohira, T., Hosoya, M., Sakai, A., Watanabe, T., Ohtsuru, A., Kawasaki, Y., Suzuki, H., Takahashi, A., Kobashi, G., Ozasa, K., Yasumura, S., Yamashita, S., Kamiya, K., Abe, M. Evacuation after the Fukushima Daiichi Nuclear Power Plant Accident Is a Cause of Diabetes: Results from the Fukushima Health Management Survey. J Diabetes Res 2015: 627390, 2015
Enomoto, M., Yoshii, H., Mita, T., Sanke, H., Yokota, A., Yamashiro, K., Inagaki, N., Gosho, M., Ohmura, C., Kudo, K., Watada, H., Onuma, T. Relationship between dietary pattern and cognitive function in elderly patients with type 2 diabetes mellitus. J Int Med Res 43(4): 506-517, 2015
Watanabe, T., Tamura, Y., Kakehi, S., Funayama, T., Takeno, K., Kawaguchi, M., Yamamoto, L., Sato, F., Ikeda, S., Taka, H., Fujimura, T., Fujitani, Y., Kawamori, R., Watada, H. Effects of sitagliptin on ectopic fat contents and glucose metabolism in type 2 diabetic patients with fatty liver: A pilot study. Journal of Diabetes Investigation 6(2): 164-172, 2015
Iida, H., Ogihara, T., Min, M., Hara, A., Kim, Y., Fujimaki, K., Tamaki, M., Fujitani, Y., Kim, H., Watada, H. Expression mechanism of tryptophan hydroxylase 1 in mouse islets during pregnancy. Journal of molecular endocrinology 55(1): 41-53, 2015
Kurano, M., Hara, M., Satoh, H., Tsukamoto, K. Hepatic NPC1L1 overexpression ameliorates glucose metabolism in diabetic mice via suppression of gluconeogenesis. Metabolism 64(5): 588-596, 2015
Nishida, Y., Rardin, M., Carrico, C., He, W., Sahu, A., Gut, P., Najjar, R., Fitch, M., Hellerstein, M., Gibson, B., Verdin, E. SIRT5 Regulates both Cytosolic and Mitochondrial Protein Malonylation with Glycolysis as a Major Target. Molecular Cell 59(2): 321-332, 2015
Matsuba, R., Sakai, K., Imamura, M., Tanaka, Y., Iwata, M., Hirose, H., Kaku, K., Maegawa, H., Watada, H., Tobe, K., Kashiwagi, A., Kawamori, R., Maeda, S. Replication Study in a Japanese Population to Evaluate the Association between 10 SNP Loci, Identified in European Genome-Wide Association Studies, and Type 2 Diabetes. PLoS One 10(5): e0126363, 2015
Berger, M., Scheel, D., Macias, H., Miyatsuka, T., Kim, H., Hoang, P., Ku, G., Honig, G., Liou, A., Tang, Y., Regard, J., Sharifnia, P., Yu, L., Wang, J., Coughlin, S., Conklin, B., Deneris, E., Tecott, L., German, M. Galphai/o-coupled receptor signaling restricts pancreatic beta-cell expansion. Proc Natl Acad Sci U S A 112(9): 2888-2893, 2015

2014年

Pereira, S., Park, E., Mori, Y., Haber, C. A., Han, P., Uchida, T., Stavar, L., Oprescu, A. I., Koulajian, K., Ivovic, A., Yu, Z., Li, D., Bowman, T. A., Dewald, J., El-Benna, J., Brindley, D. N., Gutierrez-Juarez, R., Lam, T. K., Najjar, S. M., McKay, R. A., Bhanot, S., Fantus, I. G., Giacca, A. FFA-induced Hepatic Insulin Resistance in vivo is mediated by PKC-delta, NADPH Oxidase, and Oxidative Stress. Am J Physiol Endocrinol Metab 307(1): E34-E46, 2014
Katakami, N., Kaneto, H., Matsuoka, T. A., Takahara, M., Osonoi, T., Saitou, M., Kawai, K., Ishibashi, F., Kashiwagi, A., Kawamori, R., Shimomura, I., Yamasaki, Y. Accumulation of oxidative stress-related gene polymorphisms and the risk of coronary heart disease events in patients with type 2 diabetes - An 8-year prospective study. Atherosclerosis 235(2): 408-414, 2014
Miyashita, K., Miyatsuka, T., Matsuoka, T. A., Sasaki, S., Takebe, S., Yasuda, T., Watada, H., Kaneto, H., Shimomura, I. Sequential introduction and dosage balance of defined transcription factors affect reprogramming efficiency from pancreatic duct cells into insulin-producing cells. Biochem Biophys Res Commun 444(4): 514-519, 2014
Yamamoto, E., Uchida, T., Abe, H., Taka, H., Fujimura, T., Komiya, K., Hara, A., Ogihara, T., Fujitani, Y., Ueno, T., Takeda, S., Watada, H. Increased expression of ERp57/GRP58 is protective against pancreatic beta cell death caused by autophagic failure. Biochem Biophys Res Commun 453(1): 19-24, 2014
Sakai, A., Ohira, T., Hosoya, M., Ohtsuru, A., Satoh, H., Kawasaki, Y., Suzuki, H., Takahashi, A., Kobashi, G., Ozasa, K., Yasumura, S., Yamashita, S., Kamiya, K., Abe, M., Fukushima Health Management Survey Group. Life as an evacuee after the Fukushima Daiichi nuclear power plant accident is a cause of polycythemia: the Fukushima Health Management Survey. BMC Public Health 14: 1318, 2014
Inagaki, N., Ueki, K., Tanizawa, Y., Watada, H., Nakamura, J., Yamada, Y., Shimomura, I., Nishimura, R., Yamazaki, T., Kadowaki, T. Protocol for a large-scale prospective observational study with alogliptin in patients with type 2 diabetes: J-BRAND Registry. BMJ Open 4(9): e004760, 2014
Kaku, K., Watada, H., Iwamoto, Y., Utsunomiya, K., Terauchi, Y., Tobe, K., Tanizawa, Y., Araki, E., Ueda, M., Suganami, H., Watanabe, D. Efficacy and safety of monotherapy with the novel sodium/glucose cotransporter-2 inhibitor tofogliflozin in Japanese patients with type 2 diabetes mellitus: a combined Phase 2 and 3 randomized, placebo-controlled, double-blind, parallel-group comparative study. Cardiovasc Diabetol 13(1): 65, 2014
Sawada, N., Jiang, A., Takizawa, F., Safdar, A., Manika, A., Tesmenitsky, Y., Kang, K. T., Bischoff, J., Kalwa, H., Sartoretto, J. L., Kamei, Y., Benjamin, L. E., Watada, H., Ogawa, Y., Higashikuni, Y., Kessinger, C. W., Jaffer, F. A., Michel, T., Sata, M., Croce, K., Tanaka, R., Arany, Z. Endothelial PGC-1alpha mediates vascular dysfunction in diabetes. Cell Metab 19(2): 246-258, 2014
Osonoi, Y., Mita, T., Osonoi, T., Saito, M., Tamasawa, A., Nakayama, S., Someya, Y., Ishida, H., Kanazawa, A., Gosho, M., Fujitani, Y., Watada, H. Morningness-eveningness questionnaire score and metabolic parameters in patients with type 2 diabetes mellitus. Chronobiol Int 31(9): 1017-1023, 2014
Ogawa, H., Matsui, K., Saito, Y., Sugiyama, S., Jinnouchi, H., Sugawara, M., Masuda, I., Mori, H., Waki, M., Yoshiyama, M., Watada, H. Differences between rosuvastatin and atorvastatin in lipid-lowering action and effect on glucose metabolism in Japanese hypercholesterolemic patients with concurrent diabetes. Circ J 78(10): 2512-2515, 2014
Wada, T., Haneda, M., Furuichi, K., Babazono, T., Yokoyama, H., Iseki, K., Araki, S., Ninomiya, T., Hara, S., Suzuki, Y., Iwano, M., Kusano, E., Moriya, T., Satoh, H., Nakamura, H., Shimizu, M., Toyama, T., Hara, A., Makino, H., Research Group of Diabetic Nephropathy, Ministry of Health, Labour, and Welfare of Japan. Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetes. Clin Exp Nephrol 18(4): 613-620, 2014
Miyatsuka, T., Matsuoka, T. A., Sasaki, S., Kubo, F., Shimomura, I., Watada, H., German, M. S., Hara, M. Chronological analysis with Fluorescent Timer reveals unique features of newly generated beta cells. Diabetes 63(10): 3388-3393, 2014
Sato, J., Kanazawa, A., Ikeda, F., Yoshihara, T., Goto, H., Abe, H., Komiya, K., Kawaguchi, M., Shimizu, T., Ogihara, T., Tamura, Y., Sakurai, Y., Yamamoto, R., Mita, T., Fujitani, Y., Fukuda, H., Nomoto, K., Takahashi, T., Asahara, T., Hirose, T., Nagata, S., Yamashiro, Y., Watada, H. Gut dysbiosis and detection of "live gut bacteria" in blood of Japanese patients with type 2 diabetes. Diabetes Care 37(8): 2343-2350, 2014
Sanke, H., Mita, T., Yoshii, H., Yokota, A., Yamashiro, K., Ingaki, N., Onuma, T., Someya, Y., Komiya, K., Tamura, Y., Shimizu, T., Ohmura, C., Kanazawa, A., Fujitani, Y., Watada, H. Relationship between olfactory dysfunction and cognitive impairment in elderly patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 106(3): 465-473, 2014
Shimo, N., Yasuda, T., Kaneto, H., Katakami, N., Kuroda, A., Sakamoto, F., Takahara, M., Irie, Y., Horikawa, K., Miyashita, K., Miyatsuka, T., Yoshiuchi, K., Kawamori, D., Sakamoto, K., Matsuoka, T., Kosugi, K., Shimomura, I., Matsuhisa, M. Vitamin D deficiency is significantly associated with retinopathy in young Japanese type 1 diabetic patients. Diabetes Res Clin Pract 106(2): e41-e43, 2014
Sato, F., Mita, T., Yamamoto, R., Hirose, T., Ito, C., Tamura, Y., Yokota, A., Someya, Y., Uchida, T., Uchino, H., Kawamori, R., Gosho, M., Kanazawa, A., Watada, H. Reliability and validity of the Japanese version of the Diabetes Quality-Of-Life questionnaire for Japanese patients with type 2 diabetes mellitus. Diabetol Int 5(1): 21-29, 2014
Shigihara, N., Uchida, T., Yorifuji, T., Toyofuku, Y., Tamaki, M., Fujitani, Y., Watada, H. Olmesartan and telmisartan comparably preserve pancreatic beta-cell mass with reduction of oxidative stress in db/db mice. Diabetol Int 5(1): 62-68, 2014
Tamaki, M., Kanazawa, A., Shirakami, A., Yamaguchi, H., Tamura, Y., Mita, T., Fujitani, Y., Watada, H. A case of false hypoglycemia by SMBG due to improper storage of glucometer test strips. Diabetol Int 5(3): 199-201, 2014
Mita, T., Katakami, N., Shiraiwa, T., Yoshii, H., Onuma, T., Kuribayashi, N., Osonoi, T., Kaneto, H., Kosugi, K., Umayahara, Y., Yamamoto, T., Matsumoto, K., Yokoyama, H., Tsugawa, M., Gosho, M., Shimomura, I., Watada, H. Rationale, design, and baseline characteristics of a clinical trial for prevention of atherosclerosis in patients with insulin-treated type 2 diabetes mellitus using DPP-4 inhibitor: the Sitagliptin Preventive study of Intima-media thickness Evaluation (SPIKE). Diabetol Metab Syndr 6(1): 35, 2014
Satoh, H., Kudoh, A., Hasegawa, K., Hirai, H., Watanabe, T. Yacon supplementation reduces serum free fatty acids and tumor necrosis factor alpha concentrations in patients with type 2 diabetes. Diabetology International 5(3): 165-174, 2014
Bin, B., Hojyo, S., Hosaka, T., Bhin, J., Kano, H., Miyai, T., Ikeda, M., Kimura-Someya, T., Shirouzu, M., Cho, E., Fukue, K., Kambe, T., Ohashi, W., Kim, K., Seo, J., Choi, D., Nam, Y., Hwang, D., Fukunaka, A., Fujitani, Y., Yokoyama, S., Superti-Furga, A., Ikegawa, S., Lee, T., Fukada, T. Molecular pathogenesis of spondylocheirodysplastic Ehlers-Danlos syndrome caused by mutant ZIP13 proteins. EMBO Mol Med 6(8): 1028-1042, 2014
Uchida, T., Goto, H., Kasai, T., Komiya, K., Takeno, K., Abe, H., Shigihara, N., Sato, J., Honda, A., Mita, T., Kanazawa, A., Fujitani, Y., Watada, H. Therapeutic effectiveness of potassium iodine in drug-naive patients with Graves' disease: a single-center experience. Endocrine 47(2): 506-511, 2014
Yamazaki, S., Satoh, H., Watanabe, T. Liraglutide enhances insulin sensitivity by activating AMP-activated protein kinase in male Wistar rats. Endocrinology 155(9): 3288-3301, 2014
Yasunari, E., Mita, T., Osonoi, Y., Azuma, K., Goto, H., Ohmura, C., Kanazawa, A., Kawamori, R., Fujitani, Y., Watada, H. Repetitive hypoglycemia increases circulating adrenaline level with resultant worsening of intimal thickening after vascular injury in male Goto-Kakizaki rat carotid artery. Endocrinology 155(6): 2244-2253, 2014
Tanizawa, Y., Kaku, K., Araki, E., Tobe, K., Terauchi, Y., Utsunomiya, K., Iwamoto, Y., Watada, H., Ohtsuka, W., Watanabe, D., Suganami, H. Long-term safety and efficacy of tofogliflozin, a selective inhibitor of sodium-glucose cotransporter 2, as monotherapy or in combination with other oral antidiabetic agents in Japanese patients with type 2 diabetes mellitus: multicenter, open-label, randomized controlled trials. Expert Opin Pharmacother 15(6): 749-766, 2014
Ohira, T., Hosoya, M., Yasumura, S., Satoh, H., Suzuki, H., Takahashi, A., Sakai, A., Otsuru, A., Kawasaki, Y., Ozasa, K., Kobashi, G., Kamiya, K., Yamashita, S., Abe, M. How lifestyle affects health--changes in health status before and after the earthquake. Fukushima J Med Sci 60(2): 211-212, 2014
Hara, K., Fujita, H., Johnson, T. A., Yamauchi, T., Yasuda, K., Horikoshi, M., Peng, C., Hu, C., Ma, R. C., Imamura, M., Iwata, M., Tsunoda, T., Morizono, T., Shojima, N., So, W. Y., Leung, T. F., Kwan, P., Zhang, R., Wang, J., Yu, W., Maegawa, H., Hirose, H., DIAGRAM consortium., Kaku, K., Ito, C., Watada, H., Tanaka, Y., Tobe, K., Kashiwagi, A., Kawamori, R., Jia, W., Chan, J. C., Teo, Y. Y., Shyong, T. E., Kamatani, N., Kubo, M., Maeda, S., Kadowaki, T. Genome-wide association study identifies three novel loci for type 2 diabetes. Hum Mol Genet 23(1): 239-246, 2014
Yokoi, H., Nohara, R., Daida, H., Hata, M., Kaku, K., Kawamori, R., Kishimoto, J., Kurabayashi, M., Masuda, I., Sakuma, I., Yamazaki, T., Yoshida, M. Change in carotid intima-media thickness in a high-risk group of patients by intensive lipid-lowering therapy with rosuvastatin. Int Heart J 55(2): 146-152, 2014
Uchida, T., Kasai, T., Takagi, A., Sekita, G., Komiya, K., Takeno, K., Shigihara, N., Shimada, K., Miyauchi, K., Fujitani, Y., Daida, H., Watada, H. Prevalence of amiodarone-induced thyrotoxicosis and associated risk factors in Japanese patients. Int J Endocrinol 2014: 534904, 2014
Inami, Y., Hamada, C., Seto, T., Hotta, Y., Aruga, S., Inuma, J., Azuma, K., Io, H., Kaneko, K., Watada, H., Tomino, Y. Effect of AST-120 on Endothelial Dysfunction in Adenine-Induced Uremic Rats. Int J Nephrol 2014: 164125, 2014
Yoshida, T., Higuchi, T., Suzuki, L., Koyamada, R., Okada, S. Relapse of immune thrombocytopenia associated with varicella 20 years after splenectomy. Intern Med 53(23): 2721-2723, 2014
Kuroda, K., Uchida, T., Nagai, S., Ozaki, R., Yamaguchi, T., Sato, Y., Brosens, J. J., Takeda, S. Elevated serum thyroid-stimulating hormone is associated with decreased anti-Mullerian hormone in infertile women of reproductive age. J Assist Reprod Genet 32(2): 243-247, 2014
Daida, H., Nohara, R., Hata, M., Kaku, K., Kawamori, R., Kishimoto, J., Kurabayashi, M., Masuda, I., Sakuma, I., Yamazaki, T., Yokoi, H., Yoshida, M. Can intensive lipid-lowering therapy improve the carotid intima-media thickness in Japanese subjects under primary prevention for cardiovascular disease?: The JART and JART extension subanalysis. J Atheroscler Thromb 21(7): 739-754, 2014
Teramoto, T., Kawamori, R., Miyazaki, S., Teramukai, S., Sato, Y., Okuda, Y., Shirayama, M. Lipid and blood pressure control for the prevention of cardiovascular disease in hypertensive patients: A subanalysis of the OMEGA study. J Atheroscler Thromb 22(1): 62-75, 2014
Yoshii, H., Onuma, T., Yamazaki, T., Watada, H., Matsuhisa, M., Matsumoto, M., Kitagawa, K., Kitakaze, M., Yamasaki, Y., Kawamori, R. Effects of pioglitazone on macrovascular events in patients with type 2 diabetes mellitus at high risk of stroke: The PROFIT-J Study. J Atheroscler Thromb 21(6): 563-573, 2014
Kawaguchi, M., Tamura, Y., Kakehi, S., Takeno, K., Sakurai, Y., Watanabe, T., Funayama, T., Sato, F., Ikeda, S., Ogura, Y., Saga, N., Naito, H., Fujitani, Y., Kanazawa, A., Kawamori, R., Watada, H. Association between expression of FABPpm in skeletal muscle and insulin sensitivity in intramyocellular-lipid-accumulated non-obese men. J Clin Endocrinol Metab 99(9): 3343-3352, 2014
Chamberlain, C. E., Scheel, D. W., McGlynn, K., Kim, H., Miyatsuka, T., Wang, J., Nguyen, V., Zhao, S., Mavropoulos, A., Abraham, A. G., O'Neill, E., Ku, G. M., Cobb, M. H., Martin, G. R., German, M. S. Menin determines K-RAS proliferative outputs in endocrine cells. J Clin Invest 124(9): 4093-4101, 2014
Shigihara, N., Fukunaka, A., Hara, A., Komiya, K., Honda, A., Uchida, T., Abe, H., Toyofuku, Y., Tamaki, M., Ogihara, T., Miyatsuka, T., Hiddinga, H. J., Sakagashira, S., Koike, M., Uchiyama, Y., Yoshimori, T., Eberhardt, N. L., Fujitani, Y., Watada, H. Human IAPP-induced pancreatic beta cell toxicity and its regulation by autophagy. J Clin Invest 124(8): 3634-3644, 2014
Sakai, A., Ohira, T., Hosoya, M., Ohtsuru, A., Satoh, H., Kawasaki, Y., Suzuki, H., Takahashi, A., Kobashi, G., Ozasa, K., Yasumura, S., Yamashita, S., Kamiya, K., Abe, M., Fukushima Health Management Survey Group. White blood cell, neutrophil, and lymphocyte counts in individuals in the evacuation zone designated by the government after the Fukushima Daiichi Nuclear Power Plant accident: the Fukushima Health Management Survey. J Epidemiol 25(1): 80-87, 2014
Tamura, Y., Kakehi, S., Takeno, K. Intracellular lipid accumulation and insulin sensitivity in muscle and liver: Fighting against "intracellular obesity". J Phys Fitness Sports Med 3(5): 501-505, 2014
Uchida, T., Shigihara, N., Takeno, K., Komiya, K., Goto, H., Abe, H., Sato, J., Honda, A., Fujitani, Y., Watada, H. Characteristics of patients with graves disease and intrathyroid hypovascularity compared to painless thyroiditis. J Ultrasound Med 33(10): 1791-1796, 2014
Fujimaki, K., Hirose, T., Yoshihara, T., Sato, F., Someya, Y., Ohmura, C., Kanazawa, A., Fujitani, Y., Watada, H. Efficacy and safety of nateglinide plus vildagliptin combination therapy compared with switching to vildagliptin in type 2 diabetes patients inadequately controlled with nateglinide. Journal of Diabetes Investigation 5(4): 400-409, 2014
Kawamori, R., Kaku, K., Hanafusa, T., Oikawa, T., Kageyama, S., Hotta, N. Effect of combination therapy with repaglinide and metformin hydrochloride on glycemic control in Japanese patients with type 2 diabetes mellitus. Journal of Diabetes Investigation 5(1): 72-79, 2014
Shimoji, K., Uka, T., Tamura, Y., Yoshida, M., Kamagata, K., Hori, M., Motoi, Y., Watada, H., Kawamori, R., Aoki, S. Diffusional kurtosis imaging analysis in patients with hypertension. Jpn J Radiol 32(2): 98-104, 2014
Honda, S., Arakawa, S., Nishida, Y., Yamaguchi, H., Ishii, E., Shimizu, S. Ulk1-mediated Atg5-independent macroautophagy mediates elimination of mitochondria from embryonic reticulocytes. Nat Commun 5: 4004, 2014

2013年

Ikeda, S., Tamura, Y., Kakehi, S., Takeno, K., Kawaguchi, M., Watanabe, T., Sato, F., Ogihara, T., Kanazawa, A., Fujitani, Y., Kawamori, R., Watada, H. Exercise-induced enhancement of insulin sensitivity is associated with accumulation of M2-polarized macrophages in mouse skeletal muscle. Biochem Biophys Res Commun 441(1): 36-41, 2013
Ishibashi, K., Hara, A., Fujitani, Y., Uchida, T., Komiya, K., Tamaki, M., Abe, H., Ogihara, T., Kanazawa, A., Kawamori, R., Watada, H. Beneficial effects of vildagliptin combined with miglitol on glucose tolerance and islet morphology in diet-controlled db/db mice. Biochem Biophys Res Commun 440(4): 570-575, 2013
Ichikawa, R., Daimon, M., Miyazaki, T., Kawata, T., Miyazaki, S., Maruyama, M., Chiang, S. J., Suzuki, H., Ito, C., Sato, F., Watada, H., Daida, H. Influencing factors on cardiac structure and function beyond glycemic control in patients with type 2 diabetes mellitus. Cardiovasc Diabetol 12(1): 38, 2013
Kawamori, R., Node, K., Hanafusa, T., Atsumi, Y., Naito, Y., Oka, Y. Baseline and 1-year interim follow-up assessment of Japanese patients initiating insulin therapy who were enrolled in the cardiovascular risk evaluation in people with type 2 diabetes on insulin therapy study: an international, multicenter, observational study. Cardiovasc Diabetol 12(1): 131, 2013
Rardin, M. J., He, W., Nishida, Y., Newman, J. C., Carrico, C., Danielson, S. R., Guo, A., Gut, P., Sahu, A. K., Li, B., Uppala, R., Fitch, M., Riiff, T., Zhu, L., Zhou, J., Mulhern, D., Stevens, R. D., Ilkayeva, O. R., Newgard, C. B., Jacobson, M. P., Hellerstein, M., Goetzman, E. S., Gibson, B. W., Verdin, E. SIRT5 regulates the mitochondrial lysine succinylome and metabolic networks. Cell Metab 18(6): 920-933, 2013
Nohara, R., Daida, H., Hata, M., Kaku, K., Kawamori, R., Kishimoto, J., Kurabayashi, M., Masuda, I., Sakuma, I., yamazaki, T., Yokoi, H., Yoshida, M., Justification For Atherosclerosis Regression Treatment (JART) Investigators. Effect of Long-Term Intensive Lipid-Lowering Therapy With Rosuvastatin on Progression of Carotid Intima-Media Thickness ―Justification for Atherosclerosis Regression Treatment (JART) Extension Study ―. Circ J 77(6): 1526-1533, 2013
Teramoto, T., Kawamori, R., Miyazaki, S., Teramukai, S., Mori, Y., Okuda, Y., Hiramatsu, K., OMEGA Study Group. Risk factors for primary prevention of cardiovascular disease and risk reduction by lipid control: the OMEGA study risk factor sub-analysis. Clin Exp Hypertens 36(4): 236-243, 2013
Furuichi, K., Shimizu, M., Toyama, T., Koya, D., Koshino, Y., Abe, H., Mori, K., Satoh, H., Imanishi, M., Iwano, M., Yamauchi, H., Kusano, E., Fujimoto, S., Suzuki, Y., Okuda, S., Kitagawa, K., Iwata, Y., Kaneko, S., Nishi, S., Yokoyama, H., Ueda, Y., Haneda, M., Makino, H., Wada, T., Research Group of Diabetic Nephropathy, Ministry of Health, Labour, and Welfare of Japan. Japan Diabetic Nephropathy Cohort Study: study design, methods, and implementation. Clin Exp Nephrol 17(6): 819-826, 2013
Guo, L., Inada, A., Aguayo-Mazzucato, C., Hollister-Lock, J., Fujitani, Y., Weir, G. C., Wright, C. V., Sharma, A., Bonner-Weir, S. PDX1 in ducts is not required for postnatal formation of beta-cells but is necessary for their subsequent maturation. Diabetes 62(10): 3459-3468, 2013
Shimoji, K., Abe, O., Uka, T., Yasmin, H., Kamagata, K., Asahi, K., Hori, M., Nakanishi, A., Tamura, Y., Watada, H., Kawamori, R., Aoki, S. White matter alteration in metabolic syndrome: diffusion tensor analysis. Diabetes Care 36(3): 696-700, 2013
Araki, E., Kawamori, R., Inagaki, N., Watada, H., Hayashi, N., Horie, Y., Sarashina, A., Thiemann, S., von Eynatten, M., Dugi, K., Woerle, H. J. Long-term safety of linagliptin monotherapy in Japanese patients with type 2 diabetes. Diabetes Obes Metab 15(4): 364-371, 2013
Nakanishi, R., Hirose, T., Tamura, Y., Fujitani, Y., Watada, H. Attempted suicide with liraglutide overdose did not induce hypoglycemia. Diabetes Res Clin Pract 99(1): e3-e4, 2013
Okayama, K. I., Mita, T., Gosho, M., Yamamoto, R., Yoshida, M., Kanazawa, A., Kawamori, R., Fujitani, Y., Watada, H. Carotid intima-media thickness progression predicts cardiovascular events in Japanese patients with type 2 diabetes. Diabetes Res Clin Pract 101(3): 286-292, 2013
Kanazawa, A., Tokoro, M., Ikeda, F., Ohmura, C., Sato, F., Fujitani, Y., Kawamori, R., Watada, H. Analysis of clinical factors contributing to the postglucagon increment in C-peptide levels in Japanese patients with type 2 diabetes: comparison with basal C-peptide levels and 24-h urinary C-peptide excretion. Diabetol Int 4(1): 60-65, 2013
Matsumoto, K., Kanazawa, A., Ikeda, F., Ohmura, C., Shimizu, T., Tamura, Y., Fujitani, Y., Kawamori, R., Watada, H. The area of abdominal subcutaneous adipose tissue is independently correlated with C-peptide increment during glucagon load in Japanese patients with type 2 diabetes. Diabetol Int 4(4): 243-250, 2013
Medina, A., Yamada, S., Hara, A., Hamamoto, K., Kojima, I. Involvement of the parasympathetic nervous system in the initiation of regeneration of pancreatic beta-cells. Endocr J 60(5): 687-696, 2013
Yasuda, T., Okamoto, Y., Hamada, N., Miyashita, K., Takahara, M., Sakamoto, F., Miyatsuka, T., Kitamura, T., Katakami, N., Kawamori, D., Otsuki, M., Matsuoka, T. A., Kaneto, H., Shimomura, I. Serum vitamin D levels are decreased in patients without remission of Graves' disease. Endocrine 43(1): 230-232, 2013
Abe, H., Uchida, T., Hara, A., Mizukami, H., Komiya, K., Koike, M., Shigihara, N., Toyofuku, Y., Ogihara, T., Uchiyama, Y., Yagihashi, S., Fujitani, Y., Watada, H. Exendin-4 improves beta-cell function in autophagy-deficient beta-cells. Endocrinology 154(12): 4512-4524, 2013
Ervinna, N., Mita, T., Yasunari, E., Azuma, K., Tanaka, R., Fujimura, S., Sukmawati, D., Nomiyama, T., Kanazawa, A., Kawamori, R., Fujitani, Y., Watada, H. Anagliptin, a DPP-4 Inhibitor, Suppresses Proliferation of Vascular Smooth Muscles and Monocyte Inflammatory Reaction and Attenuates Atherosclerosis in Male apo E-Deficient Mice. Endocrinology 154(3): 1260-1270, 2013
Yoshida, N., Goto, H., Suzuki, H., Nagasawa, K., Takeshita, A., Okubo, M., Miyakawa, M., Mori, Y., Fukuhara, N., Nishioka, H., Yamada, S., Takeuchi, Y. Ketoacidosis as the initial clinical condition in nine patients with acromegaly: a review of 860 cases at a single institute. Eur J Endocrinol 169(1): 127-132, 2013
Kalra, S., Sahay, R. K., Schnell, O., Sheu, W. H., Grzeszczak, W., Watada, H., Soegondo, S., Yamamoto, N., Weng, J., Rathod, R. Alpha-glucosidase inhibitor, acarbose, improves glycamic control and reduces body weight in type 2 diabetes: Findings on indian patients from the pooled data analysis. Indian J Endocrinol Metab 17(Suppl 1): S307-S309, 2013
Kalra, S., Sahay, R. K., Schnell, O., Sheu, W. H., Grzeszczak, W., Watada, H., Soegondo, S., Yamamoto, N., Weng, J., Rathod, R. Acarbose improves glycemic control and reduces body weight: Subanalysis data of South Asia region. Indian J Endocrinol Metab 17(Suppl 1): S304-S306, 2013
Yamazaki, T., Nohara, R., Daida, H., Hata, M., Kaku, K., Kawamori, R., Kishimoto, J., Kurabayashi, M., Masuda, I., Sakuma, I., Yokoi, H., Yoshida, M., Justification for Atherosclerosis Regression Treatment (JART) Investigators. Intensive lipid-lowering therapy for slowing progression as well as inducing regression of atherosclerosis in Japanese patients: subanalysis of the JART study. Int Heart J 54(1): 33-39, 2013
Koyano, H. M., Matsumoto, T. Recovery from exocrine pancreatic insufficiency in a patient with fulminant type 1 diabetes. Intern Med 52(5): 573-575, 2013
Katakami, N., Mita, T., Yoshii, H., Onuma, T., Kaneto, H., Osonoi, T., Shiraiwa, T., Kosugi, K., Umayahara, Y., Yamamoto, T., Yokoyama, H., Kuribayashi, N., Jinnouchi, H., Gosho, M., Watada, H., Shimomura, I. Rationale, design, and baseline characteristics of a trial for the prevention of diabetic atherosclerosis using a DPP-4 inhibitor: The study of preventive effects of alogliptin on diabetic atherosclerosis (SPEAD-A). J Atheroscler Thromb 20(12): 893-902, 2013
Yamamoto, K., Matsuoka, T. A., Kawashima, S., Takebe, S., Kubo, F., Miyatsuka, T., Kaneto, H., Shimomura, I. A novel function of Onecut1 protein as a negative regulator of MafA gene expression. J Biol Chem 288(30): 21648-21658, 2013
Imamura, M., Shigemizu, D., Tsunoda, T., Iwata, M., Maegawa, H., Watada, H., Hirose, H., Tanaka, Y., Tobe, K., Kaku, K., Kashiwagi, A., Kawamori, R., Maeda, S. Assessing the clinical utility of a genetic risk score constructed using 49 susceptibility alleles for type 2 diabetes in a Japanese population. J Clin Endocrinol Metab 98(10): E1667-E1673, 2013
Tamaki, M., Fujitani, Y., Hara, A., Uchida, T., Tamura, Y., Takeno, K., Kawaguchi, M., Watanabe, T., Ogihara, T., Fukunaka, A., Shimizu, T., Mita, T., Kanazawa, A., Imaizumi, M. O., Abe, T., Kiyonari, H., Hojyo, S., Fukada, T., Kawauchi, T., Nagamatsu, S., Hirano, T., Kawamori, R., Watada, H. The diabetes-susceptible gene SLC30A8/ZnT8 regulates hepatic insulin clearance. J Clin Invest 123(10): 4513-4524, 2013
Fukuda, H., Imamura, M., Tanaka, Y., Iwata, M., Hirose, H., Kaku, K., Maegawa, H., Watada, H., Tobe, K., Kashiwagi, A., Kawamori, R., Maeda, S. Replication study for the association of a single-nucleotide polymorphism, rs3746876, within KCNJ15, with susceptibility to type 2 diabetes in a Japanese population. J Hum Genet 58(7): 490-493, 2013
Abe, H., Mita, T., Yamamoto, R., Komiya, K., Kawaguchi, M., Sakurai, Y., Shimizu, T., Ohmura, C., Ikeda, F., Kawamori, R., Fujitani, Y., Watada, H. Comparison of effects of cilnidipine and azelnidipine on blood pressure, heart rate, and albuminuria in type 2 diabetics with hypertension. A pilot study. Journal of Diabetes Investigation 4(2): 202-205, 2013
Hirose, T., Ogihara, T., Tozala, S., Kanderian, S., Watada, H. Identification and comparison of insulin pharmacokinetics injected with a new 4-mm needle vs 6- and 8-mm needles accounting for endogenous insulin and C-peptide secretion kinetics in non-diabetic adult males. Journal of Diabetes Investigation 4(3): 287-296, 2013
Imamura, M., Iwata, M., Maegawa, H., Watada, H., Hirose, H., Tanaka, Y., Tobe, K., Kaku, K., Kashiwagi, A., Kadowaki, T., Kawamori, R., Maeda, S. Replication study for the association of rs391300 in SRR and rs17584499 in PTPRD with susceptibility to type 2 diabetes in a Japanese population. Journal of Diabetes Investigation 4(2): 168-173, 2013
Iwasaki, M., Hirose, T., Mita, T., Sato, F., Ito, C., Yamamoto, R., Someya, Y., Yoshihara, T., Tamura, Y., Kanazawa, A., Kawamori, R., Fujitani, Y., Watada, H. Morningness-eveningness questionnaire score correlates with glycated hemoglobin in middle-aged male workers with type 2 diabetes mellitus. Journal of Diabetes Investigation 4(4): 376-381, 2013
Mita, T., Nakayama, S., Abe, H., Gosho, M., Iida, H., Hirose, T., Kawamori, R., Watada, H. Comparison of effects of pitavastatin and atorvastatin on glucose metabolism in type 2 diabetic patients with hypercholesterolemia. Journal of Diabetes Investigation 4(3): 297-303, 2013
Masuyama, A., Kobayashi, H., Kobayashi, Y., Yokoe, I., Sugimura, Y., Maniwa, K., Sato, H., Ishida, T., Hatanaka, Y. A case of adult-onset Still's disease complicated by thrombotic thrombocytopenic purpura with retinal microangiopathy and rapidly fatal cerebral edema. Mod Rheumatol 23(2): 379-385, 2013
Hirai, H., Satoh, H., Kudoh, A., Watanabe, T. Interaction between resistin and adiponectin in the proliferation of rat vascular smooth muscle cells. Mol Cell Endocrinol 366(1): 108-116, 2013
Satoh, H., Audrey-Nguyen, M., Kudoh, A., Watanabe, T. Yacon diet (Smallanthus sonchifolius, Asteraceae) improves hepatic insulin resistance via reducing Trb3 expression in Zucker fa/fa rats. Nutr Diabetes 3: e70, 2013
Sai, E., Shimada, K., Yokoyama, T., Sato, S., Miyazaki, T., Hiki, M., Tamura, Y., Aoki, S., Watada, H., Kawamori, R., Daida, H. Association between myocardial triglyceride content and cardiac function in healthy subjects and endurance athletes. PLoS One 8(4): e61604, 2013
Sakai, K., Imamura, M., Tanaka, Y., Iwata, M., Hirose, H., Kaku, K., Maegawa, H., Watada, H., Tobe, K., Kashiwagi, A., Kawamori, R., Maeda, S. Replication study for the association of 9 east asian GWAS-Derived Loci with susceptibility to type 2 diabetes in a Japanese population. PLoS One 8(9): e76317, 2013
Ohara-Imaizumi, M., Kim, H., Yoshida, M., Fujiwara, T., Aoyagi, K., Toyofuku, Y., Nakamichi, Y., Nishiwaki, C., Okamura, T., Uchida, T., Fujitani, Y., Akagawa, K., Kakei, M., Watada, H., German, M. S., Nagamatsu, S. Serotonin regulates glucose-stimulated insulin secretion from pancreatic beta cells during pregnancy. Proc Natl Acad Sci U S A 110(48): 19420-19425, 2013

2012年

Takeno, K., Mita, T., Nakayama, S., Goto, H., Komiya, K., Abe, H., Ikeda, F., Shimizu, T., Kanazawa, A., Hirose, T., Kawamori, R., Watada, H. Masked hypertension,endothelial dysfunction, and arterial stiffness in type 2 diabetes mellitus: a pilot study. Am J Hypertens 25(2): 165-170, 2012
Katakami, N., Kaneto, H., Matsuoka, T., Takahara, M., Maeda, N., Shimizu, I., Ohno, K., Osonoi, T., Kawai, K., Ishibashi, F., Imamura, K., Kashiwagi, A., Kawamori, R., Matsuhisa, M., Funahashi, T., Yamasaki, Y., Shimomura, I. Adiponectin G276T gene polymorphism is associated with cardiovascular disease in Japanese patients with type 2 diabetes. Atherosclerosis 220(2): 437-442, 2012
Miyauchi, K., Yamazaki, T., Watada, H., Tanaka, Y., Kawamori, R., Imai, Y., Ikeda, S., Kitagawa, A., Ono, Y., Murayama, F., Choi, J. B., Suwa, S., Hayashi, D., Kishimoto, J., Daida, H. Management of home blood pressure by amlodipine combined with angiotensin II receptor blocker in type 2 diabetes. Circ J 76(9): 2159-2166, 2012
Yoshida, M., Mita, T., Yamamoto, R., Shimizu, T., Ikeda, F., Ohmura, C., Kanazawa, A., Hirose, T., Kawamori, R., Watada, H. Combination of the Framingham risk score and carotid intima-media thickness improves the prediction of cardiovascular events in patients with type 2 diabetes. Diabetes Care 35(1): 178-180, 2012
Freemantle, N., Balkau, B., Danchin, N., Wang, E., Marre, M., Vespasiani, G., Kawamori, R., Home, P. D. Factors influencing initial choice of insulin therapy in a large international non-interventional study of people with type 2 diabetes. Diabetes Obes Metab 14(10): 901-909, 2012
Kawamori, R., Inagaki, N., Araki, E., Watada, H., Hayashi, N., Horie, Y., Sarashina, A., Gong, Y., Von Eynatten, M., H.J., W., Dugi, K. A. Linagliptin monotherapy provides superior glycaemic control versus placebo or voglibose with comparable safety in Japanese patients with type 2 diabetes: a randomized, placebo and active comparator-controlled, double-blind study. Diabetes Obes Metab 14(4): 348-357, 2012
Kawamori, R., Tajima, N., Iwamoto, Y., Kashiwagi, A., Shimamoto, K., Kaku, K., Sano, H. Predictive values of serum insulin kinetics for reversion of impaired glucose tolerance to normal glucose tolerance and the effects of voglibose treatment: a retrospective post hoc analysis of a Japanese phase III study. Diabetol Int 3(4): 209-216, 2012
Sato, Y., Kondo, K., Sone, H., Kobayashi, M., Kawamori, R., Tamura, Y., Atsumi, Y., Oshida, Y., Tanaka, S., Suzuki, S., Makita, S., Ohsawa, I., Imamura, S. Present situation of exercise therapy for patients with diabetes mellitus in Japan: a nationwide survey. Diabetol Int 3(2): 86-91, 2012
Tuohetimulati, G., Uchida, T., Toyofuku, Y., Abe, H., Fujitani, Y., Hirose, T., Takeda, S., Watada, H. Effect of maternal high-fat diet on pancreatic beta cells of the offspring. Diabetol Int 3(4): 217-223, 2012
Yasuda, T., Okamoto, Y., Hamada, N., Miyashita, K., Takahara, M., Sakamoto, F., Miyatsuka, T., Kitamura, T., Katakami, N., Kawamori, D., Otsuki, M., Matsuoka, T. A., Kaneto, H., Shimomura, I. Serum vitamin D levels are decreased and associated with thyroid volume in female patients with newly onset Graves' disease. Endocrine 42(3): 739-741, 2012
Saito, R., Yamada, S., Yamamoto, Y., Kodera, T., Hara, A., Tanaka, Y., Kimura, F., Takei, I., Umezawa, K., Kojima, I. Conophylline Suppresses Pancreatic Stellate Cells and Improves Islet Fibrosis in Goto-Kakizaki Rats. Endocrinology 153(2): 621-630, 2012
Imamura, M., Maeda, S., Yamauchi, T., Hara, K., Yasuda, K., Morizono, T., Takahashi, A., Horikoshi, M., Nakamura, M., Fujita, H., Tsunoda, T., Kubo, M., Watada, H., Maegawa, H., Okada-Iwabu, M., Iwabu, M., Shojima, N., Ohshige, T., Omori, S., Iwata, M., Hirose, H., Kaku, K., Ito, C., Tanaka, Y., Tobe, K., Kashiwagi, A., Kawamori, R., Kasuga, M., Kamatani, N., Nakamura, Y., Kadowaki, T. A single-nucleotide polymorphism in ANK1 is associated with susceptibility to type 2 diabetes in Japanese populations. Hum Mol Genet 21(13): 3042-3049, 2012
Sasaki, S., Yasuda, T., Kaneto, H., Otsuki, M., Tabuchi, Y., Fujita, Y., Kubo, F., Tsuji, M., Fujisawa, K., Kasami, R., Kitamura, T., Miyatsuka, T., Katakami, N., Kawamori, D., Matsuoka, T. A., Imagawa, A., Shimomura, I. Large adrenal ganglioneuroma. Intern Med 51(17): 2365-2370, 2012
Imanishi, Y., Hashimoto, J., Ando, W., Kobayashi, K., Ueda, T., Nagata, Y., Miyauchi, A., Koyano, H., Kaji, H., Saito, T., Oba, K., Komatsu, Y., Morioka, T., Mori, K., Miki, T., Inaba, M. Matrix extracellular phosphoglycoprotein is expressed in causative tumors of oncogenic osteomalacia. J Bone Miner Metab 30(1): 93-99, 2012
Machii, N., Satoh, H., Kudoh, A., Watanabe, T. Resistin Exacerbates Insulin Resistance under the Condition of Low Adiponectin in 3T3-L1 Adipocytes. Journal of Diabetes & Metabolism 3(10): 1-6, 2012
Satoh, H., Kudoh, A., Hirai, H., Watanabe, T. Pitavastatin Ameliorates Insulin Resistance in Type 2 Diabetic Patients: Report of Two Cases. Journal of Diabetes & Metabolism 4(1): 1-3, 2012
Maeda, A., Golczak, M., Chen, Y., Okano, K., Kohno, H., Shiose, S., Ishikawa, K., Harte, W., Palczewska, G., Maeda, T., Palczewski, K. Primary amines protect against retinal degeneration in mouse models of retinopathies. Nat Chem Biol 8(2): 170-178, 2012
Fukuda, H., Imamura, M., Tanaka, Y., Iwata, M., Hirose, H., Kaku, K., Maegawa, H., Watada, H., Tobe, K., Kashiwagi, A., Kawamori, R., Maeda, S. A single nucleotide polymorphism within DUSP9 is associated with susceptibility to type 2 diabetes in a Japanese population. PLoS One 7(9): e46263, 2012

2011年

Nemoto, M., Tajima, N., Kawamori, R. Efficacy of combined use of miglitol in Type 2 diabetes patients receiving insulin therapy-placebo-controlled double-blind comparative study. Acta Diabetol 48(1): 15-20, 2011
Goto, H., Nomiyama, T., Mita, T., Yasunari, E., Azuma, K., Komiya, K., Arakawa, M., Jin, W. L., Kanazawa, A., Kawamori, R., Fujitani, Y., Hirose, T., Watada, H. Exendin-4, a glucagon-like peptide-1 receptor agonist, reduces intimal thickening after vascular injury. Biochem Biophys Res Commun 405(1): 79-84, 2011
Mita, T., Azuma, K., Goto, H., Jin, W. L., Arakawa, M., Nomiyama, T., Suzuki, R., Kubota, N., Tobe, K., Kadowaki, T., Fujitani, Y., Hirose, T., Kawamori, R., Watada, H. IRS-2 deficiency in macrophages promotes their accumulation in the vascular wall. Biochem Biophys Res Commun 415(4): 545-550, 2011
Nohara, R., Daida, H., Hata, M., Kaku, K., Kawamori, R., Kishimoto, J., Kurabayashi, M., Masuda, I., Sakuma, I., Yamazaki, T., Yokoi, H., Yoshida, M. Effect of intensive lipid-lowering therapy with rosuvastatin on progression of carotid intima-media thickness in Japanese patients: Justification for Atherosclerosis Regression Treatment (JART) study. Circ J 76(1): 221-229, 2011
Umemura, S., Kawamori, R., Matsuoka, H., Saito, Y. Effects of renal dysfunction on cardiovascular events in diabetic patients with hypertension: challenge-DM Study subgroup analysis. Clin Exp Nephrol 15(1): 64-72, 2011
Horie, Y., Kanada, S., Watada, H., Sarashina, A., Taniguchi, A., Hayashi, N., Graefe-Mody, E. U., Woerle, H. J., Dugi, K. A. Pharmacokinetic, pharmacodynamic, and tolerability profiles of the dipeptidyl peptidase-4 inhibitor linagliptin: a 4-week multicenter, randomized, double-blind, placebo-controlled phase IIa study in Japanese type 2 diabetes patients. Clin Ther 33(7): 973-989, 2011
Hirose, T., Mita, T., Fujitani, Y., Kawamori, R., Watada, H. Glucose monitoring after fruit peeling: pseudohyperglycemia when neglecting hand washing before fingertip blood sampling: wash your hands with tap water before you check blood glucose level. Diabetes Care 34(3): 596-597, 2011
Katakami, N., Kaneto, H., Osonoi, T., Kawai, K., Ishibashi, F., Imamura, K., Maegawa, H., Kashiwagi, A., Watada, H., Kawamori, R., Shimomura, I., Yamasaki, Y. Transforming growth factor β1 T868C gene polymorphism is associated with cerebral infarction in Japanese patients with type 2 diabetes. Diabetes Res Clin Pract 94(3): 57-60, 2011
Katakami, N., Kaneto, H., Takahara, M., Matsuoka, T. A., Imamura, K., Ishibashi, F., Kanda, T., Kawai, K., Osonoi, T., Matsuhisa, M., Kashiwagi, A., Kawamori, R., Shimomura, I., Yamasaki, Y. Aldose reductase C-106T gene polymorphism is associated with diabetic retinopathy in Japanese patients with type 2 diabetes. Diabetes Res Clin Pract 92(3): 57-60, 2011
Namba, M., Kaku, K., Yoshioka, N., Yamada, Y., Watada, H., Ueki, K., Terauchi, Y., Tobe, K., Araki, E., Shuto, Y., Kadowaki, T. The PREDICTIVE™ Study: a multinational, prospective observational study to evaluate the safety and efficacy of insulin detemir treatment in patients with type 1 and 2 diabetes--data from the Japan cohort. Diabetol Int 3(1): 11-20, 2011
Imamura, M., Iwata, M., Maegawa, H., Watada, H., Hirose, H., Tanaka, Y., Tobe, K., Kaku, K., Kashiwagi, A., Kawamori, R., Nakamura, Y., Maeda, S. Genetic variants at CDC123/CAMK1D and SPRY2 are associated with susceptibility to type 2 diabetes in the Japanese population. Diabetologia 54(12): 3071-3077, 2011
Jin, W. L., Azuma, K., Mita, T., Goto, H., Kanazawa, A., Shimizu, T., Ikeda, F., Fujitani, Y., Hirose, T., Kawamori, R., Watada, H. Repetitive hypoglycaemia increases serum adrenaline and induces monocyte adhesion to the endothelium in rat thoracic aorta. Diabetologia 54(7): 1921-1929, 2011
Nakamaki, S., Satoh, H., Kudoh, A., Hayashi, Y., Hirai, H., Watanabe, T. Adiponectin reduces proteinuria in streptozotocin-induced diabetic Wistar rats. Exp Biol Med (Maywood) 236(5): 614-620, 2011
Teramoto, T., Kawamori, R., Miyazaki, S., Teramukai, S. Sodium intake in men and potassium intake in women determine the prevalence of metabolic syndrome in Japanese hypertensive patients: OMEGA Study. Hypertens Res 34(8): 957-962, 2011
Hamamoto, K., Yamada, S., Hara, A., Kodera, T., Seno, M., Kojima, I. Extracellular matrix modulates insulin production during differentiation of AR42J cells: functional role of Pax6 transcription factor. J Cell Biochem 112(1): 318-329, 2011
Kubota, A., Sakuraba, K., Koh, S., Ogura, Y., Tamura, Y. Blood flow restriction by low compressive force prevents disuse muscular weakness. J Sci Med Sport 14(2): 95-99, 2011
Kawamori, R., Kaku, K., Hanafusa, T., Kashiwabara, D., Kageyama, S., Hotta, N. Efficacy and safety of repaglinide vs nateglinide for treatment of Japanese patients with type 2 diabetes mellitus. Journal of Diabetes Investigation 3(3): 302-308, 2011
Sakurai, Y., Tamura, Y., Takeno, K., Kumashiro, N., Sato, F., Kakehi, S., Ikeda, S., Ogura, Y., Saga, N., Naito, H., Katamoto, S., Fujitani, Y., Hirose, T., Kawamori, R., Watada, H. Determinants of intramyocellular lipid accumulation after dietary fat loading in non-obese men. Journal of Diabetes Investigation 2(4): 310-317, 2011
Sakurai, Y., Tamura, Y., Takeno, K., Sato, F., Fujitani, Y., Hirose, T., Kawamori, R., Watada, H. Association of T2 relaxation time determined by magnetic resonance imaging and intramyocellular lipid content of the soleus muscle in healthy subjects. Journal of Diabetes Investigation 2(5): 356-358, 2011
Yasuda, H., Hotta, N., Nakao, K., Kasuga, M., Kashiwagi, A., Kawamori, R. Superiority of duloxetine to placebo in improving diabetic neuropathic pain: Results of a randomized controlled trial in Japan. Journal of Diabetes Investigation 2(2): 132-139, 2011
Yasunari, E., Takeno, K., Funayama, H., Tomioka, S., Tamaki, M., Fujitani, Y., Kawamori, R., Watada, H., Hirose, T. Efficacy of pioglitazone on glycemic control and carotid intima-media thickness in type 2 diabetes patients with inadequate insulin therapy. Journal of Diabetes Investigation 2(1): 56-62, 2011
Yorifuji, T., Uchida, T., Abe, H., Toyofuku, Y., Tamaki, M., Fujitani, Y., Hirose, T., Kawamori, R., Takeda, S., Watada, H. 2-Methoxyestradiol ameliorates glucose tolerance with the increase in β-cell mass in db/db mice. Journal of Diabetes Investigation 2(3): 180-185, 2011
Yoshii, H., Mita, T., Sato, J., Kodama, Y., Choi, J. B., Komiya, K., Matsumoto, K., Kanno, R., Kawasumi, M., Koyano, H., Hirose, H., Onuma, T., Kawamori, R., Watada, H. Comparison of effects of azelnidipine and trichlormethiazide in combination with olmesartan on blood pressure and metabolic parameters in hypertensive type 2 diabetic patients. Journal of Diabetes Investigation 2(6): 490-496, 2011
Kudoh, A., Satoh, H., Hirai, H., Watanabe, T. Pioglitazone upregulates adiponectin receptor 2 in 3T3-L1 adipocytes. Life Sci 88(23-24): 1055-1062, 2011
Ohshige, T., Iwata, M., Omori, S., Tanaka, Y., Hirose, H., Kaku, K., Maegawa, H., Watada, H., Kashiwagi, A., Kawamori, R., Tobe, K., Kadowaki, T., Nakamura, Y., Maeda, S. Association of new loci identified in European genome-wide association studies with susceptibility to type 2 diabetes in the Japanese. PLoS ONE 6(10): e26911, 2011
Sugita, S., Kamei, Y., Akaike, F., Suganami, T., Kanai, S., Hattori, M., Manabe, Y., Fujii, N., Takai-Igarashi, T., Tadaishi, M., Oka, J., Aburatani, H., Yamada, T., Katagiri, H., Kakehi, S., Tamura, Y., Kubo, H., Nishida, K., Miura, S., Ezaki, O., Ogawa, Y. Increased systemic glucose tolerance with increased muscle glucose uptake in transgenic mice overexpressing RXRγ in skeletal muscle. PLoS ONE 6(5): e20467, 2011
Miyatsuka, T., Kosaka, Y., Kim, H., German, M. S. Neurogenin3 inhibits proliferation in endocrine progenitors by inducing Cdkn1a. Proc Natl Acad Sci U S A 108(1): 185-190, 2011

2010年

Katakami, N., Kaneto, H., Matsuoka, T. A., Takahara, M., Imamura, K., Ishibashi, F., Kanda, T., Kawai, K., Osonoi, T., Kashiwagi, A., Kawamori, R., Matsuhisa, M., Shimomura, I., Yamasaki, Y. Accumulation of gene polymorphisms related to oxidative stress is associated with myocardial infarction in Japanese type 2 diabetic patients. Atherosclerosis 212(2): 534-538, 2010
Komiya, K., Uchida, T., Ueno, T., Koike, M., Abe, H., Hirose, T., Kawamori, R., Uchiyama, Y., Kominami, E., Fujitani, Y., Watada, H. Free fatty acids stimulate autophagy in pancreatic beta-cells via JNK pathway. Biochem Biophys Res Commun 401(4): 561-567, 2010
Mita, T., Goto, H., Azuma, K., Jin, W. L., Nomiyama, T., Fujitani, Y., Hirose, T., Kawamori, R., Watada, H. Impact of insulin resistance on enhanced monocyte adhesion to endothelial cells and atherosclerogenesis independent of LDL cholesterol level. Biochem Biophys Res Commun 395(4): 477-483, 2010
Katakami, N., Kim, Y. S., Kawamori, R., Yamasaki, Y. The phosphodiesterase inhibitor cilostazol induces regression of carotid atherosclerosis in subjects with type 2 diabetes mellitus: principal results of the Diabetic Atherosclerosis Prevention by Cilostazol (DAPC) study: a randomized trial. Circulation 121(23): 2584-2591, 2010
Kobayashi, M. A., Watada, H., Kawamori, R., Maeda, S. Overexpression of acetyl-coenzyme A carboxylase beta increases proinflammatory cytokines in cultured human renal proximal tubular epithelial cells. Clin Exp Nephrol 14(4): 315-324, 2010
Maeda, S., Araki, S., Babazono, T., Toyoda, M., Umezono, T., Kawai, K., Imanishi, M., Uzu, T., Watada, H., Suzuki, D., Kashiwagi, A., Iwamoto, Y., Kaku, K., Kawamori, R., Nakamura, Y. Replication study for the association between four Loci identified by a genome-wide association study on European American subjects with type 1 diabetes and susceptibility to diabetic nephropathy in Japanese subjects with type 2 diabetes. Diabates 59(8): 2075-2079, 2010
Arakawa, M., Mita, T., Azuma, K., Ebato, C., Goto, H., Nomiyama, T., Fujitani, Y., Hirose, T., Kawamori, R., Watada, H. Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4. Diabetes 59(4): 1030-1037, 2010
Matsuoka, T. A., Kaneto, H., Miyatsuka, T., Yamamoto, T., Yamamoto, K., Kato, K., Shimomura, I., Stein, R., Matsuhisa, M. Regulation of MafA expression in pancreatic beta-cells in db/db mice with diabetes. Diabetes 59(7): 1709-1720, 2010
Katakami, N., Takahara, M., Kaneto, H., Shimizu, I., Ohno, K., Ishibashi, F., Osonoi, T., Kashiwagi, A., Kawamori, R., Shimomura, I., Matsuhisa, M., Yamasaki, Y. Accumulation of gene polymorphisms related to plaque disruption and thrombosis is associated with cerebral infarction in subjects with type 2 diabetes. Diabetes Care 33(2): 390-395, 2010
Ohshige, T., Tanaka, Y., Araki, S., Babazono, T., Toyoda, M., Umezono, T., Watada, H., Suzuki, D., Iwamoto, Y., Kawamori, R., Nakamura, Y., Maeda, S. A single nucleotide polymorphism in KCNQ1 is associated with susceptibility to diabetic nephropathy in japanese subjects with type 2 diabetes. Diabetes Care 33(4): 842-846, 2010
Yamasaki, Y., Nakajima, K., Kusuoka, H., Izumi, T., Kashiwagi, A., Kawamori, R., Shimamoto, K., Yamada, N., Nishimura, T. Prognostic value of gated myocardial perfusion imaging for asymptomatic patients with type 2 diabetes: the J-ACCESS 2 investigation. Diabetes Care 33(11): 2320-2326, 2010
Katakami, N., Matsuhisa, M., Kaneto, H., Matsuoka, T. A., Imamura, K., Ishibashi, F., Kanda, T., Kawai, K., Osonoi, T., Kashiwagi, A., Kawamori, R., Shimomura, I., Yamasaki, Y. Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism as a potential risk factor for diabetic retinopathy in Japanese patients with type 2 diabetes. Diabetes Res Clin Pract 89(1): e9-e12, 2010
Shiraiwa, T., Takahara, M., Kaneto, H., Miyatsuka, T., Yamamoto, K., Yoshiuchi, K., Sakamoto, K., Matsuoka, T. A., Matsuhisa, M., Yamasaki, Y., Shimomura, I. Efficacy of occasional self-monitoring of postprandial blood glucose levels in type 2 diabetic patients without insulin therapy. Diabetes Res Clin Pract 90(3): e91-e92, 2010
Komiya, K., Kanazawa, A., Shimizu, T., Yamamoto, R., Hirose, T., Kawamori, R., Watada, H. Investigation of clinical factors associated with development of chronic kidney disease and eGFR decline in Japanese patients with type 2 diabetes mellitus. Diabetol Int 1(2): 65-71, 2010
Uchida, T., Kawai, J., Fujitani, Y., Kawamori, R., Watada, H., Hirose, T. Efficacy and adverse effects of low-dose nateglinide in early type 2 diabetes: comparison with acarbose in a crossover study. Diabetol Int 1: 35-41, 2010
Uchida, T., Takeno, K., Goto, M., Kanno, R., Kubo, S., Takahashi, S., Azuma, K., Sakai, K., Fujitani, Y., Hirose, T., Kawamori, R., Watada, H. Superior thyroid artery mean peak systolic velocity for the diagnosis of thyrotoxicosis in Japanese patients. Endocr J 57(5): 439-443, 2010
Sato, J., Koyano, H., Sasaki, R., Koike, Y., Sugimura, S., Watada, H. Fulminant emphysematous pyelonephritis (EPN) in a diabetic patient suspected of having multiple tumors. Intern Med 49(21): 2317-2320, 2010
Kurabayashi, M., Sakuma, I., Kawamori, R., Daida, H., Yamazaki, T., Yoshida, M., Hata, M., Masuda, I., Kaku, K., Yokoi, H., Kishimoto, J., Nohara, R. Can intensive lipid-lowering therapy with statins ameliorate atherosclerosis in Japanese patients? Rationale and design of the JART study. J Atheroscler Thromb 17(4): 416-422, 2010
Saitou, M., Osonoi, T., Kawamori, R., Katakami, N., Kaneto, H., Matsuhisa, M., Yamasaki, Y. Genetic risk factors and the anti-atherosclerotic effect of pioglitazone on carotid atherosclerosis of subjects with type 2 diabetes--a retrospective study. J Atheroscler Thromb 17(4): 386-394, 2010
Yamasaki, Y., Katakami, N., Furukado, S., Kitagawa, K., Nagatsuka, K., Kashiwagi, A., Daida, H., Kawamori, R., Kaku, K. Long-term effects of pioglitazone on carotid atherosclerosis in Japanese patients with type 2 diabetes without a recent history of macrovascular morbidity. J Atheroscler Thromb 17(11): 1132-1140, 2010
Ogihara, T., Chuang, J. C., Vestermark, G. L., Garmey, J. C., Ketchum, R. J., Huang, X., Brayman, K. L., Thorner, M. O., Repa, J. J., Mirmira, R. G., Evans-Molina, C. Liver X receptor agonists augment human islet function through activation of anaplerotic pathways and glycerolipid/free fatty acid cycling. J Biol Chem 285(8): 5392-5404, 2010
Robbins, R. D., Tersey, S. A., Ogihara, T., Gupta, D., Farb, T. B., Ficorilli, J., Bokvist, K., Maier, B., Mirmira, R. G. Inhibition of deoxyhypusine synthase enhances islet {beta} cell function and survival in the setting of endoplasmic reticulum stress and type 2 diabetes. J Biol Chem 285(51): 39943-39952, 2010
Maier, B., Ogihara, T., Trace, A. P., Tersey, S. A., Robbins, R. D., Chakrabarti, S. K., Nunemaker, C. S., Stull, N. D., Taylor, C. A., Thompson, J. E., Dondero, R. S., Lewis, E. C., Dinarello, C. A., Nadler, J. L., Mirmira, R. G. The unique hypusine modification of eIF5A promotes islet beta cell inflammation and dysfunction in mice. J Clin Invest 120(6): 2156-2170, 2010
Kawamori, R. A commentary on the “consensus statement” regarding the use of BIAsp30. Journal of Diabetes Investigation 1(3): 101-102, 2010
Kubo, S., Watada, H., Kawamori, R. Combination therapy of miglitol and insulin in type 1 diabetes mellitus patients. Journal of Diabetes Investigation 1(1-2): 60-65, 2010
Tamaki, M., Fujitani, Y., Uchida, T., Hirose, T., Kawamori, R., Watada, H. Combination treatment of db/db mice with exendin-4 and gastrin preserves β-cell mass by stimulating β-cell growth and differentiation. Journal of Diabetes Investigation 1(5): 172-183, 2010
Yamashiro, K., Ikeda, F., Fujitani, Y., Watada, H., Kawamori, R., Hirose, T. Comparison of thrice-daily lispro 50/50 vs thrice-daily lispro in combination with sulfonylurea as initial insulin therapy for type 2 diabetes. Journal of Diabetes Investigation 1(4): 149-153, 2010
Kawamori, R. Pre-congresses for International Academy of Sportology. Juntendo Medical Journal 56(3): 238, 2010
kawamori, R. Sportology for the Prevention and Treatment of Diabetes Mellitus. Juntendo Medical Journal 56(3): 239-242, 2010
Tamura, Y., Watada, H., Tanaka, Y., Daimaru, N., Nomiyama, T., Sakuraba, K., Sawaki, K., Kawamori, R. Preliminary report: mitochondrial DNA 5178 polymorphism in male elite Japanese endurance runners. Metabolism 59(1): 62-63, 2010
Raum, J. C., Hunter, C. S., Artner, I., Henderson, E., Guo, M., Elghazi, L., Sosa-Pineda, B., Ogihara, T., Mirmira, R. G., Sussel, L., Stein, R. Islet beta-cell-specific MafA transcription requires the 5'-flanking conserved region 3 control domain. Mol Cell Biol 30(17): 4234-4244, 2010
Yamauchi, T., Hara, K., Maeda, S., Yasuda, K., Takahashi, A., Horikoshi, M., Nakamura, M., Fujita, H., Grarup, N., Cauchi, S., Ng, D. P., Ma, R. C., Tsunoda, T., Kubo, M., Watada, H., Maegawa, H., Okada-Iwabu, M., Iwabu, M., Shojima, N., Shin, H. D., Andersen, G., Witte, D. R., Jorgensen, T., Lauritzen, T., Sandbaek, A., Hansen, T., Ohshige, T., Omori, S., Saito, I., Kaku, K., Hirose, H., So, W. Y., Beury, D., Chan, J. C., Park, K. S., Tai, E. S., Ito, C., Tanaka, Y., Kashiwagi, A., Kawamori, R., Kasuga, M., Froguel, P., Pedersen, O., Kamatani, N., Nakamura, Y., Kadowaki, T. A genome-wide association study in the Japanese population identifies susceptibility loci for type 2 diabetes at UBE2E2 and C2CD4A-C2CD4B. Nat Genet 42(10): 864-868, 2010
Kim, H., Toyofuku, Y., Lynn, F. C., Chak, E., Uchida, T., Mizukami, H., Fujitani, Y., Kawamori, R., Miyatsuka, T., Kosaka, Y., Yang, K., Honig, G., van der Hart, M., Kishimoto, N., Wang, J., Yagihashi, S., Tecott, L. H., Watada, H., German, M. S. Serotonin regulates pancreatic beta cell mass during pregnancy. Nat Med 16(7): 804-808, 2010
Smith, S. B., Qu, H. Q., Taleb, N., Kishimoto, N. Y., Scheel, D. W., Lu, Y., Patch, A. M., Grabs, R., Wang, J., Lynn, F. C., Miyatsuka, T., Mitchell, J., Seerke, R., Desir, J., Vanden Eijnden, S., Abramowicz, M., Kacet, N., Weill, J., Renard, M. E., Gentile, M., Hansen, I., Dewar, K., Hattersley, A. T., Wang, R., Wilson, M. E., Johnson, J. D., Polychronakos, C., German, M. S. Rfx6 directs islet formation and insulin production in mice and humans. Nature 463(7282): 775-780, 2010
Shimizu, S., Konishi, A., Nishida, Y., Mizuta, T., Nishina, H., Yamamoto, A., Tsujimoto, Y. Involvement of JNK in the regulation of autophagic cell death. Oncogene 29(14): 2070-2082, 2010
Maeda, S., Kobayashi, M. A., Araki, S., Babazono, T., Freedman, B. I., Bostrom, M. A., Cooke, J. N., Toyoda, M., Umezono, T., Tarnow, L., Hansen, T., Gaede, P., Jorsal, A., Ng, D. P., Ikeda, M., Yanagimoto, T., Tsunoda, T., Unoki, H., Kawai, K., Imanishi, M., Suzuki, D., Shin, H. D., Park, K. S., Kashiwagi, A., Iwamoto, Y., Kaku, K., Kawamori, R., Parving, H. H., Bowden, D. W., Pedersen, O., Nakamura, Y. A single nucleotide polymorphism within the acetyl-coenzyme A carboxylase beta gene is associated with proteinuria in patients with type 2 diabetes. PLoS Genet 6(2): e1000842, 2010

和文原著

全て開く

2022年

細川千鶴, 佐藤寿美, 河盛隆造: 糖尿病治療薬処方の推移　専門医における過去10年の検討. 糖尿病プラクティス 39(4):466-472, 2022
田中悦子, 横井愛子, 大坂一義, 久志本理, 綿田裕孝: インスリングラルギンBS注キット「FFP」の安全性および有効性の検討　特定使用成績調査(長期使用に関する調査). 診療と新薬 59(5):225-240, 2022

2021年

佐藤淳子: 【CGM/FGMを用いた糖尿病治療-血糖トレンドを栄養指導に活かす】CGM/FGMを用いた糖尿病治療の実際と管理栄養士に期待すること. 臨床栄養 139(6):762-769, 2021

2020年

上里忠好, 荻原健, 竹田省, 綿田裕孝: 妊娠期のマウス膵島においてPDZ binding kinaseはCyclin B1の発現増強に関与する. 糖尿病と妊娠 20(2):S-38-S-39, 2020
窪田直人, 下田誠也, 本田佳子, 丸山千寿子, 石田均, 井上達秀, 絵本正憲, 田中武兵, 中塔辰明, 山口宏, 横山宏樹, 荒木栄一, 宇都宮一典, 綿田裕孝: 「食品交換表」編集委員会報告　アンケート調査からみた「食品交換表」の現状と課題. 糖尿病 63(6):405-420, 2020
柳瀬絵美子, 園田純子, 木野孝一, 綿田裕孝: 2型糖尿病患者におけるレパグリニドとSGLT2阻害剤との長期併用時の安全性および有効性の検討　レパグリニド錠特定使用成績調査. Therapeutic Research 41(4):267-280, 2020
山内敏正, 神谷英紀, 宇都宮一典, 綿田裕孝, 川浪大治, 佐藤淳子, 北田宗弘, 古家大祐, 原田範雄, 幣憲一郎, 城尾恵里奈, 鈴木亮, 坊内良太郎, 太田康晴, 近藤龍也: 糖尿病患者の栄養食事指導ーエネルギー・炭水化物・タンパク質摂取量と栄養食事指導ー. 糖尿病 63(3):91-109, 2020

2019年

及川達也, 園田純子, 木野孝一, 綿田裕孝 2型糖尿病患者におけるレパグリニドの長期投与時の安全性および有効性の検討―レパグリニド錠特定使用成績調査（RISSING Study）の最終報告― Therapeutic Research 40(3): 193-218, 2019
若林侑香, 良本佳代子, 長友昌志, 金丸洋蔵, 野尻宗子,大橋誠「糖尿病注射治療部位における皮下脂肪組織の超音波所見と血糖コントロールの注射回避後経時的変化」糖尿病, 62(10):659-666, 2019

英文総説

全て開く

2020年

Watada H: Current understanding of the effect of sodium-glucose co-transporter-2 inhibitors in Asian patients with diabetes mellitus. Diabetol Int 11(3):242-244, 2020
Watada H: Evidence-based comparison of glucagon-like peptide receptor agonists and sodium-glucose cotransporter 2 inhibitors. J Diabetes Investig 11(1):17-19, 2020
Watada H: Clinical evidence regarding factors linking metabolic abnormal obesity to pancreatic β-cell dysfunction. J Diabetes Investig 11(4):798-800, 2020

2019年

Tamura, Y. Ectopic fat, insulin resistance and metabolic disease in non-obese Asians: investigating metabolic gradation. Endocr J 66(1): 1-9, 2019
Watada, H. Unappreciated role of low-density lipoprotein receptor-related protein 1 in pancreatic β cells: Multiple roles of low-density lipoprotein receptor-related protein 1 in glucose and lipid metabolism. J Diabetes Investig 10(2): 216-218, 2019

和文総説

全て開く

2022年

Reference Type	タイトル	著者	媒体名	出版情報
Journal Article	【最新臨床脳卒中学(第2版)上-最新の診断と治療-】危険因子　糖尿病　診断の進め方.	鵜澤博嗣, 綿田裕孝.	日本臨床	日本臨牀社, 2022; 80(増刊1 最新臨床脳卒中学(上)): 227-232.
Journal Article	インセプターはインスリンのシグナル伝達を脱感作することで膵β細胞におけるインスリン感受性を制御する.	鵜澤博嗣, 綿田裕孝.	糖尿病・内分泌代謝科	科学論評社, 2022; 54(4): 466-471.
Journal Article	【注目の新薬】ツイミーグ錠（イメグリミン塩酸塩錠）.	加賀英義, 綿田裕孝.	診断と治療	診断と治療社, 2022; 110(3): 377-381.
Journal Article	【糖尿病診療update-診断・治療の最新動向-】糖尿病治療薬に関する最近の話題　新しい薬剤の話題　イメグリミンの作用機構と使い方.	加賀英義, 綿田裕孝.	日本臨床	日本臨牀社, 2022; 80(4): 645-649.
Journal Article	【糖尿病診療UPDATE2022】2型糖尿病の病態生理を一例一例で理解し、治療手段を活用しよう.	河盛隆造.	Clinic Magazine	クリニックマガジン, 2022; 49(1): 12-20.
Journal Article	【「インスリン離脱」成功症例を読み解く】【「インスリン離脱」成功症例を読み解く】.	河盛隆造.	日本医事新報	日本医事新報社, 2022; (5099): 18-38.
Journal Article	インスリン発見100周年の今、次のステップは?	河盛隆造.	Diabetes Journal: 糖尿病と代謝	公益財団法人日本糖尿病財団, 2022; 49(1): 16-21.
Journal Article	【低血糖症】低血糖症の定義、症状、鑑別疾患.	後藤広昌.	糖尿病・内分泌代謝科	科学評論社, 2022; 54(4): 385-389.
Journal Article	日本人のミニメド640Gシステム使用下での低血糖.	佐藤淳子.	糖尿病・内分泌代謝科	科学論評社, 2022; 54(4): 472-481.
Journal Article	【低血糖症】糖尿病患者における低血糖と心血管イベントおよび突然死.	三田智也.	糖尿病・内分泌代謝科	科学評論社, 2022; 54(4): 408-418.
Journal Article	糖尿病患者における循環器疾患診療　血糖変動や生活習慣が動脈硬化に与える影響.	三田智也.	糖尿病合併症	一般社団法人日本糖尿病合併症学会, 2022; 36(1): 79-83.
Journal Article	【最新の糖尿病診療と今後の展開】合併症診療Update　大血管障害.	三田智也.	内科	南江堂, 2022; 129(5): 1167-1170.
Journal Article	【ダイエットと栄養】瘦せた女性における糖代謝異常.	田村好史.	食と医療	講談社, 2022; 21: 45-50.
Journal Article	体質医学からみたこれからの予防医療　糖尿病運動療法のトピックス.	田村好史.	日本体質医学会雑誌	日本体質医学会, 2022; 84(2): 124.
Journal Article	【患者指導、医師のこの一言が患者を変える】疾患別指導　糖尿病.	田村好史, 加賀英義.	診断と治療	診断と治療社, 2022; 110(8): 975-978.
Journal Article	【かかりつけ医からみた糖尿病診療】糖尿病の治療・予防対策　運動療法.	田村好史, 加賀英義, 田端宏樹.	診断と治療	診断と治療社, 2022; 110(3): 289-293.
Journal Article	【糖尿病とミトコンドリア-両者の多様な関係性と創薬の視点-】イメグリミンの作用機序.	飯田雅, 綿田裕孝.	糖尿病プラクティス	医歯薬出版, 2022; 39(3): 258-263.
Journal Article	【最新の糖尿病診療と今後の展開】糖尿病治療薬Update　その他の糖尿病治療薬.	飯田雅, 綿田裕孝.	内科	南江堂, 2022; 129(5): 1137-1142.
Journal Article	【低血糖症】特集にあたって.	綿田裕孝.	糖尿病・内分泌代謝科	科学評論社, 2022; 54(4): 383-384.
Journal Article	体質医学からみたこれからの先制医療　臓器特異的インスリン抵抗性と生活習慣.	綿田裕孝.	日本体質医学会雑誌	日本体質医学会, 2022; 84(2): 92-96.

2021年

Reference Type	タイトル	著者	媒体名	出版情報
Journal Article	RISE study アップデート.	加賀英義, 田村好史.	糖尿病・内分泌代謝科	科学論評社, 2021; 52(3): 265-273.
Journal Article	【インスリン発見100周年を迎えて-インスリン治療の変遷】.	河盛隆造.	日本医事新報	日本医事新報社, 2021; (5069): 18-35.
Journal Article	【臨床検査を使いこなす】生化学的検査　生化学検査　糖代謝検査.	金澤昭雄.	日本医師会雑誌	日本医師会, 2021; 150(特別1): S117-S123.
Journal Article	【運動とアンチエイジング】運動によるサルコペニア改善効果.	佐藤元律, 田村好史.	アンチ・エイジング医学	メディカルレビュー社, 2021; 17(5): 6-9.
Journal Article	食事(第1回)　糖尿病の食事療法はどのように変わっていくのか.	佐藤淳子.	糖尿病プラクティス	医歯薬出版株式会社, 2021; 38(1): 87-88.
Journal Article	食事(第2回)　「個別化」を重視する食事療法の時代.	佐藤淳子.	糖尿病プラクティス	医歯薬出版株式会社, 2021; 38(2): 211-214.
Journal Article	食事(第3回)　「食事療法の個別化」を実践するために.	佐藤淳子.	糖尿病プラクティス	医歯薬出版株式会社, 2021; 38(3): 341-344.
Journal Article	【インスリンの使い方をマスターする】ステロイド治療中の患者のインスリン療法.	佐藤淳子.	月刊レジデント	医学出版, 2021; 14(2): 51-60.
Journal Article	2型糖尿病の血糖降下薬（糖尿病治療ガイド2020-2021）.	佐藤博亮, 綿田裕孝.	内分泌疾患・糖尿病・代謝疾患―診療のエッセンス	南江堂, 2021; 150(特別号(2)): S8-S9.
Journal Article	【GLP-1受容体作動薬への期待:新規創薬からの更なる飛翔-血糖値だけでない!その実力-】GLP-1受容体作動薬の動脈硬化抑制効果.	三田智也, 綿田裕孝.	糖尿病プラクティス	医歯薬出版, 2021; 38(6): 656-664.
Journal Article	【CGM/FGMを用いた糖尿病治療-血糖トレンドを栄養指導に活かす】糖尿病治療における血糖変動管理の重要性と血糖データの評価.	若杉理美, 三田智也.	臨床栄養	医歯薬出版, 2021; 139(6): 770-776.
Journal Article	【糖尿病診療の最前線】糖尿病診断の進め方.	若杉理美, 三田智也, 綿田裕孝.	臨牀と研究	大道學館出版部, 2021; 98(1): 6-13.
Journal Article	【第2章糖尿病×冠動脈疾患】Q18 DPP-4阻害薬ではなく，GLP1-RAに動脈硬化抑制作用があるのはなぜか？.	若林侑香, 綿田裕孝.	Q&Aでわかる！糖尿病×循環器疾患の治療血糖管理だけではない新しい考え方	南江堂, 2021: 87-92.
Journal Article	【薬の特徴・処方のポイント・インスリンポンプ療法がわかる!糖尿病のくすり徹底ナビゲートBOOK】(第1章)糖尿病治療薬の使いかたと処方のポイント　SGLT2阻害薬の処方のポイント.	小澁真実, 綿田裕孝.	糖尿病ケア	メディカ出版, 2021; (2021秋季増刊): 44-47.
Journal Article	【薬の特徴・処方のポイント・インスリンポンプ療法がわかる!糖尿病のくすり徹底ナビゲートBOOK】(第1章)糖尿病治療薬の使いかたと処方のポイント　α-グルコシダーゼ阻害薬(α-GI)の処方のポイント.	小澁真実, 綿田裕孝.	糖尿病ケア	メディカ出版, 2021; (2021秋季増刊): 36-39.
Journal Article	【高齢者糖尿病治療ガイド－改定のポイントを踏まえて－】臨床に役立つQ&A 高齢者に対してインスリンやGLP-1受容体作動薬などの自己注射指導を始める場合，どのように進めるのがよいでしょうか？.	常見亜佐子, 綿田裕孝.	Geriatric Medicine	ライフ・サイエンス, 2021; 59(4): 395-398.
Journal Article	【最近の糖尿病治療薬の展望】持効型インスリンとGLP-1受容体作動薬の合剤　ゾルトファイ、ソリクア.	常見亜佐子, 綿田裕孝.	カレントテラピー	ライフメディコム, 2021; 39(5): 422-426.
Journal Article	DAPA-HF study アップデート.	西田友哉, 綿田裕孝.	糖尿病・内分泌代謝科	科学論評社, 2021; 52(3): 282-286.
Journal Article	【アルコールによる代謝異常と疾患】アルコールと糖尿病.	西田友哉, 綿田裕孝.	糖尿病・内分泌代謝科	科学論評社, 2021; 52(1): 2-6.
Journal Article	循環器学2021年の進歩　糖尿病と循環器診療における進歩.	西田友哉, 綿田裕孝.	循環器専門医	一般社団法人日本循環器学会, 2021; 30: 104-106.
Journal Article	【甲状腺臨床update】バセドウ病に対する放射性ヨウ素(131-I)内用療法前のヨウ素制限の意義.	西尾理恵, 内田豊義, 綿田裕孝.	糖尿病・内分泌代謝科	科学評論社, 2021; 53(5): 500-504.
Journal Article	【生活習慣病】生活習慣病予防の基本.	中島健一, 綿田裕孝.	臨牀と研究	大道学舘出版部, 2021; 98(10): 1154-1159.
Journal Article	【特集食事療法と運動療法】特集にあたって.	田村好史.	The Lipid	メディカルレビュー社, 2021; 32(1): 14-15.
Journal Article	【新興再興感染症の脅威下における健康長寿先進国としての挑戦】コロナ禍における運動療法.	田村好史, 加賀英義, 田端宏樹, 筧佐織.	糖尿病・内分泌代謝科	科学論評社, 2021; 52(2): 116-120.
Journal Article	【食事療法と運動療法】運動療法の基礎と臨床　運動による骨格筋インスリン抵抗性改善とサルコペニア予防.	田村好史, 大塚光.	The Lipid	メディカルレビュー社, 2021; 32(1): 70-75.
Journal Article	【肥満とやせの臨床　病態の解明と新たな治療法をめぐって】最新の実地診療のためのポイントの整理と活用　サルコペニア肥満の問題点と対応.	田村好史, 田端宏樹.	Medical Practice	文光堂, 2021; 38(7): 1027-1030.
Journal Article	【個人差の理解へ向かう肥満症研究　GWAS、エピゲノム、腸内細菌、栄養学的知見から多様な病態を解明し、Precision Medicineをめざす】(第1章)代謝(エネルギー消費)の分子・細胞・個体メカニズム　身体活動と代謝と肥満.	田村好史, 田端宏樹, 筧佐織.	実験医学	羊土社, 2021; 39(5): 39-44.
Journal Article	非肥満者の代謝異常.	田村好史, 田端宏樹, 筧佐織.	循環器内科	科学評論社, 2021; 90(3): 309-314.
Journal Article	【異所性脂肪-第3の脂肪】異所性脂肪とインスリン抵抗性.	田村好史, 田端宏樹, 筧佐織, 大塚光.	外科と代謝・栄養	日本外科代謝栄養学会, 2021; 55(3): 128-132.
Journal Article	【意外と知られていない!?　自科の常識・他科の非常識】(第10章)内分泌　Basedow病はヨード(無機ヨウ素)で治療することもある.	内田豊義.	内科	南江堂, 2021; 128(3): 687-689.
Journal Article	妊娠と不妊症における甲状腺機能と甲状腺自己抗体の捉え方　最近の大規模臨床研究を踏まえて.	内田豊義, 綿田裕孝.	糖尿病・内分泌代謝科	科学評論社, 2021; 53(5): 587-592.
Journal Article	膵α細胞の分化と可塑性.	氷室美和, 宮塚健.	月刊糖尿病	医学出版, 2021; 13(3): 6-12.
Journal Article	【糖尿病治療・研究の最前線2021】基礎研究　膵島の発生.	氷室美和, 綿田裕孝.	医学のあゆみ	医歯薬出版株式会社, 2021; 276(5): 379-382.
Journal Article	【糖尿病専門医に必要な心不全の知識update】特集にあたって.	綿田裕孝.	糖尿病・内分泌代謝科	科学論評社, 2021; 52(3): 193-194.
Journal Article	第4次対糖尿病戦略5ヵ年計画.	綿田裕孝.	糖尿病・内分泌代謝科	科学論評社, 2021; 52(3): 313-316.
Journal Article	2型糖尿病治療における新しいGLP-1受容体作動薬　経口セマグルチドの作用機序ならびに特性.	綿田裕孝.	診断と治療	診断と治療社, 2021; 109(5): 717-725.

2020年

Reference Type	タイトル	著者	媒体名	出版情報
Journal Article	【肥満症-日本人の病態と最近の治療】肥満症の運動療法.	加賀英義, 田村好史.	カレントテラピー	ライフメディコム, 2020; 38(8): 28-33.
Journal Article	【糖尿病診療update-最新の診断と治療-】糖尿病非薬物療法に関する最近の話題　運動療法.	加賀英義, 田村好史.	日本臨牀	日本臨牀社, 2020; 78(7): 1087-1094.
Journal Article	【管理栄養士として知っておきたい!「糖尿病診療ガイドライン2019」改訂のポイント】糖尿病管理における運動療法の有効性と運動処方の実際.	加賀英義, 田村好史.	臨床栄養	医歯薬出版, 2020; 136(4): 478-483.
Journal Article	21世紀の健康とは?　ありふれた糖尿病にどのように対処する?　糖尿病治療のめざすこと.	河盛隆造.	あいみっく	国際医学情報センター, 2020; 41(3): 68-72.
Journal Article	【糖尿病診療UPDATEパート2〜基礎研究から臨床を理解する〜】大きく変貌した糖尿病の治療　グルカゴンの暴走を防ぐために、より早期からよりよい血糖応答の維持を.	河盛隆造.	Clinic Magazine	株式会社クリニックマガジン, 2020; 47(4): 14-18.
Journal Article	糖尿病治療のめざすこと.	河盛隆造.	New Diet Therapy	日本臨床栄養協会, 2020; 35(4): 13-19.
Journal Article	【モデル動物を用いた糖尿病・肥満症研究による病態解明と治療法開発】膵細胞の可塑性を利用したβ細胞分化誘導.	宮塚健.	糖尿病・内分泌代謝科	科学評論社, 2020; 51(4): 256-259.
Journal Article	【膵島研究update】膵β細胞のheterogeneity.	宮塚健.	糖尿病・内分泌代謝科	科学評論社, 2020; 50(2): 77-81.
Journal Article	糖尿病と腸内細菌叢.	金澤昭雄.	東京内科医会会誌	インテルナ出版, 2020; 36(1): 44-48.
Journal Article	【スルスルわかる　糖尿病と腸内細菌の関係】糖尿病と腸内細菌　肥満と腸内細菌の関係.	金澤昭雄.	糖尿病ケア	メディカ出版, 2020; 17(1): 28-30.
Journal Article	【スルスルわかる　糖尿病と腸内細菌の関係】糖尿病と腸内細菌　糖尿病と腸内細菌の関係.	金澤昭雄.	糖尿病ケア	メディカ出版, 2020; 17(1): 25-27.
Journal Article	【糖尿病診療update-最新の診断と治療-】糖尿病治療薬に関する最近の話題　配合薬.	栗田実佳, 佐藤博亮, 綿田裕孝.	日本臨牀	日本臨牀社, 2020; 78(7): 1167-1173.
Journal Article	【糖尿病・内分泌代謝疾患における妊娠と出産】クッシング症候群.	後藤広昌.	糖尿病・内分泌代謝科	科学評論社, 2020; 51(3): 207-210.
Journal Article	【甲状腺と皮膚】(Part1.)甲状腺機能低下と皮膚　(case 2)高β-カロチン血症による皮膚黄染を伴った萎縮性甲状腺炎.	荒川将之, 後藤広昌.	Visual Dermatology	学研メディカル秀潤社, 2020; 19(8): 776-777.
Journal Article	腸管内分泌細胞の新知見.	佐々木周伍, 宮塚健.	糖尿病・内分泌代謝科	科学評論社, 2020; 50(2): 118-122.
Journal Article	働く女性，キャンサーサバイバーにとってのスポーツ.	佐藤元律, 田村好史.	PEPARS	全日本病院出版会, 2020; (164): 87-91.
Journal Article	カーボカウントと糖質制限はどう違うの？.	佐藤淳子.	糖尿病ケア	メディカ出版, 2020; 17(11): 16-18.
Journal Article	カーボカウントってなに？どんな患者に適しているの？.	佐藤淳子.	糖尿病ケア	メディカ出版, 2020; 17(11): 7-11.
Journal Article	【抗糖尿病薬が有する多面的作用とそのメカニズム】抗糖尿病薬のがんに対する多面的作用とそのメカニズム.	佐藤博亮.	糖尿病・内分泌代謝科	科学評論社, 2020; 51(5): 391-395.
Journal Article	【いま知っておきたい!　内科最新トピックス】巻頭トピックス　糖尿病患者の食事療法は変わるのか.	佐藤博亮, 綿田裕孝.	内科	南江堂, 2020; 126(3): 367-370.
Journal Article	【抗糖尿病薬が有する多面的作用とそのメカニズム】抗糖尿病治療薬の動脈硬化性疾患に対する多面的作用とそのメカニズム.	三田智也.	糖尿病・内分泌代謝科	科学評論社, 2020; 51(5): 378-384.
Journal Article	順天堂医院足の疾患センター設立　足の疾患センターにおける意義・役割　糖尿病・代謝内分泌内科の立場から.	三田智也.	クリニシアン	エーザイ株式会社, 2020; 67(2-3): 222-225.
Journal Article	オートファジーと膵β細胞.	西田友哉, 綿田裕孝.	週刊医学のあゆみ	医師薬出版株式会社, 2020; 272(9): 905-908.
Journal Article	経口セマグルチド.	西田友哉, 綿田裕孝.	糖尿病・内分泌代謝科	科学評論社, 2020; 50(5): 379-382.
Journal Article	スライディングスケールの落とし穴.	西尾理恵, 金澤昭雄.	糖尿病薬・インスリン治療	羊土社, 2020; 22(5): 188-192.
Journal Article	【改訂版　糖尿病薬・インスリン治療　基本と使い分けUpdate　新しい薬剤・デバイス・エビデンスも理解し、ベストな血糖管理を!】(第4章)病棟・救急で困る、こんなときどうする?　スライディングスケールの落とし穴.	西尾理恵, 金澤昭雄.	レジデントノート	羊土社, 2020; 22(5): 998-1002.
Journal Article	GLP-1受容体作動薬による糖尿病治療への期待.	青山周平, 西田友哉, 綿田裕孝.	循環器内科	科学論評社, 2020; 87(6): 778-783.
Journal Article	運動をすると血糖がよくなるしくみ.	田村好史.	糖尿病ケア2020秋季増刊	メディカ出版, 2020: 71-74.
Journal Article	非肥満者における代謝血管障害とインスリン抵抗性　なぜアジア人は非肥満でも生活習慣病になるのか？.	田村好史.	化学と生物	国際文献社, 2020; 58(9): 497-498.
Journal Article	【糖尿病:異所性脂肪に刮目せよ!-その意義と食事・運動・薬剤による最適解を考える-】異所性脂肪蓄積に対する食事・運動・薬物療法.	田村好史.	糖尿病プラクティス	医歯薬出版株式会社, 2020; 37(4): 445-450.
Journal Article	「糖尿病重症化予防と理学療法」　第7回　糖尿病・健康寿命延伸における運動の意義と理学療法士への期待.	田村好史.	理学療法学	日本理学療法士学会, 2020; 47(2): 199-203.
Journal Article	【サルコペニア肥満】高齢者における骨格筋の量および質の変化と疾患リスク.	田村好史, 染谷由希, 筧佐織, 加賀英義.	日本サルコペニア・フレイル学会誌	メディカルレビュー社, 2020; 4(1): 39-44.
Journal Article	骨格筋の量と質と疾患　Bunkyo Health Study.	田村好史, 染谷由希, 筧佐織, 加賀英義.	糖尿病・内分泌代謝科	科学評論社, 2020; 50(6): 476-480.
Journal Article	【知りたいところをすべて解説!甲状腺疾患と薬物治療の急所】代表的な甲状腺疾患の病態と薬物治療　バセドウ病.	内田豊義.	薬事	じほう, 2020; 62(13): 2495-2499.
Journal Article	グルカゴン測定法検証のための委員会報告　新たな測定法によるグルカゴン値は糖尿病病態の把握に役立つ.	北村忠弘, 綿田裕孝, 長坂昌一郎, 石原寿光, 柴輝男, 植木浩二郎, 難波光義.	糖尿病	日本糖尿病学会, 2020; 63(12): 826-834.
Journal Article	糖尿病学の現況と将来展望　基礎編　膵島研究のこれまでと今後の展望.	綿田裕孝.	DIABETES JOURNAL 糖尿病と代謝	協和企画, 2020; 48(1): 1-5.

2019年

Reference Type	タイトル	著者	媒体名	出版情報
Journal Article	糖尿病の食事療法の課題.	宇都宮一典, 綿田裕孝.	DIABETES JOURNAL 糖尿病と代謝	協和企画, 2019; 47(2): 8-15.
Journal Article	糖代謝　糖尿病性合併症　糖尿病性乳酸アシドーシス.	荻原健.	内分泌症候群（第3版）－その他の内分泌疾患を含めて－	日本臨牀社, 2019: 167-171.
Journal Article	不活動の弊害や運動療法の効果に関する基礎的メカニズム.	加賀英義, 田村好史.	プラクティス	医歯薬出版株式会社, 2019; 36(4): 416-422.
Journal Article	運動療法.	加賀英義, 綿田裕孝.	臨牀と研究	大道學館出版部, 2019; 96(6): 45-50.
Journal Article	糖尿病患者のメタゲノム解析.	金澤昭雄.	内分泌・糖尿病・代謝内科	科学評論社, 2019; 49(5): 358-362.
Journal Article	糖尿病性腎臓病(DKD)の管理・治療戦略―糖尿病専門医の立場から.	金澤昭雄, 綿田裕孝.	日本医事新報	日本医事新報社, 2019; 4944: 44-48.
Journal Article	2型糖尿病と腸内フローラ.	金澤昭雄, 綿田裕孝.	糖尿病最新の治療2019-2021	南江堂, 2019: 39-43.
Journal Article	2型糖尿病における腸内細菌叢とメトホルミンの関連.	金澤昭雄, 綿田裕孝.	日本体質医学会雑誌	日本体質医学会, 2019; 81(1): 18-24.
Journal Article	ビグアナイド(metformin).	古川康彦, 田村好史.	内科	南江堂, 2019; 123(3): 395-398.
Journal Article	経口血糖降下薬の使い分け.	古川康彦, 綿田裕孝.	レジデントノート増刊	羊土社, 2019; 21(5): 100-104.
Journal Article	骨格筋の老化.	佐藤元律, 田村好史.	内分泌・糖尿病・代謝内科	科学評論社, 2019; 48(4): 313-316.
Journal Article	日本の新しい糖尿病食事療法を考える.	佐藤淳子, 綿田裕孝.	日本体質医学会雑誌	日本体質医学会, 2019; 81(2): 1-7.
Journal Article	腎臓を守る第二の方法は造血機能の維持で造血能力の低下は貧血や全身の酸素不足を招く.	佐藤博亮.	健康365	H&I, 2019; (第9月号): 50-51.
Journal Article	高血糖は腎機能低下の重大原因で腎機能を守るには糖化産物AGEをためないことが大切.	佐藤博亮.	健康365	H&I, 2019; (第9月号): 48-49.
Journal Article	血糖変動の評価方法と病態への影響.	三田智也.	診断と治療	診断と治療社, 2019; 107(3): 334-338.
Journal Article	運動療法.	山崎望, 田村好史.	動脈硬化診療のすべて・日本医師会雑誌	南江堂, 2019; 148(特別号(2)): S218-S221.
Journal Article	糖尿病管理におけるAmbulatory Glucose Profileの臨床活用のためのアルゴリズム.	小川渉, 西村理明, 池上博司, 綿田裕孝, 鈴木亮, 浦上達彦, 渥美義仁.	糖尿病の最新治療	フジメディカル出版, 2019; 10(2): 102-113.
Journal Article	糖尿病の食事療法を補助するスマートフォンアプリの現状.	常見亜佐子, 綿田裕孝.	内分泌･糖尿病･代謝内科	科学評論社, 2019; 49(1): 56-61.
Journal Article	GLP-1受容体作動薬と循環器疾患－その大きな期待.	西田友哉, 綿田裕孝.	循環器内科	科学評論社, 2019; 85(3): 355-360.
Journal Article	糖代謝　耐糖能異常　耐糖能異常（IGT).	船山崇, 綿田裕孝.	内分泌症候群（第3版）－その他の内分泌疾患を含めて－	日本臨牀社, 2019: 5-11.
Journal Article	異所性脂肪とインスリン抵抗性.	田村好史.	イルシー	特定非営利活動法人国際生命科学研究機構, 2019; 138: 42-49.
Journal Article	異所性脂肪蓄積を規定する体質と生活習慣.	田村好史.	日本体質医学会雑誌	日本体質医学会, 2019; 81(2): 116-121.
Journal Article	なぜ運動なのか?健康寿命に関わるサイエンスとエビデンスを紐解く.	田村好史.	東京都医師会雑誌	公益財団法人東京都医師会, 2019; 72(6): 31-35.
Journal Article	食事・運動、異所性脂肪と健康寿命.	田村好史.	下都賀郡市医師会報	下都賀郡市医師会, 2019; 183: 16-22.
Journal Article	無機ヨウ素の上手な使い方.	内田豊義.	臨床で使える！甲状腺疾患診療のテキスト	日本医事新報社, 2019: 105-107.
Journal Article	食品交換表のこれまでと現状と今後.	綿田裕孝, 佐藤淳子.	プラクティス	医師薬出版株式会社, 2019; 36(6): 696-701.
Journal Article	糖尿病の運動療法の課題.	木屋舞, 田村好史.	DIABETES JOURNAL 糖尿病と代謝	協和企画, 2019; 47(1): 6-13.

和文著書

全て開く

2022年

Reference Type	タイトル	著者	編集者	媒体名	出版情報
Book Section	重症感染症.	加賀英義, 田村好史.	（編集）森保道.	新版糖尿病コンサルテーションブック	医歯薬出版, 2022; 124-130.
Book Section	【代謝・栄養の異常】低血糖症.	後藤広昌.	（編集）綿田裕孝.	内科学第12版	朝倉書店, 2022; Ⅳ404-Ⅳ407.
Book Section	【代謝・栄養の異常】インスリノーマ.	後藤広昌.	（編集）綿田裕孝.	内科学第12版	朝倉書店, 2022; Ⅳ408-Ⅳ409.
Book Section	【11 代謝疾患】糖尿病の運動療法.	田村好史.	（編集）福井次矢, 高木誠, 小室一成.	今日の治療指針 2022年版［ポケット判］私はこう治療している	医学書院, 2022; 746-747.
Book Section	【内科疾患に対する運動療法】メタボリックシンドローム，肥満症の運動療法.	田村好史, 加賀英義.	（編集）日本医師会.	健康スポーツ医学実践ガイド多職種連携のすゝめ	公益社団法人日本医師会, 2022; 66-71.
Book Section	【代謝・栄養の異常】代謝・栄養異常における新しい展開.	綿田裕孝.	（編集）綿田裕孝.	内科学第12版	朝倉書店, 2022; Ⅳ340.

2021年

Reference Type	タイトル	著者	編集者	媒体名	出版情報
Book Section	【1. 糖尿病の診断と分類】分類の進め方（成因と病態・病期）.	荻原健, 綿田裕孝.	（編集）門脇孝, 下村伊一郎.	最新ガイドラインに基づく代謝・内分泌疾患診療指針2021-'22	総合医学社, 2021; 11-17.
Book Section	運動療法の効果と実際、注意点.	加賀英義, 田村好史.	（編集）綿田裕孝, 荒木栄一, 山内敏正.	糖尿病最新の治療2022-2024	南江堂, 2021; 105-109.
Book Section	【2. 糖尿病の治療】運動療法.	加賀英義, 田村好史.	（編集）門脇孝, 下村伊一郎.	最新ガイドラインに基づく代謝・内分泌疾患診療指針2021-'22	総合医学社, 2021; 29-36.
Book Section	【第1編内科編】第3章運動療法.	加賀英義, 田村好史, 河盛隆造.	（編集）柴輝男, 安原洋.	新体系看護学全書別巻治療法概説第4版	メヂカルフレンド社, 2021; 74-93.
Book Section	糖尿病の薬剤.	加賀英義, 綿田裕孝.	（監修）藤原俊之, （編集）高橋哲也.	理学療法NAVI リスクに備えて臨床に活かす理学療法にすぐに役立つ薬の知識	医学書院, 2021; 194-202.
Book Section	第6章標準的な食事を接種したときの全身での代謝.	加賀英義, 綿田裕孝.	（編集）植木浩二郎.	シリーズ〈栄養と疾病の化学〉3 糖尿病と食	朝倉書店, 2021; 86-107.
Book Section	【総論Ⅰ. 老年医学の基礎知識/4. 高齢者の臓器の特徴と機能評価】E. 内分泌機能.	西尾理恵, 綿田裕孝.	（編集）滝口裕一, 磯部威, 津橋由佳里.	高齢者がん治療エビデンス&プラクティス	南江堂, 2021; 37-41.
Book Section	【迷わないための基礎知識II　救急診療に必要な解剖・生理・生化学的知識】検査のための基礎知識　糖・脂質代謝検査.	中島健一, 綿田裕孝.		救急医学	へるす出版, 2021; 881-886.
Book Section	第4次「対糖尿病戦略5ヵ年計画」.	綿田裕孝.	（編集）綿田裕孝, 荒木栄一, 山内敏正.	糖尿病最新の治療2022-2024	南江堂, 2021; 1-4.

2020年

Reference Type	タイトル	著者	編集者	媒体名	出版情報
Book Section	メタボリックシンドローム.	加賀英義, 田村好史.	（監修）富野康日己.	診察基本手技マニュアル	医歯薬出版, 2020; 30-31.
Book Section	不妊治療中１型糖尿病患者におけるisCGM（FreeStyle リブレ）＋CSⅡによるコントロール改善.	常見亜佐子, 池田富貴.	（編集）小出景子, 渥美義仁.	いま読んでおきたい！血糖データの活かし方	南山堂, 2020; 280-287.
Book Section	HbA1c－治療目標としての価値と展望－.	綿田裕孝.	（編集）小出景子, 渥美義仁.	いま読んでおきたい！血糖データの活かし方	南山堂, 2020; 20-26.
Book Section	運動療法.	田村好史.	日本糖尿病学会.	糖尿病専門医研修ガイドブック（改訂第8版）	診断と治療社, 2020; 220-224.
Book Section	境界型とメタボリックシンドローム.	綿田裕孝.	日本糖尿病学会.	糖尿病専門医研修ガイドブック（改訂第8版）	診断と治療社, 2020; 179-180.
Book Section	肝疾患.	綿田裕孝.	日本糖尿病学会.	糖尿病専門医研修ガイドブック（改訂第8版）	診断と治療社, 2020; 426-428.
Book Section	4 低血糖症.	綿田裕孝, 後藤広昌.		新臨床内科学(第10版)	医学書院, 2020; 754-758.
Book Section	GLP-1 受容体作動薬(毎日投与)の使い方.	綿田裕孝, 若林侑香.	（編著）寺内康夫, 白川純.	血糖管理のための糖尿病治療薬活用マニュアル	中外医学社, 2020; 135-141.

2019年

Reference Type	タイトル	著者	編集者	媒体名	出版情報
Book Section	血糖降下薬による治療（インスリンを除く）.	佐藤淳子, 三田智也, 綿田裕孝.	日本糖尿病学会.	糖尿病診療ガイドライン2019	南江堂, 2019; 69-91.
Book Section	14.糖尿病合併症の療養指導　「5足病変・フットケア」.	佐藤博亮.	（編集）寺内康夫, 白川純.	糖尿病療養指導グリーンノート	中外医学社, 2019; 363-365.
Book Section	14.糖尿病合併症の療養指導　「6高血圧」.	佐藤博亮.	（編集）寺内康夫, 白川純.	糖尿病療養指導グリーンノート	中外医学社, 2019; 366-368.
Book Section	16.特殊な状況での療養指導「3震災時や災害時の療養指導」.	佐藤博亮.	（編集）寺内康夫, 白川純.	糖尿病療養指導グリーンノート	中外医学社, 2019; 425-427.
Book Section	合併症時の運動療法.	田村好史.	（編集）門脇孝, 荒木栄一, 綿田裕孝.	糖尿病最新の治療2019-2021	南江堂, 2019; 104-106.
Book Section	運動で血糖値が下がるしくみ.	田村好史.	（編集）細井雅之.	糖尿病ケア2019年春季増刊　病気のしくみ・合併症・治療による変化がわかる　糖尿病の病態生理イラスト図鑑	メディカ出版, 2019; 188-191.
Book Section	運動療法.	田村好史.	（編集）日本糖尿病学会.	糖尿病診療ガイドライン2019	南江堂, 2019; 57-68.
Book Section	運動とメタボリックシンドローム.	田村好史.	（編集）田城孝雄, 内藤久士.	健康長寿のためのスポートロジー〔改訂版〕	一般財団法人放送大学教育振興会, 2019; 68-78.
Book Section	運動と糖尿病.	田村好史.	（編集）田城孝雄, 内藤久士.	健康長寿のためのスポートロジー〔改訂版〕	一般財団法人放送大学教育振興会, 2019; 79-93.